<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Mac OS X version 5.4.0" />
<title>FORM 10-Q</title>
</head>
<body style=
"FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; MARGIN-TOP:0px; COLOR:#000000">

<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b>UNITED STATES</b></p>
<p style="MARGIN:0px" align="center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>
<p style="MARGIN:0px" align="center">Washington, D.C. 20549</p>
<p style="MARGIN:0px"><br /></p>
<p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><b>FORM
10-Q</b></p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="21"></td>
<td width="28"></td>
<td width="646"></td>
</tr>
<tr>
<td width="697" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(Mark One)</p>
</td>
</tr>
<tr>
<td width="21" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-FAMILY:'Wingdings'; MARGIN:0px" align="center">þ</p>
</td>
<td width="28" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"></p>
</td>
<td width="646" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b>For the quarterly period
ended March&nbsp;31, 2018</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">OR</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="22"></td>
<td width="29"></td>
<td width="646"></td>
</tr>
<tr>
<td width="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-FAMILY:'Wingdings'; MARGIN:0px" align="center">o</p>
</td>
<td width="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="646" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">For the transition period from
<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>
to
<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b>Commission file number:
001-35285</b></p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="188"></td>
<td width="320"></td>
<td width="188"></td>
</tr>
<tr>
<td width="188" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="320" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><b>Vaxart,
Inc.</b></p>
</td>
<td width="188" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
<tr>
<td width="188" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="320" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(Exact Name of Registrant as
Specified in its Charter)</p>
</td>
<td width="188" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="33"></td>
<td width="324"></td>
<td width="31"></td>
<td width="285"></td>
<td width="33"></td>
</tr>
<tr>
<td width="33" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="324" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><b>Delaware</b></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="285" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><b>59-1212264</b></p>
</td>
<td width="33" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
<tr>
<td width="33" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="324" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(State or other jurisdiction
of incorporation or organization)</p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="285" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(IRS Employer Identification
No.)</p>
</td>
<td width="33" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="35"></td>
<td width="324"></td>
<td width="27"></td>
<td width="278"></td>
<td width="41"></td>
</tr>
<tr>
<td width="35" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="324" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><b>290 Utah Ave., Suite 200,
South San Francisco</b>, <b>CA</b></p>
</td>
<td width="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="278" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><b>94080</b></p>
</td>
<td width="41" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
<tr>
<td width="35" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="324" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(Address of principal
executive offices)</p>
</td>
<td width="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="278" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(Zip Code)</p>
</td>
<td width="41" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="201"></td>
<td width="295"></td>
<td width="201"></td>
</tr>
<tr>
<td width="201" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="295" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><b>(650) 550-3500</b></p>
</td>
<td width="201" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
<tr>
<td width="201" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
<td width="295" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(Registrant<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s telephone
number, including area code)</p>
</td>
<td width="201" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Indicate by check mark
whether the registrant (1)&nbsp;has filed all reports required to
be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12&nbsp;months (or for such shorter
period that the registrant was required to file such reports), and
(2)&nbsp;has been subject to such filing requirements for the past
90&nbsp;days.&nbsp;&nbsp;Yes&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">þ</font>&nbsp;&nbsp;&nbsp;No&nbsp;<font style="FONT-FAMILY:'Wingdings'">¨</font></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Indicate by check mark
whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of
Regulation S-T during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such
files).&nbsp;&nbsp;Yes&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">þ</font>&nbsp;&nbsp;&nbsp;No&nbsp;<font style="FONT-FAMILY:'Wingdings'">¨</font></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company, or
an emerging growth company. See the definitions of <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>large
accelerated filer,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>accelerated filer<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> and
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>smaller reporting company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> and
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>emerging growth company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> in
Rule&nbsp;12b-2 of the Exchange Act.</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="411"></td>
<td width="286"></td>
</tr>
<tr>
<td width="411" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Large accelerated filer&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">¨</font></p>
</td>
<td width="286" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Accelerated filer&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">¨</font></p>
</td>
</tr>
<tr>
<td width="411" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Non-accelerated filer&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">¨</font>&nbsp;(Do not check if a smaller
reporting company)</p>
</td>
<td width="286" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Smaller reporting company&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">þ</font></p>
</td>
</tr>
<tr>
<td width="411" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Emerging growth company <font style=
"FONT-FAMILY:'Wingdings'">¨</font></p>
</td>
<td width="286" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">If an emerging growth
company, indicate by check mark if the registrant has elected not
to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. <font style=
"FONT-FAMILY:'Wingdings'"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman"><font face=
"Wingdings">o</font></font></font></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Indicate by check mark
whether the registrant is a shell company (as defined in
Rule&nbsp;12b-2 of the Exchange
Act).&nbsp;&nbsp;&nbsp;Yes&nbsp;<font style=
"FONT-FAMILY:'Wingdings'">o</font>&nbsp;&nbsp;&nbsp;No&nbsp;<font style="FONT-FAMILY:'Wingdings'">þ</font></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px">The Registrant had 7,141,189 shares of common
stock, $0.10 par value, outstanding as of May&nbsp;11, 2018.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><br />
<br /></p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px; always:"><br /></p>
<p style="MARGIN:0px; PADDING-RIGHT:48px" align="center"><b>FORM
10-Q</b></p>
<p style="MARGIN:0px; PADDING-RIGHT:48px" align="center"><b>FOR THE
QUARTER ENDED MARCH 31, 2018</b></p>
<p style="MARGIN:0px; PADDING-RIGHT:48px" align="center">
<b><a name="TOC" id="TOC">TABLE OF CONTENTS</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<table width="765" bordercolor="transparent" style=
"FONT-SIZE:10pt; WIDTH:765px; MARGIN-TOP:0px" cellpadding="0"
cellspacing="0" align="center">
<tr style="FONT-SIZE:0px">
<td width="83"></td>
<td width="15"></td>
<td width="64"></td>
<td width="444"></td>
<td width="31"></td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="525" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center">Page</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#FI">Part I</a></p>
</td>
<td width="525" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#FI">FINANCIAL INFORMATION</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#FS">Item 1.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#FS">Financial Statements
(Unaudited)</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">1</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br />
&nbsp;</p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#BS">Condensed Consolidated Balance
Sheets</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">1</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#IS">Condensed Consolidated
Statements of Operations and Comprehensive Income (Loss)</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">2</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#STOCK">Condensed Consolidated
Statement of Stockholders’ Equity (Deficit)</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">3</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br />
&nbsp;</p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">&nbsp;</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#CASH">Condensed Consolidated
Statements of Cash Flows</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">4</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#NOTE">Notes to the Condensed
Consolidated Financial Statements</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">6</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#MDNA">Item 2.</a></p>
</td>
<td width="484" style=
"WIDTH:484px; VERTICAL-ALIGN:top; MARGIN-TOP:0px; PADDING-BOTTOM:0px; TEXT-ALIGN:left; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
align="left" valign="top">
<p style="MARGIN:0px"><a href="#MDNA">Management’s Discussion and
Analysis of Financial Condition and Results of</a>&nbsp;<a href=
"#MDNA">Operations</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">28</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#QA">Item 3</a>.</p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#QA">Quantitative and Qualitative
Disclosures About Market Risk</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">34</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#C&amp;P">Item 4.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#C&amp;P">Controls and
Procedures</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">35</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#OI">Part II</a></p>
</td>
<td width="525" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#OI">OTHER INFORMATION</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#LAW">Item 1.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#LAW">Legal Proceedings</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">36</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#RISK">Item 1A.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#RISK">Risk Factors</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">36</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#SALE">Item 2.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#SALE">Unregistered Sales of Equity
Securities and Use of Proceeds</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">73</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#DEF">Item 3.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#SALE">Defaults Upon Senior
Securities</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">73</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#MINE">Item 4.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#MINE">Mine Safety
Disclosures</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">73</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#OIN">Item 5.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#OIN">Other Information</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">73</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#EXH">Item 6.</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#EXH">Exhibits</a></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">74</p>
</td>
</tr>
<tr>
<td width="83" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
</tr>
<tr>
<td width="163" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><a href="#SIGN">SIGNATURES</a></p>
</td>
<td width="444" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="31" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:9px" align="right">77</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><br />
<br /></p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p>&nbsp;</p>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px; always:">&nbsp;</p>
<p style="MARGIN:0px" align="center"><b><a name="FI" id="FI">PART I
FINANCIAL INFORMATION</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b><a name="FS" id=
"FS">Item&nbsp;1.&nbsp;&nbsp;Financial Statements
(Unaudited)</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b>VAXART, INC. AND
SUBSIDIARIES</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b><a name="BS" id=
"BS">Condensed Consolidated Balance Sheets</a></b></p>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>(In
thousands, except share and per share amounts)</b></p>
<p style="MARGIN:0px"><br /></p>
<table width="980" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr style="HEIGHT:10.6pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:10.6pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt 12pt" align=
"center"></p>
</td>
<td width="15%" colspan="2" style=
"BORDER-TOP:0px; HEIGHT:10.6pt; BORDER-RIGHT:0px; WIDTH:15.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style=
"FONT-SIZE:8pt">March&nbsp;31,&nbsp;2018</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:10.6pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="14%" colspan="2" style=
"BORDER-TOP:0px; HEIGHT:10.6pt; BORDER-RIGHT:0px; WIDTH:14.18%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style=
"FONT-SIZE:8pt">December&nbsp;31,&nbsp;2017</font></b></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:10.6pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt 12pt" align=
"center"><b><u><font style=
"FONT-SIZE:10pt">Assets</font></u></b></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">(Unaudited)</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:windowtext 1pt solid; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Current assets:</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">Cash and cash equivalents</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">17,495</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,571</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">Short-term investments</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,415</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">Accounts receivable, net of allowance</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">13,349</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">630</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">Prepaid expenses and other current
assets</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,052</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">137</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 24pt"><font style=
"FONT-SIZE:10pt">Total current assets</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">31,896</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,753</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Property and equipment, net</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,014</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">730</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Intangible assets, net</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">23,627</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">40</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 45.35pt; TEXT-INDENT:-9pt">
<font style="FONT-SIZE:10pt">Total assets</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">56,537</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">4,523</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><u><font style="FONT-SIZE:10pt">Liabilities and Stockholders’
Equity (Deficit)</font></u></b></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Current liabilities:</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">Accounts payable</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,744</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,390</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12.25pt"><font style=
"FONT-SIZE:10pt">Current portion of secured promissory note payable
to Oxford Finance</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,667</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,528</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt; COLOR:black">Short-term note payable</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">214</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt"><font style=
"FONT-SIZE:10pt">L<font style="COLOR:black">iability related to
sale of future royalties, current portion</font></font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,037</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12.25pt"><font style=
"FONT-SIZE:10pt">Other accrued liabilities</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,139</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,605</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 24pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 23.75pt"><font style=
"FONT-SIZE:10pt">Total current liabilities</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">7,801</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">4,523</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Convertible promissory notes, long-term, related
parties</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">35,282</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">L<font style="COLOR:black">iability related to
sale of future royalties, net of current portion</font></font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">14,561</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Secured promissory note payable to Oxford Finance,
net of current portion</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,069</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,440</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Total liabilities</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">25,431</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">43,245</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt"><font style=
"FONT-SIZE:10pt">Commitments and contingencies
(Note&nbsp;10)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 24.65pt 0pt 26.55pt; TEXT-INDENT:-8.55pt">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 27.6pt 0pt 26.55pt; TEXT-INDENT:-8.55pt">
<font style="FONT-SIZE:10pt">Stockholders’ equity
(deficit):</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:0.45in">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 27.6pt 0pt 26.55pt; TEXT-INDENT:-8.55pt">
<font style="FONT-SIZE:10pt">Preferred Stock: $0.10 par value;
5,000,000 shares authorized; none issued and outstanding as of
March 31, 2018; 1,221,064 issued and outstanding as of
December&nbsp;31, 2017, with aggregate liquidation value of
$39,956</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:0.45in; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:23.85pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 27.6pt 0pt 26.55pt; TEXT-INDENT:-8.55pt">
<font style="FONT-SIZE:10pt">Common Stock: $0.10 par value;
200,000,000 shares authorized; <font style=
"COLOR:black">7,141,189</font> and 138,492 shares issued and
outstanding as of March 31, 2018 and December&nbsp;31, 2017,
respectively</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">714</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:23.85pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 27.6pt 0pt 26.55pt; TEXT-INDENT:-8.55pt">
<font style="FONT-SIZE:10pt">Additional paid-in capital</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">108,060</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">41,259</font></p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 26.55pt; TEXT-INDENT:-8.55pt">
<font style="FONT-SIZE:10pt">Accumulated deficit</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(77,668</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(79,982</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 45.35pt; TEXT-INDENT:-9pt">
<font style="FONT-SIZE:10pt">Total stockholders’ equity
(deficit)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">31,106</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(38,722</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr style="HEIGHT:11.5pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:67.66%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 2.15pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:13.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:1.28%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:12.9%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.5pt; BORDER-RIGHT:0px; WIDTH:0.94%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:11.95pt">
<td width="67%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:67.66%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-9pt"><font style=
"FONT-SIZE:10pt">Total liabilities and stockholders’ equity
(deficit)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="13%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:13.98%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">56,537</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:1.28%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:12.9%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">4,523</font></p>
</td>
<td style=
"BORDER-TOP:0px; HEIGHT:11.95pt; BORDER-RIGHT:0px; WIDTH:0.94%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">The accompanying notes are an
integral part of these unaudited condensed consolidated financial
statements.<br /></p>
<p style=
"FONT-SIZE:12pt; FONT-FAMILY:Courier New,Times New Roman; PADDING-LEFT:174px; MARGIN:0px; TEXT-INDENT:-2px"
align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">1</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p>&nbsp;<a href="#TOC">Table of Contents</a></p>
<p><b>VAXART, INC. AND SUBSIDIARIES</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b><a name="IS" id=
"IS">Condensed Consolidated Statements of Operations and
Comprehensive Income (Loss)</a></b></p>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>(In
thousands, except share and per share amounts)</b></p>
<p style="MARGIN:0px" align="center"><b>(Unaudited)</b></p>
<p style="MARGIN:0px"><br /></p>
<table width="1000" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="28%" colspan="5" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:28.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Three
Months&nbsp;Ended&nbsp;March&nbsp;31,</font></b></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2018</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:13.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2017</font></b></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">Revenue:</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt">Revenue from government contract</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">610</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,310</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt">Royalty revenue</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">893</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Total
revenue</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,503</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,310</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">Operating expenses:</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Research</font>
<font style="FONT-SIZE:10pt">and development</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,408</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,879</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">General</font>
<font style="FONT-SIZE:10pt">and administrative</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,010</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">678</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0.7pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 1in"><font style=
"FONT-SIZE:10pt">Total operating expenses</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5,418</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">4,557</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0.7pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 102pt"><font style=
"FONT-SIZE:10pt">Operating loss</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(3,915</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,247</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Other
income and (expenses):</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Bargain purchase
gain</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">6,988</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Interest</font>
<font style="FONT-SIZE:10pt">income</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">13</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Interest</font>
<font style="FONT-SIZE:10pt">expense</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(437</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(744</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt; COLOR:black">Non-cash interest expense on
liability related to sale of future royalties</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(298</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt; COLOR:black">(Loss) gain on revaluation of
financial instruments</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(3</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">182</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Foreign exchange gain,
net</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 1in"><font style=
"FONT-SIZE:10pt">Total other income and (expenses)</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">6,257</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(549</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt">Net income (<font style=
"COLOR:black">loss) before income taxes</font></font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,342</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,796</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr style="HEIGHT:11.25pt">
<td width="68%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 71.5pt"><font style=
"FONT-SIZE:10pt">Provision for income taxes</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">28</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:11.25pt; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:13pt">
<td width="68%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt">Net income (<font style=
"COLOR:black">loss)</font></font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,314</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,796</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">Series&nbsp;B and C preferred
dividend</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(339</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(710</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt">Net comprehensive income (loss)
attributable to common stockholders</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,975</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(3,506</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Net
income (loss) per share – basic</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">0.54</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(25.84</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Net
income (loss) per share - diluted</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">0.49</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(25.84</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Shares
used to compute net income (loss) per share - basic</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,656,360</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">135,658</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.56%; BORDER-BOTTOM:0px; PADDING-BOTTOM:2.05pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Shares
used to compute net income (loss) per share - diluted</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:2.05pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.56%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.64%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5,299,751</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:2.05pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.2%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">135,658</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1%; BORDER-BOTTOM:0px; PADDING-BOTTOM:2.05pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">The accompanying notes are an
integral part of these unaudited condensed consolidated financial
statements.</p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px" align="center">2<br /></p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px" align="center"><br />
&nbsp;</p>
<p style="FONT-SIZE:11pt; MARGIN:0px" align="center"><b><a name=
"STOCK" id="STOCK">Condensed Consolidated Statement of
Stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> Equity
(Deficit)</a></b></p>
<p style="MARGIN:0px" align="center"><b>(In thousands, except share
amounts)</b></p>
<p style="MARGIN:0px" align="center"><b>(Unaudited)</b></p>
<p style="MARGIN:0px"><br /></p>
<table width="1018" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="10%" colspan="2" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
rowspan="3" align="right" valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="right">
<b><font style="FONT-SIZE:8pt">Additional</font></b></p>
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="right">
<b><font style="FONT-SIZE:8pt">Paid-in</font></b></p>
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="right">
<b><font style="FONT-SIZE:8pt">Capital</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
rowspan="3" valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Total</font></b></p>
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Stockholders’</font></b></p>
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">(Deficit) Equity</font></b></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt">&nbsp;</p>
</td>
<td width="20%" colspan="4" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20.02%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt -0.7pt" align=
"center"><b><font style=
"FONT-SIZE:8pt">Preferred&nbsp;Stock</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="20%" colspan="4" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:20%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Common&nbsp;Stock</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="10%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
rowspan="2" valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Accumulated</font></b></p>
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Deficit</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt -0.7pt" align=
"center"><b><font style="FONT-SIZE:8pt">Shares</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="10%" colspan="2" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt -0.7pt" align=
"center"><b><font style="FONT-SIZE:8pt">Amount</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Shares</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="10%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Amount</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Balances as of
January&nbsp;1,&nbsp;2018</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">1,221,064</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt"><font size="2">$</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">1</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">138,492</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">41,259</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(79,982)</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(38,722)</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Issuance of common stock upon conversion of
convertible promissory notes, related parties</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,571,702</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">157</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">35,420</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">35,577</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Issuance of common stock upon conversion of
&nbsp;convertible</font></p>
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; preferred
stock</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">(1,221,064)</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">(1)</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">1,918,543</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">192</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">(191)</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Reclassification of warrant to equity</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">—</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">70</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">70</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Issuance of common stock upon <font style=
"COLOR:black">reverse merger</font></font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">3,510,439</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">365</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">31,403</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">31,768</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Issuance of common stock upon exercise of stock
options</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">2,013</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">—</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">13</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">13</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Stock-based compensation</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">86</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">86</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 12pt; TEXT-INDENT:-12pt"><font style=
"FONT-SIZE:10pt">Net income</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size="2">—
</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,314</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,314</font></p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
</tr>
<tr style="PAGE-BREAK-INSIDE:avoid">
<td width="22%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:22%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 19.4pt; TEXT-INDENT:-7.9pt">
<font style="FONT-SIZE:10pt">Balances as of
March&nbsp;31,&nbsp;2018</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt"><font size="2">$</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt -0.7pt" align=
"right"><font size="2">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">7,141,189</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt; COLOR:black">714</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt -0.7pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
align="right" valign="bottom">
<p style="MARGIN:0in 0in 0pt" align="right"><font size=
"2">108,060</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(77,668)</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:left; MARGIN:0in 0in 0pt" align="left">
<font size="2">$</font></p>
</td>
<td width="8%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:8%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">31,106</font></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">The accompanying notes are an
integral part of these unaudited condensed consolidated financial
statements.</p>
<p style="MARGIN:0px" align="center"><br />
<br /></p>
<p style="MARGIN:0px" align="center">3</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<b>VAXART, INC. AND SUBSIDIARIES</b>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b><a name="CASH" id=
"CASH">Condensed Consolidated Statements of Cash Flows</a></b></p>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>(In
thousands)</b></p>
<p style="MARGIN:0px" align="center"><b>(Unaudited)</b></p>
<p style="MARGIN:0px" align="center"><br /></p>
<table width="979" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 9.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt"
align="center">&nbsp;</p>
</td>
<td width="25%" colspan="5" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:25.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center"><b><font style="FONT-SIZE:8pt">Three
Months&nbsp;Ended&nbsp;March&nbsp;31,</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 9.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt"
align="center">&nbsp;</p>
</td>
<td width="11%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center"><b><font style="FONT-SIZE:8pt">2018</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
<td width="11%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.86%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center"><b><font style="FONT-SIZE:8pt">2017</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 9.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt"
align="center">&nbsp;</p>
</td>
<td width="11%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
<td width="11%" colspan="2" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.86%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:center; MARGIN:0in 0in 0pt"
align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash flows from operating
activities:</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:right; MARGIN:0in 0in 0pt"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:right; MARGIN:0in 0in 0pt"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Net income
(loss)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">$</font></p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">2,314</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">$</font></p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(</font><font style=
"FONT-SIZE:10pt">2,796</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Adjustments to reconcile
net income (loss) to net cash used in operating
activities:</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Bargain purchase
gain</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(6,988</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Depreciation and
amortization</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">511</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">97</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Stock-based
compensation</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">86</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">124</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Amortization of discount
on short-term investments</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">5</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Loss (gain) on
revaluation of financial instruments</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">3</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(181</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest
expense</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">323</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">651</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Amortization of note
discount</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">18</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">36</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Non-cash interest expense
related to sale of future royalties</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">298</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 27pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Change in operating
assets and liabilities:</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Accounts
receivable</font><font style="FONT-SIZE:10pt">, net of
allowance</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">1,947</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(770</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Prepaid expenses and
other assets</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(469</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(187</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Accounts
payable</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(3,097</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(1,424</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Accrued
liabilities</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(5,536</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">169</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 81.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 81.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Net cash used in
operating activities</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(10,590</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(4,276</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash flows from investing
activities:</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Purchase of property and
equipment</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(140</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(79</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash acquired in reverse
merger</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">25,525</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash paid for fractional
shares in merger</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(21</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Purchases of short-term
investments</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(573</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(4,430</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Proceeds from maturities
of short-term investments</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">1,988</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">3,665</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 63.35pt; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Net cash provided by
(used in) investing activities</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">26,779</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:right; MARGIN:0in 0in 0pt"
align="right">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(844</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 63.35pt; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; TEXT-ALIGN:right; MARGIN:0in 0in 0pt"
align="right">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash flows from financing
activities:</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Repayment of principal
on</font> <font style="FONT-SIZE:10pt">secured promissory note
payable to Oxford Finance</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(278</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"MARGIN:0in 0in 0pt 45.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Proceeds from issuance of
common stock upon exercise of stock options</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">13</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 63.35pt; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Net cash used in
financing activities</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(265</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style="FONT-SIZE:10pt; COLOR:black">—
</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 63.35pt; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Net increase (decrease)
in cash and cash equivalents</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">15,924</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">(5,120</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">)</font></p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents
at beginning of the period</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">1,571</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">8,405</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 11.5pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right">&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="72%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:72.08%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt 27.35pt; TEXT-AUTOSPACE:; TEXT-INDENT:-9.35pt">
<font style="FONT-SIZE:10pt; COLOR:black">Cash and cash equivalents
at end of the period</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">$</font></p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">17,495</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.26%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt; COLOR:black">$</font></p>
</td>
<td width="10%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:"
align="right"><font style=
"FONT-SIZE:10pt; COLOR:black">3,285</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="PAGE-BREAK-AFTER:avoid; MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">The accompanying notes are an
integral part of these unaudited condensed consolidated financial
statements.</p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">4<br /></p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px" align="center"><b>Condensed Consolidated
Statements of Cash Flows</b></p>
<p style="MARGIN:0px" align="center"><b>(In thousands)</b></p>
<p style="MARGIN:0px" align="center"><b>(Unaudited)</b></p>
<p style="MARGIN:0px" align="center"><br /></p>
<table width="979" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr style="FONT-SIZE:0px">
<td width="451"></td>
<td width="13"></td>
<td width="7"></td>
<td width="66"></td>
<td width="13"></td>
<td width="7"></td>
<td width="66"></td>
<td width="12"></td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="162" colspan="5" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Three
Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="74" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="74" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="74" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="74" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:15px; MARGIN:0px; TEXT-INDENT:-12px">
<b>Supplemental disclosure of cash flow information:</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="451" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:36px; MARGIN:0px; TEXT-INDENT:-12px">
Interest paid</p>
</td>
<td width="13" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="16" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="16" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">95</p>
</td>
<td width="13" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="16" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="16" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">57</p>
</td>
<td width="12" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<table width="979" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr style="FONT-SIZE:0px">
<td width="451"></td>
<td width="13"></td>
<td width="7"></td>
<td width="66"></td>
<td width="13"></td>
<td width="7"></td>
<td width="66"></td>
<td width="12"></td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:15px; MARGIN:0px; TEXT-INDENT:-12px">
<b>Supplemental disclosure of non-cash financing activity:</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:35px; MARGIN:0px; TEXT-INDENT:-12px">
Issuance of common stock upon reverse merger, net of cash paid for
partial shares</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">31,768</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="451" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:35px; MARGIN:0px; TEXT-INDENT:-12px">
Conversion of convertible promissory notes, related parties into
common stock upon reverse merger</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">35,577</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="451" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:36px; MARGIN:0px; TEXT-INDENT:-12px">
Reclassification of convertible preferred stock warrant liability
to equity</p>
</td>
<td width="13" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">70</p>
</td>
<td width="13" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="451" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:35px; MARGIN:0px; TEXT-INDENT:-12px">
Acquisition of property and equipment included in accounts
payable</p>
</td>
<td width="13" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">72</p>
</td>
<td width="13" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="66" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">The accompanying notes are an
integral part of these unaudited condensed consolidated financial
statements.</p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br />
<br /></p>
<p style="MARGIN:0px" align="center">5</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p align="center"><b>VAXART, INC. AND SUBSIDIARIES</b></p>
<p align="center"></p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px" align="center"><b><a name="NOTE" id=
"NOTE">Notes to the Condensed Consolidated Financial Statements
(Unaudited)</a></b></p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px"><b>NOTE 1.&nbsp;&nbsp;Organization and Basis
of Presentation</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt"><i>General&nbsp;</i></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Vaxart Biosciences, Inc. was
originally incorporated in California in March&nbsp;2004, under the
name West Coast Biologicals, Inc. The Company changed its name to
Vaxart, Inc. (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>Private
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font>) in July&nbsp;2007, and reincorporated in the state of
Delaware.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">On February 13,&nbsp;2018,
Private Vaxart completed a business combination with Aviragen
Therapeutics, Inc. (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>), pursuant
to which Aviragen merged with Private Vaxart, with Private Vaxart
surviving as a wholly-owned subsidiary of Aviragen (the
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Merger<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). Pursuant
to the terms of the Merger, Aviragen changed its name to Vaxart,
Inc. (together with its subsidiaries, the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”<font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif; COLOR:black'>&nbsp;or
“Vaxart”</font></font>) and Private Vaxart changed its name to
Vaxart Biosciences, Inc. All of Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
convertible promissory notes and convertible preferred stock was
converted into common stock, following which each share of common
stock was converted into approximately 0.22148 shares of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock (the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Conversion<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). Except as
otherwise noted in these Financial Statements, all shares, equity
securities and per share amounts of Private Vaxart are presented to
give retroactive effect to the Conversion.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Immediately following the
completion of the Merger, the Company effected a reverse stock
split at a ratio of one new share for every eleven shares of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock outstanding (the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>Reverse
Stock Split<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). Except as
otherwise noted in these Financial Statements, all share, equity
security and per share amounts are presented to give retroactive
effect to the Reverse Stock Split.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Immediately after the Reverse
Stock Split there were approximately 7.1&nbsp;million shares of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock outstanding. Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
stockholders, warrantholders and optionholders owned approximately
51% of the fully-diluted common stock of the Company, with
Aviragen<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s stockholders and optionholders immediately prior to the
Merger owning approximately 49% of the fully-diluted common stock
of the Company. The Company also assumed all of Private
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s outstanding stock options and warrants with proportionate
adjustments to the number of underlying shares and exercise prices
based on an exchange ratio, based on the combined impact of the
Conversion and the Reverse Stock Split, of approximately 0.0201346
shares of the Company for each share of Private Vaxart.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s principal
operations are based in South San Francisco, California, and it
operates in one&nbsp;reportable segment, which is the discovery and
development of oral recombinant protein vaccines, based on its
proprietary oral vaccine platform, and small-molecule antiviral
drugs.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt"><i>Liquidity and Going
Concern</i></p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt" align="justify"><br /></p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">Since incorporation, the Company has been involved
primarily in performing research and development activities, hiring
personnel, and raising capital to support these activities. The
Company has experienced losses and negative cash flows from
operations since its inception. As of March&nbsp;31, 2018, the
Company had an accumulated deficit of $77.7&nbsp;million and a loan
with an outstanding balance of $4.7 million from Oxford Finance,
LLC (<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Oxford Finance<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>), repayable
in monthly installments by the end of 2020 (see Note 9).</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">The Company expects to incur increasing costs as
research and clinical trials are advanced and, therefore, expects
to continue to incur losses and negative operating cash flows for
the next several years. Absent additional funding or adjustments to
currently planned operating activities, and in view of the
uncertainties regarding future royalty revenue on sales of
Relenza<sup>®</sup> and Inavir<sup>®</sup>, management believes
that the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s cash, cash
equivalents and short-term investments, together with funds
acquired from Aviragen through the Merger, are only sufficient to
fund the Company into the first quarter of 2019.</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">The Company reviews its operations and clinical
plans on a continuing basis and has not yet entered into any
commitments for its upcoming clinical trials. The Company plans to
finance its operations with royalty revenue on sales of
Relenza<sup>®</sup> and Inavir<sup>®</sup>, additional equity or
debt financing arrangements, revenue from its contract with the
Department of Health and Human Services, Office of Biomedical
Advanced Research and Development Authority (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>HHS
BARDA<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font>), and potentially with additional funding from government
contracts or strategic alliances with partner companies. The
availability and amount of such funding is not certain.</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">The uncertainties inherent in the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s future operations and in its ability to obtain additional
funding raise substantial doubt about its ability to continue as a
going concern beyond one year from the date these financial
statements are issued. The financial statements do not include any
adjustments that might result from the outcome of this
uncertainty.</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:2pt"
align="center">6</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:2pt"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">While management believes its plan to raise
additional funds will alleviate the conditions that raise
substantial doubt, these plans are not entirely within its control
and cannot be assessed as being probable of occurring.&nbsp; If
adequate funds are not available, the Company may be required to
reduce operating expenses, delay or reduce the scope of its product
development programs, obtain funds through arrangements with others
that may require the Company to relinquish rights to certain of its
technologies or products that the Company would otherwise seek to
develop or commercialize itself, or cease operations.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px"><b>NOTE 2.&nbsp;&nbsp;Summary of Significant
Accounting Policies</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Basis of
Presentation</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company has prepared the accompanying condensed consolidated
financial statements pursuant to the rules and regulations of the
Securities and Exchange Commission (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>SEC<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). Certain
information and footnote disclosures normally included in
consolidated financial statements prepared in accordance with
accounting principles generally accepted in the United States of
America (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>U.S.
GAAP<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font>) have been condensed or omitted pursuant to these rules and
regulations. These condensed consolidated financial statements
should be read in conjunction with the audited financial statements
of Vaxart Biosciences, Inc. and footnotes related thereto for the
year ended December&nbsp;31, 2017, included in our Form&nbsp;8-K/A
filed with the SEC on April 2, 2018. In the opinion of management,
the unaudited condensed consolidated financial statements include
all adjustments (consisting only of normal recurring adjustments)
necessary to present fairly the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s financial
position and the results of its operations and cash flows. The
results of operations for such interim periods are not necessarily
indicative of the results to be expected for the full year.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Basis of
Consolidation</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
condensed consolidated financial statements include the financial
statements of Vaxart, Inc. and its subsidiaries. All significant
transactions and balances between Vaxart, Inc. and its subsidiaries
have been eliminated in consolidation.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Use of
Estimates</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect
the reported amounts of assets, liabilities, revenues and expenses
and disclosure of contingent assets and liabilities in the
financial statements and accompanying notes. Actual results and
outcomes could differ from these estimates and assumptions.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Foreign
Currencies</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Foreign exchange gains and losses for assets and
liabilities of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s non-U.S.
subsidiaries for which the functional currency is the U.S. dollar
are recorded in foreign exchange gain (loss), net in the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s statement of operations and comprehensive income (loss).
The Company has no subsidiaries for which the local currency is the
functional currency.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Cash and Cash
Equivalents</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company considers all highly liquid debt investments with an
original maturity of three months or less when purchased to be cash
equivalents. Cash equivalents, which may consist of amounts
invested in money market funds, corporate bonds and commercial
paper, are stated at fair value.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Short-Term
Investments</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s short term investments have only comprised commercial
paper and corporate bonds. The short term investments are
classified as held to maturity based on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s positive
intent and ability to hold the securities to maturity. This
classification is reevaluated at each balance sheet date. Short
term investments are stated at amortized cost, adjusted for
amortization of premiums and accretion of discounts to maturity.
Such amortization is presented as interest income in the statement
of operations and comprehensive income (loss). The specific
identification method is used to determine the realized gain or
loss on securities sold or otherwise disposed. When the fair value
of a debt security classified as held to maturity is less than its
amortized cost, the Company assesses whether or not: (i)&nbsp;it
has the intent to sell the security or (ii)&nbsp;it is more likely
than not that the Company will be required to sell the security
before its anticipated recovery. If either of these conditions is
met, the Company must recognize an other than temporary impairment
through earnings for the difference between the debt
security<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s amortized cost basis and its fair value. Gains and losses
are recognized in earnings when the investments are sold or
impaired.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt" align="justify">
<b>Concentration of Credit Risk</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Financial instruments that potentially subject the
Company to significant concentrations of credit risk consist
principally of cash, cash equivalents, short-term investments and
accounts receivable. The Company places its cash, cash equivalents
and shortterm investments at financial institutions that management
believes are of high credit quality. The Company is exposed to
credit risk in the event of default by the financial institutions
holding the cash and cash equivalents to the extent such amounts
are in excess of the federally insured limits. The Company has not
experienced any losses on its deposits since inception.</p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The primary focus of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s investment strategy is to preserve capital and meet
liquidity requirements. The Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s investment
policy addresses the level of credit exposure by limiting the
concentration in any one&nbsp;corporate issuer or sector and
establishing a minimum allowable credit rating. The Company
generally requires no collateral from its customers.</p>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">7</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>Accounts
Receivable</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Accounts receivable arise from the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s royalty
revenue receivable for sales, net of estimated returns, of
Inavir<sup>®</sup> and Relenza<sup>®</sup>, and from its contract
with HHS BARDA (see Note 6), and are reported at amounts expected
to be collected in future periods. An allowance for uncollectible
accounts will be recorded based on a combination of historical
experience, aging analysis, and information on specific accounts,
with related amounts not recorded as a reserve against revenue
recognized. Account balances will be written off against the
allowance after all means of collection have been exhausted and the
potential for recovery is considered remote.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Property and
Equipment</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Property and equipment is carried at cost less
accumulated depreciation. Depreciation is computed using the
straight-line method over the estimated useful lives of the
respective assets. Depreciation begins at the time the asset is
placed in service. Maintenance and repairs are charged to
operations as incurred. Upon sale or retirement of assets, the cost
and related accumulated depreciation are removed from the balance
sheet and the resulting gain or loss is reflected in other income
and (expenses) in the period realized.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The useful lives of the
property and equipment are as follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table width="100%" bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="242"></td>
<td></td>
</tr>
<tr>
<td width="242" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:48px; MARGIN:0px" align="justify">Laboratory
equipment</p>
</td>
<td style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="justify">5 years</p>
</td>
</tr>
<tr>
<td width="242" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:48px; MARGIN:0px" align="justify">Office and
computer equipment</p>
</td>
<td style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="justify">3 years</p>
</td>
</tr>
<tr>
<td width="242" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:48px; MARGIN:0px" align="justify">Leasehold
improvements</p>
</td>
<td style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="justify">Shorter of remaining lease
term or estimated useful life</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Intangible
Assets</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Intangible assets comprise developed technology,
in-process research and development and intellectual property and
are carried at cost less accumulated amortization. Amortization is
computed using the straight-line method over useful lives ranging
from 1.3 to 11.75 years for developed technology and 20&nbsp;years
for intellectual property. In-process research and development is
considered to be indefinite-lived and is not amortized.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Impairment of Long-Lived
Assets</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company reviews its long lived assets, including property and
equipment and intangible assets, for impairment whenever events or
changes in circumstances indicate the carrying amount of these
assets may not be recoverable. Recoverability of these assets is
measured by comparison of the carrying amount of each asset to the
future undiscounted cash flows the asset is expected to generate
over its remaining life. When indications of impairment are present
and the estimated undiscounted future cash flows from the use of
these assets is less than the assets<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> carrying
value, the related assets will be written down to fair value. There
have been no impairments of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s long lived
assets for the periods presented.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Accrued Clinical and
Manufacturing Expenses</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company accrues for estimated costs of research and development
activities conducted by third party service providers, which
include the conduct of preclinical studies and clinical trials, and
contract manufacturing activities. The Company records the
estimated costs of research and development activities based upon
the estimated amount of services provided but not yet invoiced and
includes these costs within other accrued liabilities in the
balance sheets and within research and development expense in the
condensed consolidated statements of operations and comprehensive
income (loss). These costs are a significant component of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s research and development expenses.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company estimates the
amount of services provided through discussions with internal
personnel and external service providers as to the progress or
stage of completion of the services and the agreed-upon fee to be
paid for such services. The Company makes significant judgments and
estimates in determining the accrued balance in each reporting
period. As actual costs become known, it adjusts its accrued
estimates. Although the Company does not expect its estimates to be
materially different from amounts actually incurred, its
understanding of the status and timing of services performed, the
number of subjects enrolled, and the rate of enrollment may vary
from its estimates and could result in the Company reporting
amounts that are too high or too low in any particular period. The
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s accrued expenses are dependent, in part, upon the receipt
of timely and accurate reporting from contract research
organizations and other third-party service providers. To date, the
Company has not experienced any material differences between
accrued costs and actual costs incurred.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Convertible Preferred
Stock Warrant Liability</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company has issued certain convertible preferred stock warrants.
These warrants were recorded within other accrued liabilities in
the balance sheets at fair value due to down round protection
features contained in the convertible preferred stock into which
the warrants are exercisable. At the end of each reporting period,
changes in fair value of the warrants since the prior period were
recorded as a component of gain (loss) on revaluation of financial
instruments in the condensed consolidated statements of operations
and comprehensive income (loss). In the event that the terms of the
warrant change such that liability accounting is no longer
required, the fair value on the date of such change is released to
equity.</p>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">8</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>Convertible Promissory
Notes Embedded Derivative Liability</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company recorded derivative instruments related to redemption
features embedded within the outstanding convertible promissory
notes. The embedded derivatives were accounted for as liabilities
at their estimated fair value when the convertible promissory notes
were issued and were re measured to fair value as of each balance
sheet date, with the related re-measurement adjustment being
recognized as a component of gain (loss) on revaluation of
financial instruments in the condensed consolidated statements of
operations and comprehensive income (loss).</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Revenue
Recognition</b><font style=
"FONT-SIZE:12pt">&nbsp;</font><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company recognizes revenue when its customer obtains control of
promised goods or services, in an amount that reflects the
consideration which the Company expects to receive in exchange for
those goods or services. To determine revenue recognition, the
Company performs the following five steps:</p>
<p style=
"FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:72px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(i)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:72px; TEXT-INDENT:-2px"
align="justify">identification of the promised goods or services in
the contract;</p>
<p style=
"FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:72px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
(ii)</p>
<p style=
"MARGIN-BOTTOM:6px; MARGIN-TOP:0px; PADDING-LEFT:72px; TEXT-INDENT:-2px"
align="justify">determination of whether the promised goods or
services are performance obligations including whether they are
distinct in the context of the contract;</p>
<p style=
"FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:72px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
(iii)</p>
<p style=
"MARGIN-BOTTOM:6px; MARGIN-TOP:0px; PADDING-LEFT:72px; TEXT-INDENT:-2px"
align="justify">measurement of the transaction price, including the
constraint on variable consideration;</p>
<p style=
"FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:72px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
(iv)</p>
<p style=
"MARGIN-BOTTOM:6px; MARGIN-TOP:0px; PADDING-LEFT:72px; TEXT-INDENT:-2px"
align="justify">allocation of the transaction price to the
performance obligations based on estimated selling prices; and</p>
<p style=
"FONT-SIZE:12pt; MARGIN-BOTTOM:-2px; WIDTH:72px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
(v)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:72px; TEXT-INDENT:-2px"
align="justify">recognition of revenue when (or as) the Company
satisfies each performance obligation. A performance obligation is
a promise in a contract to transfer a distinct good or service to
the customer and is the unit of account.</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; CLEAR:left" align=
"justify">Revenue from royalties earned as a percentage of sales,
including milestone payments based on achieving a specified level
of sales, where a license is deemed to be the predominant item to
which the royalties relate, is recognized as revenue at the later
of (i) when the related sales occur, or (ii) when the performance
obligation to which some or all of the royalty has been allocated
has been satisfied (or partially satisfied).</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">The Company performs research and development work
under its cost plus fixed fee contract with HHS BARDA. The Company
recognizes revenue under research contracts only when a contract
has been executed and the contract price is fixed or determinable.
<font style="COLOR:#212121">Revenue from the HHS BARDA contract is
recognized in the period during which the related costs are</font>
<font style="COLOR:#212121">incurred</font> <font style=
"COLOR:#212121">and the related services are rendered, provided
that the applicable conditions under the contract have been met.
Costs of contract revenue are recorded as a component of operating
expenses in the</font> condensed <font style=
"COLOR:#212121">consolidated statements of operations</font> and
comprehensive income (loss)<font style="COLOR:#212121">.</font></p>
<p style="MARGIN:0px" align="justify">Under the cost reimbursable
contract with HHS BARDA, the Company is reimbursed for allowable
costs, and recognizes revenue as allowable costs are incurred and
the fixed fee is earned. Reimbursable costs under the contract
primarily include direct labor, subcontract costs, materials,
equipment, travel, and approved overhead and indirect costs. Fixed
fees under cost reimbursable contracts are earned in proportion to
the allowable costs incurred in performance of the work relative to
total estimated contract costs, with such costs incurred
representing a reasonable measurement of the proportional
performance of the work completed. Under the HHS BARDA contract,
certain activities must be pre approved in order for their costs to
be deemed allowable direct costs. The HHS BARDA contract provides
the U.S.&nbsp;government the ability to terminate the contract for
convenience or to terminate for default if the Company fails to
meet its obligations as set forth in the statement of work.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Management believes that if
the government were to terminate the HHS BARDA contract for
convenience, the costs incurred through the effective date of such
termination and any settlement costs resulting from such
termination would be allowable costs. Payments to the Company under
cost reimbursable contracts, such as this contract, are provisional
payments subject to adjustment upon annual audit by the government.
Management believes that revenue for periods not yet audited has
been recorded in amounts that are expected to be realized upon
final audit and settlement. When the final determination of the
allowable costs for any year has been made, revenue and billings
may be adjusted accordingly in the period that the adjustment is
known.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Research and Development
Costs</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Research and development costs are expensed as
incurred. Research and development costs consist primarily of
salaries and benefits, stock based compensation, consultant fees,
third party costs for conducting clinical trials and the
manufacture of clinical trial materials, certain facility costs and
other costs associated with clinical trials. Payments made to other
entities are under agreements that are generally cancelable by the
Company. Advance payments for research and development activities
are recorded as prepaid expenses. The prepaid amounts are expensed
as the related services are performed.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">9</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>Stock-Based
Compensation</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;The
Company measures the fair value of all stock-based awards to
employees, including stock options, on the grant date and records
the fair value of these awards, net of estimated forfeitures, to
compensation expense over the service period. The fair value of
awards to nonemployees is measured on the date of performance at
the fair value of the consideration received or the fair value of
the equity instruments issued, whichever is more reliably measured.
The fair value of options is estimated using the Black-Scholes
valuation model.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Net Income (Loss) Per
Share Attributable to Common Stockholders</b>&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;Basic
net income (loss) per share is computed by dividing net income
(loss) by the weighted average number of common shares outstanding
during the period, without consideration of potential common
shares. The net loss attributable to common stockholders is
calculated by adjusting the net loss of the Company for the
cumulative dividends on the Series&nbsp;B and Series&nbsp;C
convertible preferred stock.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Diluted net income (loss) per
common share is computed giving effect to all potential dilutive
common shares, comprising common stock issuable upon exercise of
stock options and warrants. The Company uses the treasury-stock
method to compute diluted income (loss) per share with respect to
its stock options and warrants. For purposes of this calculation,
options and warrants to purchase common stock are considered to be
potential common shares and are only included in the calculation of
diluted net loss per share when their effect is dilutive. In the
event of a net loss, the effects of all potentially dilutive shares
are excluded from the diluted net loss per share calculation as
their inclusion would be antidilutive.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Recently Adopted
Accounting Pronouncements</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In May 2017, the FASB issued
ASU 2017-09, <i>Compensation - Stock Compensation (Topic 718):
Scope of Modification Accounting.</i> This update provides guidance
about which changes to the terms or conditions of a share-based
payment award require an entity to apply modification accounting in
Topic 718. This guidance is effective for annual periods beginning
after December 15, 2017, including interim periods within that
year, and must be applied prospectively to an award modified on or
after the adoption date. The Company adopted this standard
effective January 1, 2018, and its adoption had no effect on the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s financial condition or results of operations.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In January&nbsp;2017, the
FASB&nbsp;issued ASU No.&nbsp;2017 04 , <i>Intangibles Goodwill and
Other (Topic&nbsp;350) Simplifying the Test for Goodwill
Impairment</i>&nbsp;(<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>ASU&nbsp;2017 04<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>), which
will simplify the goodwill impairment calculation by eliminating
Step 2 from the current goodwill impairment test. The new standard
does not change how a goodwill impairment is identified. The
standard will be effective January&nbsp;1, 2020, with early
adoption permitted, and is to be applied prospectively from the
date of adoption. The Company adopted this standard effective
January 1, 2018, and its adoption had no effect on the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s financial condition or results of operations.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In January&nbsp;2017, the
FASB&nbsp;issued ASU No.&nbsp;2017 01, <i>Business Combinations
(Topic&nbsp;805) Clarifying the Definition of a
Business</i>&nbsp;(<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>ASU&nbsp;2017 01<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>), which
will simplify the goodwill impairment calculation by eliminating
Step 2 from the current goodwill impairment test. The new standard
clarifies the definition of a business to help companies evaluate
whether acquisition or disposal transactions should be accounted
for as asset groups or as businesses. The Company adopted this
standard when it became effective on January 1, 2018, and its
adoption had no effect on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s financial
condition or results of operations, although it was applied in the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s determination that the Merger should be accounted for as a
business combination.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In August 2016, the FASB
issued Accounting Standards Update (ASU) 2016-15, <i>Statement of
Cash Flows (Topic 230): Classification of Certain Cash Receipts and
Cash Payments</i>, which provides additional guidance on the
presentation and classification of certain items in the statement
of cash flows. The standard is effective for fiscal years beginning
after December&nbsp;15, 2017, with early adoption permitted. The
Company adopted this standard effective January 1, 2018, and its
adoption had no effect on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s financial
condition or results of operations.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In May&nbsp;2014, the FASB
issued ASU&nbsp;2014 09, <i>Revenue from Contracts with Customers
(Topic&nbsp;606)</i>, which supersedes nearly all existing revenue
recognition guidance under Topic&nbsp;605, <i>Revenue</i>
<i>Recognition</i>. The new standard requires a company to
recognize revenue when it transfers goods and services to customers
in an amount that reflects the consideration that the company
expects to receive for those goods or services. ASU&nbsp;2014 09
defines a five step process that includes identifying the contract
with the customer, identifying the performance obligations in the
contract, determining the transaction price, allocating the
transaction price to the performance obligations in the contract
and recognizing revenue when (or as) the entity satisfies the
performance obligations. In July&nbsp;2015, the FASB&nbsp;approved
a one year deferral of the effective date of the new standard to
2018 for public companies, with an option that would permit
companies to adopt the new standard as early as the original
effective date of 2017.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">10</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify">The Company has <font style=
"COLOR:#212121">determined that its HHS BARDA government contract
is not within the scope of ASU 2014-09 as the government entity is
not a customer under the agreement.</font> The Company adopted this
standard with respect to its royalty revenue using the modified
retrospective method on January&nbsp;1, 2018. Under the modified
retrospective transition method, the cumulative effect of applying
the standard is recognized at the date of initial application for
all contracts not completed as of the date of adoption. The
adoption of ASU&nbsp;2014 09&nbsp;did not have any effect on the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s financial condition or results of operations and therefore
no cumulative effect adjustment was recorded, although the Company
has modified its accounting policies to reflect the requirements of
this standard and make additional disclosures.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Recent Accounting
Pronouncements</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In February&nbsp;2016, the
FASB&nbsp;issued ASU&nbsp;2016 02 <i>Leases (Topic&nbsp;842)</i>,
which replaces most current lease guidance when it becomes
effective. This standard update intends to increase the
transparency and improve comparability by requiring entities to
recognize assets and liabilities on the balance sheet for all
leases, with certain exceptions. The new standard states that a
lessee will recognize a lease liability for the obligation to make
lease payments and a right-of-use asset for the right to use the
underlying asset for the lease term. Leases will be classified as
either finance or operating, with classification affecting the
pattern of expense recognition in the statements of operations. The
new guidance will be effective for the Company starting in the
first quarter of fiscal 2019, with early adoption permitted. The
Company plans to adopt the new guidance effective January&nbsp;1,
2019, using the modified retrospective method. The adoption will
have no impact on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s statements
of operations or cash flows but will increase both its reported
assets and reported liabilities in equal amounts that have not yet
been quantified.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company has reviewed all
other significant newly-issued accounting pronouncements and
concluded that they either are not applicable to the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s operations or no material effect is expected on its
condensed consolidated financial statements as a result of future
adoption.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px"><b>NOTE 3.&nbsp;&nbsp;Business
Combination</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">On February&nbsp;13, 2018,
the Company acquired Aviragen in a reverse merger (see
Note&nbsp;1). Aviragen presently has in-process research and
development as it is currently conducting a Phase 2 trial, it has
previously developed drugs that were licensed to others who brought
them to market and it has a workforce that is considered to have
the necessary skills, knowledge, and experience to perform a
process, that when applied to the in-process research and
development is critical to the ability to convert it into outputs.
Based on this evaluation, the Company determined that the Merger
should be accounted for as a business combination.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Since the date of the Merger,
the results of Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s operations
have been included in the condensed consolidated financial
statements. As a result of the acquisition, the Company eliminated
the majority of its debt and acquired a significant cash balance in
exchange for equity securities.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The total purchase price for
Aviragen is summarized as follows (in thousands):</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="536"></td>
<td width="12"></td>
<td width="7"></td>
<td width="76"></td>
<td width="6"></td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Common stock</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">31,789</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Total</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">31,789</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="center">11</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px" align="justify"><a href="#TOC">Table of
Contents</a></p>
<p style="MARGIN:0px" align="justify"><br />
&nbsp;</p>
<p style="MARGIN:0px" align="justify">In connection with the
Aviragen acquisition, the Company allocated the total purchase
consideration to the net assets and liabilities acquired, including
identifiable intangible assets, based on their respective fair
values at the acquisition date.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The following table
summarizes the preliminary allocation of the purchase price to the
fair value of the respective assets and liabilities acquired (in
thousands):</p>
<p style=
"FONT-SIZE:12pt; FONT-FAMILY:Courier New,Times New Roman; PADDING-LEFT:174px; MARGIN:0px; TEXT-INDENT:-2px"
align="justify">&nbsp;</p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="536"></td>
<td width="12"></td>
<td width="7"></td>
<td width="76"></td>
<td width="6"></td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Cash and cash
equivalents</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">25,525</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Accounts receivable</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">14,666</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Prepaid expenses</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">446</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Property and equipment</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">170</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Intangible assets:</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">Developed technology
<sup>(1)</sup></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">22,400</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">In-process research and
development <sup>(2)</sup></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,600</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px">Total assets</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">64,807</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Accounts payable</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">(3,379</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Other current
liabilities</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(6,351</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Liability related to sale
of future royalties</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">(16,300</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px">Net assets acquired</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">38,777</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Purchase price</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(31,789</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Bargain purchase gain
<sup>(3)</sup></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">6,988</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify">__________</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:24px; MARGIN-TOP:0px; FLOAT:left">
(1)</p>
<p style="PADDING-LEFT:24px; MARGIN:0px; TEXT-INDENT:-2px" align=
"justify">Developed technology comprises Inavir<sup>®</sup> and
Relenza<sup>®</sup>, both influenza vaccines on which the Company
is presently receiving royalty revenue, which, based on preliminary
valuations, are being amortized on a straight-line basis over the
estimated periods of future royalties of 11.75 and 1.3 years,
respectively.</p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:24px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left">
(2)</p>
<p style="PADDING-LEFT:24px; MARGIN:0px; TEXT-INDENT:-2px" align=
"justify">In-process research and development relates to
teslexivir, or BTA074, a direct-acting antiviral that is being
developed as a treatment for genital warts and is presently
undergoing Phase 2 clinical trials. The preliminary valuation was
prepared by an independent third party based on estimated
discounted cash flows based on probability-weighted future
development expenditures and revenue streams provided by the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s management.</p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:24px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left">
(3)</p>
<p style="PADDING-LEFT:24px; MARGIN:0px; TEXT-INDENT:-2px" align=
"justify">The bargain purchase gain represents the excess of a
preliminary valuation of the fair value of tangible and identified
intangible assets, less liabilities, acquired over the purchase
price.</p>
<p style="CLEAR:left; MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="center">12</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="justify">In addition, the Company
incurred and expensed costs directly related to the Merger totaling
approximately $1.4 million, of which approximately $0.5 million was
incurred in the three months ended March&nbsp;31, 2018, and is
included in general and administrative expenses in the condensed
consolidated statement of operations and comprehensive income
(loss). The Company is in the process of gathering the information
necessary to evaluate the tax impact of the acquisition, including
the treatment of the bargain purchase gain<font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'>, and to
finalize the discount rate and underlying assumptions utilized in
the valuation of the intangible assets acquired</font>. The Company
expects to complete its evaluation of the impact, if any, during
fiscal 2018.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Selected amounts related to
Aviragen<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s business included in the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s condensed
consolidated statement of operations for the three months ended
March&nbsp;31, 2018, are as follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="536"></td>
<td width="12"></td>
<td width="7"></td>
<td width="76"></td>
<td width="6"></td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Revenue</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">893,000</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="536" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px; TEXT-INDENT:-24px">Net
loss</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(362,000</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px">)</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The unaudited pro forma
information in the table below summarizes the combined results of
operations of Vaxart Biosciences, Inc. with those of Aviragen as
though these entities were combined as of January&nbsp;1, 2017. The
results of Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s business
for the three months ended March&nbsp;31, 2017, are based on the
actual unaudited financial statements prepared for the three months
ended March&nbsp;31, 2017, and for the three months ended
March&nbsp;31, 2018, are based on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s results of
operations, <font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif; COLOR:black'>increased
by</font> Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s activities
in the forty-three days prior to the closing of the Merger. The pro
forma financial information for all periods presented also includes
the removal of direct acquisition-related costs, the reduction in
interest expense on borrowing converted into equity in the reverse
merger, and the actual depreciation and amortization that would
have been charged assuming the fair value adjustments to property
and equipment and intangible assets had been applied as of
January&nbsp;1, 2017. This unaudited pro forma information is
summarized as follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="401"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="5"></td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="191" colspan="5" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Three
Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="89" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="89" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center">&nbsp;</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center">&nbsp;</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center">&nbsp;</p>
</td>
<td width="183" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"PADDING-LEFT:24px; MARGIN:0px; PADDING-RIGHT:4px; TEXT-INDENT:-18px">
Total revenue</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">13,039</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">7,176</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="401" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"PADDING-LEFT:24px; MARGIN:0px; PADDING-RIGHT:4px; TEXT-INDENT:-18px">
Net income (loss)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,899</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(7,915)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="FONT-FAMILY:inherit,Times New Roman; MARGIN:0px">The pro
forma financial information as presented above is for informational
purposes only and is not indicative of the consolidated results of
operations of future periods or the results of operations that
would have been achieved had the acquisition had taken place on
January&nbsp;1, 2017.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">13</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>NOTE 4.&nbsp;&nbsp;Fair
Value of Financial Instruments</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">Fair value accounting is applied for all financial
assets and liabilities and nonfinancial assets and liabilities that
are recognized or disclosed at fair value in the financial
statements on a recurring basis (at least annually). Financial
instruments include cash and cash equivalents, short-term
investments, accounts receivable, accounts payable and accrued
liabilities that approximate fair value due to their relatively
short maturities. As shortterm investments are classified as
held-to-maturity, they are recorded at their amortized cost.</p>
<p style="MARGIN-BOTTOM:11px; MARGIN-TOP:0px; LINE-HEIGHT:12pt"
align="justify">Assets and liabilities recorded at fair value on a
recurring basis in the balance sheets are categorized based upon
the level of judgment associated with inputs used to measure their
fair values. The accounting guidance for fair value provides a
framework for measuring fair value and requires certain disclosures
about how fair value is determined. Fair value is defined as the
price that would be received to sell an asset or paid to transfer a
liability (an exit price) in an orderly transaction between market
participants at the reporting date. The accounting guidance also
establishes a three-level valuation hierarchy that prioritizes the
inputs to valuation techniques used to measure fair value based
upon whether such inputs are observable or unobservable. Observable
inputs reflect market data obtained from independent sources, while
unobservable inputs reflect market assumptions made by the
reporting entity.</p>
<p style="MARGIN:0px" align="justify">The three-level hierarchy for
the inputs to valuation techniques is briefly summarized as
follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="PADDING-LEFT:48px; MARGIN:0px; PADDING-RIGHT:0px" align=
"justify">Level&nbsp;1&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;Inputs
are unadjusted, quoted prices in active markets for identical
assets or liabilities at the measurement date;</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="PADDING-LEFT:48px; MARGIN:0px; PADDING-RIGHT:0px" align=
"justify">Level&nbsp;2&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>&nbsp;Inputs
are observable, unadjusted quoted prices in active markets for
similar assets or liabilities, unadjusted quoted prices for
identical or similar assets or liabilities in markets that are not
active, or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the
related assets or liabilities; and</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="PADDING-LEFT:48px; MARGIN:0px; PADDING-RIGHT:0px" align=
"justify">Level&nbsp;3&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–
</font>&nbsp;Unobservable inputs that are significant to the
measurement of the fair value of the assets or liabilities that are
supported by little or no market data.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s money
market funds are classified within Level&nbsp;1 of the fair value
hierarchy and are valued based on quoted prices in active markets
for identical securities. The Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s corporate
bonds and commercial paper, classified as cash equivalents, are
classified within Level&nbsp;2 of the fair value hierarchy and are
valued based on quoted prices for similar assets or prices derived
from observable market data. Level&nbsp;3 liabilities consist of
convertible promissory notes embedded derivative liabilities and a
convertible preferred stock warrant liability as they are valued by
using inputs that are unobservable in the market. The determination
of the fair values of the convertible promissory notes embedded
derivative is discussed in Note 8.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The following tables present
the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s financial
assets and liabilities that are measured at fair value at March 31,
2018 and December&nbsp;31, 2017:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="290"></td>
<td width="13"></td>
<td width="8"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="10"></td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="72" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;1</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;2</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;3</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><b>March&nbsp;31, 2018</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="148" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Recurring Financial Assets:</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">Money
Market Funds</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:78px; MARGIN:0px; TEXT-INDENT:-19px">
Corporate Bonds</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px; TEXT-INDENT:-18px">Total
assets</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="290"></td>
<td width="13"></td>
<td width="8"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="48"></td>
<td width="22"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="10"></td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="72" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;1</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;2</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;3</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><b>March&nbsp;31, 2018</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="148" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Recurring Financial Liabilities:</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">
Convertible promissory notes embedded derivative liability</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:78px; MARGIN:0px; TEXT-INDENT:-19px">
Convertible preferred stock warrant liability</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="22" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px; TEXT-INDENT:-18px">Total
liabilities</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="22" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">14</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="290"></td>
<td width="13"></td>
<td width="8"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="10"></td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="72" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;1</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;2</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;3</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><b>December&nbsp;31, 2017</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="148" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Recurring Financial Assets:</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">Money
Market Funds</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:78px; MARGIN:0px; TEXT-INDENT:-19px">
Corporate Bonds</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px; TEXT-INDENT:-18px">Total
assets</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="290"></td>
<td width="13"></td>
<td width="8"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="10"></td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="72" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;1</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;2</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Level&nbsp;3</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><b>December&nbsp;31, 2017</b></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="148" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Recurring Financial Liabilities:</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">
Convertible promissory notes embedded derivative liability</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:78px; MARGIN:0px; TEXT-INDENT:-19px">
Convertible preferred stock warrant liability</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">67</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">67</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="290" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:96px; MARGIN:0px; TEXT-INDENT:-18px">Total
liabilities</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">67</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">67</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The following tables present
a reconciliation of all liabilities measured at fair value on a
recurring basis using significant unobservable inputs
(Level&nbsp;3) for the three months ended March&nbsp;31, 2018 and
2017:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="295"></td>
<td width="17"></td>
<td width="9"></td>
<td width="75"></td>
<td width="17"></td>
<td width="8"></td>
<td width="75"></td>
<td width="17"></td>
<td width="12"></td>
<td width="17"></td>
<td width="8"></td>
<td width="45"></td>
<td width="7"></td>
<td width="22"></td>
<td width="7"></td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="22" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="295" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Convertible</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="12" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Convertible
Promissory</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Preferred
Stock</b></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Notes
Embedded</b></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Warrant
Liability</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="12" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Derivative
Liability</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="7" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="13" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="13" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Balance at January&nbsp;1, 2018</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">67</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">67</p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Issuances</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Revaluation loss included in (loss)&nbsp;gain&nbsp;on revaluation
of financial instruments, net</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="29" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="29" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3</p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Settlements</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">(70</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">)</p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">(70</p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">
Balance at March&nbsp;31, 2018</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Total gains included in other income and (expenses) attributable to
liabilities still held as of March&nbsp;31, 2018</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="29" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="29" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="295"></td>
<td width="17"></td>
<td width="9"></td>
<td width="75"></td>
<td width="17"></td>
<td width="8"></td>
<td width="75"></td>
<td width="17"></td>
<td width="12"></td>
<td width="17"></td>
<td width="8"></td>
<td width="45"></td>
<td width="7"></td>
<td width="22"></td>
<td width="7"></td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="22" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="295" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Convertible</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="12" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Convertible
Promissory</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Preferred
Stock</b></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Notes
Embedded</b></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="13" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Warrant
Liability</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="114" height="12" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Derivative
Liability</b></p>
</td>
<td width="17" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="84" height="12" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Total</b></p>
</td>
<td width="7" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="13" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="17" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="13" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="7" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Balance at January&nbsp;1, 2017</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">134</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3,280</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3,414</p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Issuances</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Revaluation gains included in (loss) gain&nbsp;on revaluation of
financial instruments, net</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">(32</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">)</p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="29" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">(150</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">)</p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="29" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">(182</p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Settlements</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">
Balance at March&nbsp;31, 2017</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">102</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3,130</p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">3,232</p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="105" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="75" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="7" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="295" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style=
"FONT-SIZE:9pt; PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Total gains included in other income and (expenses) attributable to
liabilities still held as of March&nbsp;31, 2017</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">32</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="105" height="29" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">150</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">$</p>
</td>
<td width="75" height="29" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="right">182</p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">15</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px"><b>NOTE&nbsp;5.&nbsp;&nbsp;Balance Sheet
Components</b></p>
<p style="MARGIN:0px"><br /></p>
<p style=
"FONT-SIZE:10pt; MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(a)</p>
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-2px">
<b><i>Cash Equivalents and Short Term Investments</i></b></p>
<p style="CLEAR:left; MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Cash equivalents and
short term investments, all of which are classified as held to
maturity securities and mature within one year, consisted of the
following:</p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="205"></td>
<td width="11"></td>
<td width="7"></td>
<td width="56"></td>
<td width="11"></td>
<td width="10"></td>
<td width="61"></td>
<td width="11"></td>
<td width="6"></td>
<td width="62"></td>
<td width="11"></td>
<td width="8"></td>
<td width="56"></td>
<td width="11"></td>
<td width="6"></td>
<td width="58"></td>
<td width="3"></td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="380" colspan="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>March 31,
2018</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gross</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gross</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Estimated</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="63" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Amortized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Unrecognized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Unrecognized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Fair</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Carrying</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="63" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Cost</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gains</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Losses</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Value</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Value</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px">(in thousands)</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Money market funds</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Corporate bonds</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Total</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="3" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">Reported as:</p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="3" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Cash equivalents</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Short-term investments</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Total</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">5,600</p>
</td>
<td width="3" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="205"></td>
<td width="11"></td>
<td width="7"></td>
<td width="56"></td>
<td width="11"></td>
<td width="10"></td>
<td width="61"></td>
<td width="11"></td>
<td width="6"></td>
<td width="62"></td>
<td width="11"></td>
<td width="8"></td>
<td width="56"></td>
<td width="11"></td>
<td width="6"></td>
<td width="58"></td>
<td width="3"></td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="380" colspan="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>December 31,
2017</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gross</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gross</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Estimated</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="63" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Amortized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Unrecognized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Unrecognized</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Fair</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Carrying</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="63" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Cost</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Gains</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="69" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Losses</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="65" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Value</b></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Value</b></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px">(in thousands)</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Money market funds</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Corporate bonds</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Total</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="11" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="3" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">Reported as:</p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="11" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="3" height="27" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Cash equivalents</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,192</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Short-term investments</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="61" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="62" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="56" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="58" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,415</p>
</td>
<td width="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="205" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px">Total</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="61" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="62" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="8" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="56" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="11" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="58" height="23" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,607</p>
</td>
<td width="3" height="23" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(b)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
<b><i>Accounts Receivable, Net of Allowance</i></b></p>
<p style="CLEAR:left; MARGIN:0px">Accounts receivable, net of
allowance, comprises the following:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="341"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="17"></td>
<td width="7"></td>
<td width="84"></td>
<td width="5"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="88" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>March&nbsp;31,&nbsp;2018</b></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>December&nbsp;31,&nbsp;2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom"></td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom"></td>
<td width="198" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Royalties receivable</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">11,939</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Government contract - billed</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">230</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom"></td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">477</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Government contract - unbilled</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p align="right">112</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top"></td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">153</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom"></td>
</tr>
<tr>
<td><font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Tax credit receivable</font></td>
<td></td>
<td style="BORDER-BOTTOM:#000000 1px solid"></td>
<td style="BORDER-BOTTOM:#000000 1px solid">
<p align="right">1,068</p>
</td>
<td></td>
<td style="BORDER-BOTTOM:#000000 1px solid"></td>
<td style="BORDER-BOTTOM:#000000 1px solid">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—
&nbsp;&nbsp;</font></p>
</td>
<td></td>
</tr>
<tr>
<td width="341" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:90px; MARGIN:0px; TEXT-INDENT:-19px">
Accounts receivable, net of allowance</p>
</td>
<td width="12" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">13,349</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">630</p>
</td>
<td width="5" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">16</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(c)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
<b><i>Property and Equipment, Net</i></b></p>
<p style="CLEAR:left; MARGIN:0px">Property and equipment, net
consists of the following:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="374"></td>
<td width="13"></td>
<td width="7"></td>
<td width="84"></td>
<td width="9"></td>
<td width="7"></td>
<td width="84"></td>
<td width="6"></td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>March&nbsp;31,&nbsp;2018</b></p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>December&nbsp;31,&nbsp;2017</b></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="193" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Laboratory equipment</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,771</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,565</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Office
and computer equipment</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">296</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">175</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Leasehold improvements</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">281</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">226</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="374" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">Total property and
equipment</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,348</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,966</p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="374" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">Less:
accumulated depreciation</p>
</td>
<td width="13" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">(1,334</p>
</td>
<td width="9" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">)</p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">(1,236</p>
</td>
<td width="6" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">)</p>
</td>
</tr>
<tr>
<td width="374" height="26" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:76px; MARGIN:0px; TEXT-INDENT:-19px">
Property and equipment, net</p>
</td>
<td width="13" height="26" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="26" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" height="26" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,014</p>
</td>
<td width="9" height="26" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="26" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" height="26" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">730</p>
</td>
<td width="6" height="26" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Depreciation expense for the
three months ended March&nbsp;31, 2018 and 2017, was $98,000 and
$96,000, respectively.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(d)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
<b><i>Intangible Assets</i></b></p>
<p style="CLEAR:left; MARGIN:0px">Intangible assets consist of the
following:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="341"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="17"></td>
<td width="7"></td>
<td width="84"></td>
<td width="5"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="88" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>March&nbsp;31,&nbsp;2018</b></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>December&nbsp;31,&nbsp;2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="198" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Purchased technology</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">22,400</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
In-process research and development</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,600</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Intellectual property</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">80</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">80</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Total
cost</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">24,080</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">80</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Less
accumulated amortization</p>
</td>
<td width="12" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">453</p>
</td>
<td width="17" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" height="25" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">40</p>
</td>
<td width="5" height="25" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:90px; MARGIN:0px; TEXT-INDENT:-19px">
Intangible assets, net</p>
</td>
<td width="12" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">23,627</p>
</td>
<td width="17" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" height="29" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">40</p>
</td>
<td width="5" height="29" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Total amortization expense
was $413,000 and $1,000 in the three-month periods ended
March&nbsp;31, 2018 and 2017, respectively. As of March 31, 2018,
the estimated future amortization expense by year is as follows (in
thousands):</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="341"></td>
<td width="17"></td>
<td width="7"></td>
<td width="84"></td>
<td width="5"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>December&nbsp;31,&nbsp;2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">2018
(nine months remaining)</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,428</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
2019</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,254</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
2020</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,757</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
2021</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,758</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
2022</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,757</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:57px; MARGIN:0px; TEXT-INDENT:-19px">
Thereafter</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">12,073</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" height="24" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">Total</p>
</td>
<td width="17" height="24" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" height="24" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" height="24" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">22,027</p>
</td>
<td width="5" height="24" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
(e)</p>
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-2px">
<b><i>Accrued Liabilities</i></b></p>
<p style="CLEAR:left; MARGIN:0px"><br /></p>
<p style="MARGIN:0px">Accrued liabilities consist of the
following:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="341"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="17"></td>
<td width="7"></td>
<td width="84"></td>
<td width="5"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="88" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>March&nbsp;31,&nbsp;2018</b></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>December&nbsp;31,&nbsp;2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="198" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Accrued
compensation</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,076</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,320</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Accrued
clinical and manufacturing expenses</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">359</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">69</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Accrued
professional and consulting services</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">254</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">113</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Convertible preferred stock warrant liability</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">67</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Other</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">450</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">36</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">Total</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,139</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,605</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">17</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a><br /></p>
<p><b>NOTE&nbsp;6.&nbsp;&nbsp;Revenue</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><i>U.S. Government HHS BARDA Contract</i></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In September&nbsp;2015, HHS
BARDA awarded the Company a contract to support the advanced
development of a more effective and universal influenza vaccine to
improve seasonal and pandemic influenza preparedness. On each of
May&nbsp;25 and July 18, 2017, the Company entered into a
Modification of Contract with HHS BARDA, the combined effect being
to increase the value of the existing $14&nbsp;million contract by
$1.7&nbsp;million and to extend it through June 30, 2018. The
modified contract is a cost plus fixed fee contract, which
reimburses the Company for allowable direct contract costs plus
allowable indirect costs and a fixed fee, totaling
$15.7&nbsp;million. During the three months ended March 31, 2018
and 2017, the Company recognized revenue of $0.6&nbsp;million and
$2.3&nbsp;million, respectively. Billings under the contract are
based on approved provisional indirect billing rates, which permit
recovery of fringe benefits, overhead and general and
administrative expenses. Indirect rates as well as allowable costs
are subject to audit by HHS BARDA on an annual basis. Management
believes that revenues recognized to date have been recorded in
amounts that are expected to be realized upon final audit and
settlement. When the final determination of the allowable costs for
any year has been made, revenue and billings may be adjusted
accordingly in the period that the adjustments are known and
collection is probable. Costs relating to contract acquisition are
expensed as incurred.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company does not consider
any of the revenue recorded as of March 31, 2018 or 2017, to be at
risk of reversal.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Royalty agreements</i></p>
<p style="MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px" align="justify">Aviragen entered into a
royalty-bearing research and license agreement with
GlaxoSmithKline, plc (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>GSK<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) in 1990
for the development and commercialization of zanamivir, a
neuraminidase inhibitor (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>NI<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) marketed
by GSK as Relenza<sup>®</sup> to treat influenza. Most of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s Relenza<sup>®</sup> patents have expired and the only
substantial remaining intellectual property related to the
Relenza<sup>®</sup> patent portfolio, which is solely owned by the
Company and exclusively licensed to GSK, is scheduled to expire in
July 2019 in Japan. The post-Merger royalty revenue related to
Relenza<sup>®</sup> recognized in the three months ended March 31,
2018, was $341,000.</p>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="justify">The Company also generates
royalty revenue from the sale of Inavir<sup>®</sup> in Japan,
pursuant to a collaboration and license agreement that Aviragen
entered into with Daiichi Sankyo in 2009. In September 2010,
laninamivir octanoate was approved for sale by the Japanese
Ministry of Health and Welfare for the treatment of influenza in
adults and children, which Daiichi Sankyo markets as
Inavir<sup>®</sup>. Under the agreement, the Company currently
receives a 4% royalty on net sales of Inavir<sup>®</sup> in Japan
and was eligible to earn sales milestone payments, including a
one-off payment of $5.0 million if net sales exceeded 20 billion
Yen in one year. This target was achieved in the three months ended
March 31, 2018, prior to the Merger, and Aviragen recognized the
related $5.0 million as royalty revenue prior to the Merger. The
post-Merger royalty revenue related to Inavir<sup>®</sup>
recognized in the three months ended March 31, 2018, was $552,000.
Such royalty revenue is subject to a 5% withholding tax in Japan,
for which $28,000 was included in income tax expense.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Under the Inavir<sup>®</sup>
collaboration and license agreement, the Company and Daiichi Sankyo
have cross-licensed the world-wide rights to develop and
commercialize the related intellectual property, and have agreed to
share equally in any royalties, license fees, or milestone or other
payments received from any third-party licenses outside of Japan.
Patents on the composition of matter for LANI in Japan generally
expire in 2024.</p>
<p style="MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px" align="justify">In April 2016, Aviragen
entered into a Royalty Interest Acquisition Agreement (the
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>HCRP Agreement<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) with
HealthCare Royalty Partners III, L.P. (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>HCRP<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) (See Note
7). Under the Agreement, HCRP made a $20.0 million cash payment to
Aviragen in consideration for acquiring certain royalty rights
(<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Royalty Rights<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) related to
the approved product Inavir<sup>®</sup> in the Japanese market. The
Royalty Rights were obtained pursuant to the collaboration and
license agreements (the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>License
Agreement<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) and a
commercialization agreement that the Company entered into with
Daiichi Sankyo Company, Limited.</p>
<p style="MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px" align="center">18</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p><br /></p>
<p style="MARGIN:0px"><b>NOTE&nbsp;7. &nbsp;Liabilities Related to
Sale of Future Royalties</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">In April 2016, Aviragen sold
certain royalty rights related to the approved product Inavir®,
sold by Daiichi Sankyo in the Japanese market, for $20.0 million to
HCRP. Under the relevant accounting guidance, due to a limit on the
amount of royalties that HCRP can earn under the arrangement, this
transaction was accounted for as a liability that will be amortized
using the interest method over the life of the arrangement. The
Company has no obligation to pay any amounts to HCRP other than to
pass through to HCRP its share of royalties as they are received
from Daiichi Sankyo. In order to record the amortization of the
liability, the Company is required to estimate the total amount of
future royalty payments to be received under the License Agreement
and the payments that will be passed through to HCRP over the life
of this agreement. The sum of the pass-through amounts less the net
proceeds received will be recorded as non-cash interest expense
over the life of the liability. Consequently, the Company imputes
interest on the unamortized portion of the liability and records
non-cash interest expense using an estimated effective interest
rate. The Company will periodically assess the expected royalty
payments, and to the extent such payments are greater or less than
the initial estimate, the Company will adjust the amortization of
the liability and interest rate. As a result of this accounting,
even though the Company does not retain HCRP<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s share of
the royalties, it will continue to record non-cash revenue related
to those royalties until the amount of the associated liability and
related interest is fully amortized.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table shows the
activity within the liability account since the Merger (in
thousands):</p>
<p style="MARGIN:0px">&nbsp;</p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="449"></td>
<td width="13"></td>
<td width="12"></td>
<td width="81"></td>
<td width="7"></td>
</tr>
<tr>
<td width="449" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">Total
Liability related to sale of future royalties, February 13,
2018</p>
</td>
<td width="13" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">16,300</p>
</td>
<td width="7" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="449" height="19" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Non-cash interest expense recognized</p>
</td>
<td width="13" height="19" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" height="19" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="81" height="19" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff">
<p style="MARGIN:0px" align="right">298</p>
</td>
<td width="7" height="19" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="449" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:54px; MARGIN:0px">Total Liability related to
sale of future royalties, March 31, 2018</p>
</td>
<td width="13" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" height="22" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="22" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">16,598</p>
</td>
<td width="7" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b>NOTE&nbsp;8.&nbsp;&nbsp;Convertible
Promissory Notes, Related Parties</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">On December&nbsp;10, 2014,
the Company entered into a note purchase agreement with certain
existing preferred stockholders under which the Company issued
convertible promissory notes during December&nbsp;2014 for total
proceeds of $18.4&nbsp;million.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">On November&nbsp;20, 2015,
the Company entered into a second note purchase agreement with
certain existing preferred stockholders under which the Company
issued convertible promissory notes during November&nbsp;and
December&nbsp;2015 for total proceeds of $11.0&nbsp;million. These
notes were issued with the same terms as the notes issued in
2014.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">As the holders of the
convertible promissory notes each have an equity ownership in the
Company, the convertible promissory notes were considered to be a
related party transaction.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The convertible promissory
notes bore interest at a rate of 8.0% per annum. The principal and
accrued interest on the notes were automatically convertible, upon
a future issuance of convertible preferred stock having total
proceeds of at least $25.0&nbsp;million, into that same stock at a
conversion price equal to 90% of the price paid by other investors
in the financing event. Upon a liquidation event, such as an
acquisition or initial public offering, at the election of the
majority of the noteholders in each issuance, the principal and
accrued interest on the notes could either (i)&nbsp;be paid in full
at the initial closing of the liquidation event, or
(ii)&nbsp;automatically convert into the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
Series&nbsp;C convertible preferred stock at a conversion price
based on a specified valuation.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">After two&nbsp;years, if the
notes had not been converted, the holders of a majority of the
principal amount had the option to require the entire principal
balance and accrued interest to become due and payable. However, in
December&nbsp;2016, in conjunction with the loan agreement with
Oxford Finance (see note&nbsp;9), all of the holders of convertible
promissory notes signed subordination agreements, under which they
agreed not to demand or receive any payment until all amounts owed
to Oxford Finance under the loan agreement were fully paid in cash,
thus extending the due dates of the promissory notes potentially to
January 2021. This change reflected a debt modification that was
not considered substantially significant. Accordingly, the Company
did not apply extinguishment accounting, but accounted for the
modification on a prospective basis.</p>
<p style="MARGIN:0px" align="center">19<br /></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px" align="justify"><a href="#TOC">Table of
Contents</a></p>
<p style="MARGIN:0px" align="justify"><br />
&nbsp;</p>
<p style="MARGIN:0px" align="justify">The convertible promissory
notes had redemption features that were determined to be a compound
embedded derivative requiring bifurcation and separate accounting
at estimated fair value. The estimated fair value of the embedded
derivative upon issuance was a liability of $1.9&nbsp;million for
the notes issued in 2014 and $1.3&nbsp;million for the notes issued
in 2015. The estimated fair value of these derivative instruments
was recognized as a debt discount and as an embedded derivative
liability on the balance sheet upon issuance of the convertible
promissory notes. The embedded derivative required periodic re
measurements to fair value while the instruments were still
outstanding (see Note 4). There was no beneficial conversion
feature as the conversion feature value was accounted for in the
embedded derivative.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company estimated the
fair value of the compound embedded derivative utilizing a Monte
Carlo Simulation model. The inputs used to determine the estimated
fair value of the embedded derivative instrument included the
probability of an underlying event triggering the redemption event
and its timing prior to the maturity date of the convertible
promissory notes. The fair value measurement was based upon
significant inputs not observable in the market, including a
valuation of the Company performed by an independent third-party at
each balance sheet date. By December 31, 2017, the embedded
derivative had zero value because the Merger (see Note 1), which
was considered 90% probable of occurring, would not have triggered
redemption and, had the Merger not occurred, it was unlikely that
the Company would have found an alternative source of financing on
favorable terms, so there would have been zero redemption value.
The embedded derivative was extinguished when the Merger occurred
on February 13, 2018.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The Company incurred total
debt issuance costs of $20,000 in connection with the 2014 issuance
and $7,000 in connection with the 2015 issuance. The debt issuance
costs, which were recorded as an additional debt discount, were
being amortized over the term of the notes.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s accrued
interest associated with the convertible promissory notes amounted
to $6.3&nbsp;million and the unamortized debt discount to $0.4
million as of December&nbsp;31, 2017.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">On February&nbsp;13, 2018,
the balance of the convertible promissory notes was $35.6 million,
comprising accrued interest associated with the convertible
promissory notes amounted to $6.6&nbsp;million plus principal of
$29.4 million, offset by the unamortized debt discount to $0.4
million. On that date, in conjunction with the Merger, the
convertible promissory notes were exchanged for 1,571,702 shares of
the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s common
stock which, based on the closing stock price of $9.05, had a value
of $14.2 million. The difference of $21.4 million was recorded as a
capital contribution.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">20</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px"><b>NOTE&nbsp;9.&nbsp;&nbsp;Secured Promissory
Note Payable to Oxford Finance</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">On December&nbsp;22, 2016,
the Company entered into a loan and security agreement
(the&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>Loan
Agreement<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) with
Oxford Finance, under which the Company borrowed $5.0&nbsp;million.
The $5.0&nbsp;million loan, which bears interest at 30-day U.S.
LIBOR plus 6.17%, is evidenced by a secured promissory note and is
repayable over four&nbsp;years, with interest only payable over the
first 12 months and the balance fully amortized over the subsequent
36 months. The loan is secured by substantially all the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s assets, except for intellectual property.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In conjunction with the
execution of the Loan Agreement, all the holders of convertible
promissory notes signed subordination agreements, under which they
agreed to subordinate in favor of Oxford Finance all amounts due
under their promissory notes and any security interest in the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s property. In addition, the holders of the notes agreed
that they would not demand or receive any payment until all amounts
owed to Oxford Finance under the Loan Agreement have been fully
paid in cash. Upon repayment, an additional final payment equal to
$325,000 is due, which is being accreted as interest expense over
the term of the loan using the effective interest method.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In connection with the Loan
Agreement, the Company issued a warrant to Oxford Finance to
purchase 7,563&nbsp;shares of its Series&nbsp;C convertible
preferred stock at an exercise price of $33.11&nbsp;per share
(the&nbsp;<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Warrant<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). The fair
value of the Warrant at the date of issuance was approximately
$134,000, which was recorded as debt discount and is being
amortized as interest expense over the term of the loan using the
effective interest method. The annual effective interest rate of
the note, including the accretion of the final payment and the
amortization of the debt discount, is approximately 10.5%. The
Company recorded interest expense related to the Loan Agreement of
$130,000, of which $95,000 was paid, during the three months ended
March&nbsp;31, 2018, and $126,000, of which $57,000 was paid,
during the three months ended March 31, 2017.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The Warrant provided that if
the share price at the next equity financing was less than the
Warrant exercise price, then the Warrant would be for the new class
of shares, the exercise price would be the new class share price,
and the number of shares would be calculated by dividing $250,000
by the new class share price. Due to this anti-dilution protection,
the Company determined that the Warrant needed to be recorded as a
liability, and therefore estimated the fair value of the Warrant
upon issuance and at each balance sheet date, with any changes in
the fair value being recorded within the gain (loss) on revaluation
of financial instruments line in the statements of operations and
comprehensive income (loss).</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Due to the antidilution
protection, following the Merger, the Warrant was amended to allow
the holder to purchase 10,914 shares of common stock at an exercise
price of $22.99 per share. Since the amended Warrant contains no
non-standard antidilution protections or similar features, the fair
value of approximately $70,000 on February 13, 2018, was
transferred to equity.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="center">21</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>NOTE 10. &nbsp;Commitments
and Contingencies</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:60px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:36px">
(a)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:60px; TEXT-INDENT:-2px">
<b><i>Leases</i></b></p>
<p style="CLEAR:left; MARGIN:0px" align="justify">The Company has
leased four&nbsp;office and research and development facilities in
South San Francisco, California, under noncancelable operating
leases. The first lease, for office and research and development
premises, expired on July 31, 2017, following the
landlord<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s exercise of its six-month termination option on January
31, 2017. The second lease, for office and research and development
premises, expires in April&nbsp;2020, subject to the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s option to extend the lease at the then market rate for an
additional five year period. The third lease, for office premises,
was entered in May 2017 and has been extended until December 31,
2018. The fourth lease, for office premises, began in April 2018
and expires on December 31, 2018. In addition, following the
Merger, the Company also leases office space in Alpharetta,
Georgia, under a lease expiring on February 28, 2021. Rent expense
is recognized on a straight line basis over the noncancelable term
of each operating lease and, accordingly, the Company records the
difference between cash rent payments and the recognition of rent
expense as a deferred rent liability, which is included within
accrued expenses. Rent expense was $146,000 and $161,000 for the
three months ended March&nbsp;31, 2018 and 2017, respectively.
Under the terms of the lease agreements, the Company is also
responsible for certain insurance, property tax and maintenance
expenses. Future minimum payments under the facility leases as of
December 31, 2018 as follows (in thousands):</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="315"></td>
<td width="32"></td>
<td width="14"></td>
<td width="44"></td>
<td width="9"></td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">Year
ending December&nbsp;31,</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">2018 (9
months remaining)</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">548</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">
2019</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">568</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">
2020</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">411</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">
2021</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">56</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="PADDING-LEFT:16px; MARGIN:0px; TEXT-INDENT:-16px">
Thereafter</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="315" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="PADDING-LEFT:38px; MARGIN:0px; TEXT-INDENT:-16px">
Total</p>
</td>
<td width="32" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;&nbsp;</p>
</td>
<td width="14" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;$</p>
</td>
<td width="44" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,583</p>
</td>
<td width="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:60px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:36px">
(b)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:60px; TEXT-INDENT:-2px">
<b><i>Indemnifications</i></b></p>
<p style="CLEAR:left; MARGIN:0px" align="justify">In the ordinary
course of business, the Company enters into agreements that may
include indemnification provisions. Pursuant to such agreements,
the Company may indemnify, hold harmless and defend indemnified
parties for losses suffered or incurred by the indemnified party.
Some of the provisions will limit losses to those arising from
third party actions. In some cases, the indemnification will
continue after the termination of the agreement. The maximum
potential amount of future payments the Company could be required
to make under these provisions is not determinable. The Company has
never incurred material costs to defend lawsuits or settle claims
related to these indemnification provisions. The Company has also
entered into indemnification agreements with its directors and
officers that may require the Company to indemnify its directors
and officers against liabilities that may arise by reason of their
status or service as directors or officers to the fullest extent
permitted by Delaware corporate law. The Company currently has
directors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> and
officers<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font> insurance.</p>
<p style="MARGIN:0px"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:60px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:36px">
(c)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:60px; TEXT-INDENT:-2px">
<b><i>Litigation</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"justify">From time to time the Company may be involved in claims
arising in connection with its business. Based on information
currently available, the Company believes that the amount, or
range, of reasonably possible losses in connection with any pending
actions against it in excess of established reserves, in the
aggregate, not to be material to its consolidated financial
condition or cash flows. However, losses may be material to the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s operating results for any particular future period,
depending on the level of income or loss for such period.</p>
<p style="FONT-SIZE:9.5pt; MARGIN:0px">
<b>NOTE&nbsp;11.&nbsp;&nbsp;Stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>
Equity</b></p>
<p style="MARGIN:0px"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:60px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:36px">
(a)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:60px; TEXT-INDENT:-2px">
Convertible Preferred Stock</p>
<p style=
"MARGIN-BOTTOM:16px; MARGIN-TOP:0px; CLEAR:left; LINE-HEIGHT:12pt"
align="justify">The Company is authorized to issue 5,000,000 shares
of preferred stock, $0.10 par value per share. The
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s board of directors may, without further action by the
stockholders, fix the rights, preferences, privileges and
restrictions of up to an aggregate of 5,000,000 shares of preferred
stock in one or more series and authorize their issuance. These
rights, preferences and privileges could include dividend rights,
conversion rights, voting rights, terms of redemption, liquidation
preferences, sinking fund terms and the number of shares
constituting any series or the designation of such series, any or
all of which may be greater than the rights of our common stock.
The issuance of preferred stock could adversely affect the voting
power of holders of common stock and the likelihood that such
holders will receive dividend payments and payments upon
liquidation. In addition, the issuance of preferred stock could
have the effect of delaying, deterring or preventing a change of
control or other corporate action. No shares of preferred stock are
currently outstanding, and we have no present plan to issue any
shares of preferred stock.</p>
<p style="MARGIN:0px" align="center">22</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="FONT-SIZE:9.5pt; MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt" align="justify">All of
Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
convertible preferred stock was converted into common stock on
February 13, 2018, in conjunction with the Merger. As of
December&nbsp;31, 2017, convertible preferred stock consisted of
the following:</p>
<p style="MARGIN:0px; LINE-HEIGHT:12pt"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="100"></td>
<td width="17"></td>
<td width="98"></td>
<td width="17"></td>
<td width="97"></td>
<td width="21"></td>
<td width="21"></td>
<td width="78"></td>
<td width="21"></td>
<td width="21"></td>
<td width="81"></td>
</tr>
<tr>
<td width="100" height="51" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="51" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="51" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>Shares<br />
authorized</b></p>
</td>
<td width="17" height="51" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="97" height="51" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>Shares<br />
outstanding</b></p>
</td>
<td width="21" height="51" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="99" height="51" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>Net<br />
carrying<br />
value</b></p>
</td>
<td width="21" height="51" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="102" height="51" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>Liquidation<br />
preference</b></p>
</td>
</tr>
<tr>
<td width="100" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="17" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="17" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="97" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="21" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="99" height="17" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(in thousands)</p>
</td>
<td width="21" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="102" height="17" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center">(in thousands)</p>
</td>
</tr>
<tr>
<td width="100" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Series A</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">94,988</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="97" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">94,988</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="78" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,949</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">2,737</p>
</td>
</tr>
<tr>
<td width="100" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">Series B</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">747,095</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="97" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">520,973</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="78" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">16,115</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">17,219</p>
</td>
</tr>
<tr>
<td width="100" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Series C</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">820,088</p>
</td>
<td width="17" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="97" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">605,103</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="78" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">19,877</p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">20,000</p>
</td>
</tr>
<tr>
<td width="100" height="20" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:47px; MARGIN:0px">Total</p>
</td>
<td width="17" height="20" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="98" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">1,662,171</p>
</td>
<td width="17" height="20" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="97" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">1,221,064</p>
</td>
<td width="21" height="20" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="21" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="78" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">38,941</p>
</td>
<td width="21" height="20" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="21" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" height="20" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">39,956</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Significant provisions of the
convertible preferred stock were as follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Dividends</i> <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font> The holders
of Series&nbsp;C convertible preferred stock were entitled to
receive non-compounding cumulative dividends, in preference to any
dividends payable to holders of Series&nbsp;B and Series&nbsp;A
convertible preferred stock or common stock, at an annual dividend
rate of $2.64416 per share, as adjusted for any stock splits, stock
dividends, recapitalizations, or the like. Such cumulative
dividends were payable within ten days of demand of the holders of
at least a majority of the then outstanding Series&nbsp;C
convertible preferred stock, or automatically upon a liquidation
event. Dividends accumulated from the date of issuance and were
payable, whether or not declared, before any dividend on
Series&nbsp;B and Series&nbsp;A convertible preferred stock or
common stock could be paid or declared. Series&nbsp;C convertible
preferred stock shares issued as stock dividends were not entitled
to cumulative dividends. The holders of Series&nbsp;C convertible
preferred stock could elect whether the cumulative dividends would
be paid in cash or in shares of Series&nbsp;C convertible preferred
stock based on the original issue price of Series&nbsp;C
convertible preferred stock of $33.05196 per share. In the event
the board of directors declared a cash dividend in addition to the
above cumulative dividends (a Special Dividend), the holders of
Series&nbsp;C convertible preferred stock would have been entitled
to receive, in preference to any dividends payable to the holders
of Series&nbsp;B and Series&nbsp;A convertible preferred stock or
common stock, a per share amount equal to the sum of: (a)&nbsp;the
original issue price of Series&nbsp;C convertible preferred stock,
and (b)&nbsp;all accrued and/or declared but unpaid dividends on
such Series&nbsp;C convertible preferred stock, including the
cumulative dividends. No dividends were declared during any of the
periods presented. As of February 13, 2018, when the convertible
preferred stock was converted into common stock, and
December&nbsp;31, 2017, accumulated and undeclared dividends for
Series&nbsp;C convertible preferred stock were $7.3&nbsp;million
and $7.1&nbsp;million, respectively ($12.06 per share and $11.74
per share, respectively, of the outstanding Series&nbsp;C
convertible preferred stock). On February 13, 2018, in conjunction
with the Merger, the Series&nbsp;C convertible preferred stock and
the related accumulated dividends were converted into 696,028 and
253,851 shares of common stock, respectively.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The holders of Series&nbsp;B
convertible preferred stock were entitled to receive
non-compounding cumulative dividends, in preference to any
dividends payable to holders of Series&nbsp;A convertible preferred
stock or common stock, at the annual dividend rate of $2.64416 per
share, as adjusted for any stock splits, stock dividends,
recapitalizations, or the like. Such cumulative dividends were
payable within ten days of demand of the holders of at least a
majority of the then outstanding Series&nbsp;B convertible
preferred stock or automatically upon a liquidation event.
Dividends accumulated from the date of issuance and were payable,
whether or not declared, before any dividend on Series&nbsp;A
convertible preferred stock or common stock could be paid or
declared. Series&nbsp;B convertible preferred shares issued as
stock dividends were not entitled to cumulative dividends. The
holders of Series&nbsp;B convertible preferred stock could elect
whether the cumulative dividends would be paid in cash or in shares
of Series&nbsp;B convertible preferred stock based on the original
issue price of Series&nbsp;B convertible preferred stock of
$33.05196 per share. In the event the board of directors declared a
cash dividend in addition to the above cumulative dividends (a
Special Dividend), the holders of Series&nbsp;B convertible
preferred stock would have been entitled to receive, in preference
to any dividends payable to the holders of Series&nbsp;A
convertible preferred stock or common stock, a per share amount
equal to the sum of: (a)&nbsp;the original issue price of
Series&nbsp;B convertible preferred stock, and (b)&nbsp;all accrued
and/or declared but unpaid dividends on such Series&nbsp;B
convertible preferred stock, including the cumulative dividends. No
dividends were declared during any of the periods presented. As of
February 13, 2018, when the convertible preferred stock was
converted into common stock, and December&nbsp;31, 2017,
accumulated and undeclared dividends for Series&nbsp;B convertible
preferred stock were $7.6&nbsp;million and $7.5&nbsp;million,
respectively ($15.78 per share and $15.56 per share, respectively,
of the 483,387 shares of outstanding Series&nbsp;B convertible
preferred stock on which dividends accrued). On February 13, 2018,
in conjunction with the Merger, the Series&nbsp;B convertible
preferred stock and the related accumulated dividends were
converted into 599,259 and 265,340 shares of common stock,
respectively.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">23</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px" align="justify"><a href="#TOC">Table of
Contents</a></p>
<p style="MARGIN:0px" align="justify"><br />
&nbsp;</p>
<p style="MARGIN:0px" align="justify">The holders of Series&nbsp;A
convertible preferred stock were entitled to receive noncumulative
dividends, in preference to any dividends payable to holders of
common stock, at the annual dividend rate of $2.30449 per share, as
adjusted for any stock splits, stock dividends, recapitalizations,
or the like, if declared by the board of directors. On February 13,
2018, in conjunction with the Merger, the Series&nbsp;A convertible
preferred stock was converted into 104,065 shares of common
stock.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Conversion</i>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>
At the option of the holder, each share of convertible preferred
stock was convertible, one for one, subject to adjustment for anti
dilution protection, into shares of common stock. Each share
automatically converted into the number of shares of common stock
into which the shares were convertible at the then applicable
conversion ratio upon: (1)&nbsp;the closing of the sale of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock in a public offering provided the offering
price per share was not less than three&nbsp;times the
Series&nbsp;C convertible preferred stock original issue price of
$33.05196 and the aggregate gross proceeds were not less than
$30.0&nbsp;million, or (2)&nbsp;upon receipt of a written consent
of the holders of a majority of the then outstanding shares of
convertible preferred stock voting as a single class on an as
converted basis.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Liquidation</i>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>
In the event of any liquidation, dissolution or winding up of the
Company, including a merger or acquisition where the beneficial
owners of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s common and
convertible preferred stock owned less than 50% of the surviving
entity, or a sale of all or substantially all assets, the holders
of Series&nbsp;C convertible preferred stock would have been
entitled to receive a per share amount equal to $33.05196 (subject
to adjustment for stock splits, stock dividends, recapitalizations,
or the like), plus all dividends accrued, payable and/or in arrears
(whether or not declared) minus the amount of any Special Dividends
previously paid. After payment of the full liquidation preference
of Series&nbsp;C convertible preferred stock, the holders of
Series&nbsp;B convertible preferred stock would have been entitled
to receive a per share amount equal to $33.05196 (subject to
adjustment for stock splits, stock dividends, recapitalizations, or
the like), plus all dividends accrued, payable and/or in arrears
(whether or not declared) minus the amount of any Special Dividends
previously paid. After payment of the full liquidation preference
of Series&nbsp;B convertible preferred stock, the holders of
Series&nbsp;A convertible preferred stock would have been entitled
to receive an amount equal to $28.80613 per share, as adjusted,
plus all declared but unpaid dividends prior and in preference to
any distribution to the holders of common stock. In each case, if
the proceeds of such an event were insufficient to permit the
liquidation payment to a particular class, any proceeds legally
available for distribution to that class would have been
distributed ratably among the holders of that class in proportion
to the preferential amounts that each holder was entitled to
receive. Following payment of all convertible preferred stock
preferences, any remaining legally available assets of the Company
would have been distributed to the holders of common stock and
convertible preferred stock pro rata, based on the greatest number
of shares of common stock held on an as converted basis.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Voting</i> <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font> The holders
of convertible preferred stock were entitled to the number of votes
equal to the number of shares of common stock into which each share
of Series&nbsp;A, Series&nbsp;B, and Series&nbsp;C convertible
preferred stock could have been converted on the record date for
the vote or consent of the stockholders, except as otherwise
required by law, and had voting rights and powers equal to the
voting rights and powers of the common stockholders. The holders of
Series&nbsp;A convertible preferred stock, voting as a separate
class, were entitled to elect one&nbsp;member of the board of
directors. As long as a specified investor held at least
one&nbsp;share of Series&nbsp;C convertible preferred stock, the
specified investor was able to designate one&nbsp;member of the
board of directors, who would have been elected by the holders of
Series&nbsp;C convertible preferred stock voting as a separate
class. As long as a specified investor held least one&nbsp;share of
Series&nbsp;B convertible preferred stock, the specified investor
was able to designate one&nbsp;member of the board of directors,
who would have been elected by the holders of Series&nbsp;B
convertible preferred stock voting as a separate class. The holders
of common stock, voting as a separate class, were entitled to elect
two&nbsp;members of the board of directors, one of whom was the
duly appointed chief executive officer of the Company.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">24</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><i>Protective Provisions</i>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>
So long as at least 20,134&nbsp;shares of Series&nbsp;C convertible
preferred stock remained outstanding and for so long as at least
20,134&nbsp;shares of Series&nbsp;B convertible preferred stock
remained outstanding, Series&nbsp;C holders and Series&nbsp;B
holders, voting as a single class on an asconverted basis, needed
to approve certain specified corporate actions such as amending the
certificate of incorporation, authorizing additional shares of
stock or additional directors, redeeming stock and entering into
certain strategic relationships.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Redemption</i>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">–</font>
The convertible preferred stock was not redeemable. There were no
liquidation events under the control of preferred stockholders that
could have resulted in liquidation in which only the preferred
stockholders would have participated. Accordingly, the convertible
preferred stock was classified within stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> equity
(deficit) on the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s condensed
consolidated balance sheets.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:60px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:36px">
(b)</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:60px; TEXT-INDENT:-2px">
<b><i>Common Stock</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"justify">Except as otherwise required by law or as otherwise
provided in any certificate of designation for any series of
preferred stock, the holders of common stock possess all voting
power for the election of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s directors
and all other matters requiring stockholder action. Holders of
common stock are entitled to one vote per share on matters to be
voted on by stockholders. Holders of common stock are entitled to
receive such dividends, if any, as may be declared from time to
time by the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s board of
directors in its discretion out of funds legally available
therefore. In no event will any stock dividends or stock splits or
combinations of stock be declared or made on common stock unless
the shares of common stock at the time outstanding are treated
equally and identically. As of March&nbsp;31, 2018, no dividends
had been declared by the board of directors.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">In
the event of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s voluntary
or involuntary liquidation, dissolution, distribution of assets or
winding-up, the holders of the common stock will be entitled to
receive an equal amount per share of all of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s assets of
whatever kind available for distribution to stockholders, after the
rights of the holders of the preferred stock have been satisfied.
There are no sinking fund provisions applicable to the common
stock.</p>
<p style="MARGIN:0px" align="justify">The Company had shares of
common stock reserved for issuance as follows:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="320"></td>
<td width="14"></td>
<td width="102"></td>
<td width="14"></td>
<td width="122"></td>
</tr>
<tr>
<td width="320" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="14" height="14" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="239" height="14" colspan="3" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="320" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="14" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="17" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>March 31, 2018</b></p>
</td>
<td width="14" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="122" height="17" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><b>December 31, 2017</b></p>
</td>
</tr>
<tr>
<td width="320" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="14" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="14" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="122" height="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="320" height="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Convertible preferred stock outstanding</p>
</td>
<td width="14" height="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="14" height="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="15" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">1,221,064</p>
</td>
</tr>
<tr>
<td width="320" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">Options issued and outstanding</p>
</td>
<td width="14" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">832,942</p>
</td>
<td width="14" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">304,850</p>
</td>
</tr>
<tr>
<td width="320" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Available for future grants of equity
awards</p>
</td>
<td width="14" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">380,426</p>
</td>
<td width="14" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
</tr>
<tr>
<td width="320" height="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">Cumulative convertible preferred stock
dividends</p>
</td>
<td width="14" height="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="14" height="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">441,096</p>
</td>
</tr>
<tr>
<td width="320" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Convertible preferred stock warrants</p>
</td>
<td width="14" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">10,914</p>
</td>
<td width="14" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">10,914</p>
</td>
</tr>
<tr>
<td width="320" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="PADDING-LEFT:95px; MARGIN:0px">Total</p>
</td>
<td width="14" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="102" height="22" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">1,224,282</p>
</td>
<td width="14" height="22" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="122" height="22" style=
"BORDER-TOP:#000000 1px solid; MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">1,977,924</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">
<b>NOTE&nbsp;12.&nbsp;&nbsp;Equity Incentive Plans</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Prior to the Merger, the
Company issued equity awards for compensation purposes to
employees, directors and consultants under the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s 2007
Equity Incentive Plan (the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>2007
Plan<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font>). The 2007 Plan expired in July 2017. As of March&nbsp;31,
2018, the Company had no shares of common stock available for
issuance under the 2007 Plan. Equity awards under the 2007 Plan do
not become available for future issuance if such awards are
forfeited or otherwise terminate. Each stock option to acquire
shares of Private Vaxart stock, whether vested or unvested, that
had not previously been exercised was assumed in the Merger.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">In November 2016,
Aviragen<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s stockholders approved the 2016 Equity Incentive Plan
(<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>2016 Equity Plan<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>), under
which all outstanding awards under their previous plans became
available for issuance under the 2016 Equity Plan if such awards
are forfeited or otherwise terminate. The purpose of the 2016
Equity Plan is to assist the Company in attracting and retaining
valued employees, consultants and non-employee directors by
offering them a greater stake in the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s success
and a closer identity with it, and to encourage ownership of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s shares by such persons.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">25</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="justify">Under the 2016 Equity Plan,
the Company is authorized to issue incentive stock options
(<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>ISOs<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>),
non-qualified stock options (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>NQSOs<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>),
restricted stock (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>RSAs<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>) and
restricted stock units (<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>RSUs<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>). Awards
that expire or are canceled generally become available for issuance
again under the 2016 Equity Plan. The number of shares of the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock available under the 2016 Equity Plan will be
subject to adjustment in the event of a stock split, stock dividend
or other extraordinary dividend, or other similar change in the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s common stock or capital structure. Awards may vest over
varying periods, as specified by the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s Board of
Directors for each grant, and have a maximum term of ten years from
the grant date.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">A summary of stock option
transactions in the three months ended March 31, 2018, is as
follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="234"></td>
<td width="13"></td>
<td width="64"></td>
<td width="12"></td>
<td width="64"></td>
<td width="12"></td>
<td width="7"></td>
<td width="64"></td>
<td width="5"></td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Weighted</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Shares</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Number&nbsp;of</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Average</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Available</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Options</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Exercise</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>For&nbsp;Grant</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Outstanding</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="71" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Price</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:24px; MARGIN:0px">Balance at January&nbsp;1,
2018</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">304,850</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">9.50</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Assumed on consummation of
Merger</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">291,102</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">627,106</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">24.14</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Exercised</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">(2,013</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">)</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">6.49</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Forfeited</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(17,208</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">)</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">8.83</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px; TEXT-INDENT:24px">Canceled</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">66,597</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">(79,793</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">)</p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">23.53</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right"><br /></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="234" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:36px; MARGIN:0px">Balance at March&nbsp;31,
2018</p>
</td>
<td width="13" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">357,699</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">832,942</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="64" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">19.20</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">In
addition, the 2016 Equity Plan has a reserve of 22,727 shares
available for future issuance as RSAs and RSUs. As of March 31,
2018, no such awards have been granted under the 2016 Equity
Plan.</p>
<p style="MARGIN:0px" align="justify">Total stock based
compensation recognized for options was as follows:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="341"></td>
<td width="12"></td>
<td width="7"></td>
<td width="81"></td>
<td width="17"></td>
<td width="7"></td>
<td width="84"></td>
<td width="5"></td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="198" colspan="5" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Three Months
Ended March&nbsp;31.</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="88" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="92" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="198" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">(in
thousands)</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">
Research and development</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">44</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">69</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-12px">General
and administrative</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">42</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px" align="right">55</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#ffffff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="341" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="PADDING-LEFT:72px; MARGIN:0px">Total stock-based
compensation</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="81" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">86</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="7" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="84" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">124</p>
</td>
<td width="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">As of March&nbsp;31, 2018,
the unrecognized stock based compensation cost related to
outstanding unvested stock options that are expected to vest was
$0.4&nbsp;million, which the Company expects to recognize over an
estimated weighted average period of 1.90 years.</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">26</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>NOTE 13.&nbsp;&nbsp;Net
Loss Per Share Attributable to Common Stockholders</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
the calculation of basic and diluted net loss per share (in
thousands, except share and per share amounts):</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<table width="715" bordercolor="transparent" style=
"WIDTH:536.35pt; BORDER-COLLAPSE:collapse" cellpadding="0"
cellspacing="0" align="center">
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.1in'
align="center">&nbsp;</p>
</td>
<td width="28%" colspan="5" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:28.78%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center"><b><font style=
"FONT-SIZE:8pt; COLOR:black">Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</font></b></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.1in'
align="center">&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center"><b><font style=
"FONT-SIZE:8pt; COLOR:black">2018</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:2.36%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center">&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:13.2%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center"><b><font style=
"FONT-SIZE:8pt; COLOR:black">2017</font></b></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.2in; TEXT-INDENT:-0.1in'>
&nbsp;</p>
</td>
<td width="28%" colspan="5" style=
"WIDTH:28.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:center; MARGIN:0in 0in 0pt'
align="center">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Net income (loss) attributable to
common stockholders – basic calculation</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">1,975</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'
align="right"><font style="FONT-SIZE:10pt">(3,506</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
)</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Interest charges applicable to
convertible promissory notes</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">295</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt; COLOR:black">Series&nbsp;B and C
preferred dividend</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">339</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; TEXT-AUTOSPACE:'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:white; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt; COLOR:black">Series&nbsp;A preferred
dividend</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">(28)</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Net income (loss) used for net income
(loss) per share – diluted calculation</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">2,581</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">(3,506</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt; COLOR:black">Shares used to compute
net income (loss) per share&nbsp;– basic</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">3,656,360</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">135,658</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Potential common shares from exercise
of options</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">25,550</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Shares issuable upon conversion of
convertible promissory notes, related party</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">750,924</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"WIDTH:1.44%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"WIDTH:11.78%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Shares issuable upon conversion of
Series&nbsp;B and C convertible preferred stock and accrued
dividends</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">866,917</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt; COLOR:black">Shares used to compute
net income (loss) per share&nbsp;– diluted</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">5,299,751</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">135,658</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Net income (loss) per share&nbsp;–
basic</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">0.54</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">(25.84</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.36%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right">&nbsp;</p>
</td>
<td width="2%" style=
"WIDTH:2.24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"WIDTH:68.98%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in'>
<font style="FONT-SIZE:10pt">Net income (loss) per share&nbsp;–
diluted</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">0.49</font></p>
</td>
<td width="2%" style=
"WIDTH:2.36%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.44%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.78%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; TEXT-ALIGN:right; MARGIN:0in 0in 0pt'
align="right"><font style="FONT-SIZE:10pt">(25.84</font></p>
</td>
<td width="2%" style=
"WIDTH:2.24%; BACKGROUND:#cceeff; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman","serif"; MARGIN:0in 0in 0pt'>
<font style="FONT-SIZE:10pt">)</font></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">No adjustment has been made
to the net loss attributable to common stockholders in the three
months ended March&nbsp;31, 2017, as the effect would be
anti-dilutive due to the net loss.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">The following potentially
dilutive securities were excluded from the computation of diluted
weighted average shares outstanding because they would have been
antidilutive:</p>
<p style="MARGIN:0px"><br /></p>
<table width="550" bordercolor="transparent" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:550pt; BORDER-COLLAPSE:collapse; BORDER-BOTTOM:0px; BORDER-LEFT:0px"
cellpadding="0" cellspacing="0" align="center">
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in"
align="center">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="25%" colspan="3" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:25.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style=
"FONT-SIZE:8pt">Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</font></b></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in"
align="center">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2018</font></b></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2017</font></b></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style=
"TEXT-ALIGN:center; MARGIN:0in 0in 0pt 0.5in; TEXT-INDENT:-0.25in"
align="center">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="top">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="25%" colspan="3" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:25.4%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Options to purchase common
stock</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">529,332</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">272,287</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Warrant to purchase common
stock</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5,700</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Warrant to purchase convertible
preferred stock</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,613</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">7,563</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Series B and C convertible preferred
stock outstanding, including cumulative dividends</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,501,566</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Series A convertible preferred stock
outstanding</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt"><font style="FONT-SIZE:10pt">—
</font></font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">94,988</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Convertible promissory notes, related
party (as converted)</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">687,362</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:white; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="68%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:68.64%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.6in; TEXT-INDENT:-0.2in">
<font style="FONT-SIZE:10pt">Total potentially dilutive securities
excluded from denominator of the diluted earnings per share
computation</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.06%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.2%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="10%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:10.4%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">538,645</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.12%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,563,766</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.7%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">27</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px; always:" align="justify"><a href="#TOC">Table
of Contents</a></p>
<p style="MARGIN:0px; always:" align="justify"><br />
&nbsp;</p>
<p style="MARGIN:0px"><b><a name="MDNA" id=
"MDNA">Item&nbsp;2.&nbsp;&nbsp;Management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s Discussion
and Analysis of Financial Condition and Results of
Operations</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:6px"><em>You should</em>
<font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif; COLOR:black'><em>
carefully consider the following risk factors, as well as the other
information in this Quarterly Report on Form 10-Q, and in our other
public filings. The occurrence of any of the following risks could
harm our business, financial condition, results of operations
and/or growth prospects or cause our actual results to differ
materially from those contained in forward-looking statements we
have made in this Quarterly Report on Form 10-Q and those we may
make from time to time. You should consider all of the risk factors
described when evaluating our business.</em></font></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:20px"><b><i>Forward-Looking
Statements</i></b></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:6px"><i>This discussion
contains certain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act. Forward-looking statements are identified by words
such as <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>believe,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>will,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>may,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>estimate,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>continue,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>anticipate,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>intend,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>should,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>plan,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>expect,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>predict,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>could,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>potentially<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> or the
negative of these terms or similar expressions. You should read
these statements carefully because they discuss future
expectations, contain projections of future results of operations
or financial condition, or state other <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>forward-looking<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font>
information. These statements relate to our future plans,
objectives, expectations, intentions and financial performance and
the assumptions that underlie these statements. These
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those anticipated in the forward-looking statements. Factors
that might cause such a difference include, but are not limited to,
those discussed in this Quarterly Report on Form 10-Q in Part II,
Item 1A <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">—
</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>Risk Factors,<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> and
elsewhere in this Quarterly Report on Form 10-Q. Forward-looking
statements are based on our management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s beliefs
and assumptions and on information currently available to our
management. These statements, like all statements in this Quarterly
Report on Form 10-Q, speak only as of their date, and we undertake
no obligation to update or revise these statements in light of
future developments. We caution investors that our business and
financial performance are subject to substantial risks and
uncertainties.</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Company Overview and
Background</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">The
Company is a clinical-stage company focused on the development of
oral recombinant protein vaccines based on its proprietary oral
vaccine platform and of small-molecule antiviral drugs. Recombinant
vaccines rely on a genetically engineered antigen to generate an
immune response. The tablet vaccine candidates are based on a
proprietary vector-based technology platform and are designed to
generate broad and durable immune responses to protect against
infectious diseases. Management believes that tablet vaccines are
easier to distribute and administer than injectable vaccines and
have the potential to increase vaccination rates. The initial
tablet vaccine candidates target a variety of infectious diseases,
including: seasonal influenza, for which positive topline results
were recently reported from a Phase 2 challenge study; norovirus, a
widespread cause of the stomach flu, for which positive safety and
immunogenicity results were recently reported from a Phase 1b
study; respiratory syncytial virus, or RSV, a common cause of
respiratory tract infections; and human papillomavirus, or HPV, a
cause of cervical cancer.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">The
Company also has three Phase 2 clinical stage antiviral compounds:
BTA074, or teslexivir, an antiviral treatment for condyloma caused
by human papillomavirus types 6 &amp; 11; vapendavir, a capsid
inhibitor for the prevention or treatment of rhinovirus upper
respiratory infections; and BTA585, or enzaplatovir, a fusion
protein inhibitor in development for the treatment of RSV
infections.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s future funding requirements will depend on many factors,
including the following:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the timing and costs of its planned clinical trials
for its product candidates, both tablet vaccines and small-molecule
antiviral drugs;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the timing and costs of its planned preclinical
studies of its product candidates;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">its success in establishing and scaling commercial
manufacturing capabilities;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the amount and timing of royalties received on
sales of Relenza<sup>®</sup> and Inavir<sup>®</sup>;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the number and characteristics of product
candidates that it pursues;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the outcome, timing and costs of seeking regulatory
approvals;</p>
<p style=
"PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px; TEXT-INDENT:0px"
align="center">28</p>
<p style=
"PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style=
"PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN:0px; PADDING-RIGHT:0px; TEXT-INDENT:0px"
align="center">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">revenue received from commercial sales of its
product candidates, which will be subject to receipt of regulatory
approval;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the terms and timing of any future collaborations,
licensing, consulting or other arrangements that it may enter
into;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the amount and timing of any payments that may be
required in connection with the licensing, filing, prosecution,
maintenance, defense and enforcement of any patents or patent
applications or other intellectual property rights; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px"
align="justify">the extent to which Vaxart in-licenses or acquires
other products and technologies.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left"><b>Recent
Events</b></p>
<p style="MARGIN:0px" align="justify">On February 13,&nbsp;2018,
the Company completed the Merger with Aviragen and all of Private
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s convertible promissory notes and convertible preferred
stock were converted into common stock, following which each share
of common stock was converted into approximately 0.22148 shares of
the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s common
stock.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Immediately following the
completion of the Merger, the Company effected a reverse stock
split at a ratio of one new share for every eleven shares of its
common stock outstanding, or the Reverse Stock Split. Except as
otherwise noted in this Quarterly Report on Form 10-Q, all share,
equity security and per share amounts are presented to give
retroactive effect to the Reverse Stock Split.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">Immediately after the Merger
and the Reverse Stock Split there were approximately
7.1&nbsp;million shares of the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s common
stock outstanding. In addition, immediately after the Merger,
Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
stockholders, warrantholders and optionholders owned approximately
51% of the common stock of the Company and the stockholders and
optionholders of Aviragen immediately prior to the Merger owned
approximately 49% of the common stock of the Company (on a fully
diluted basis.</p>
<p style="MARGIN:0px" align="center">29</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><b>Results of
Operations</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
selected items in the condensed consolidated statements of
operations and comprehensive loss for the three months ended
March&nbsp;31, 2018 and 2017, which include the operations of
Aviragen for the period from February 13, 2018 to March 31,
2018:</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px"><br /></p>
<table width="718" bordercolor="transparent" style=
"BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0" align=
"center">
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="29%" colspan="5" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:29%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">Three
Months&nbsp;Ended&nbsp;March&nbsp;31,</font></b></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:13.48%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2018</font></b></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="13%" colspan="2" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:13.48%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<b><font style="FONT-SIZE:8pt">2017</font></b></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
<td width="27%" colspan="4" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:27.4%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
<font style="FONT-SIZE:8pt">(in thousands)</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">
&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">Revenue:</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt">Revenue from government contract</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">610</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,310</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt">Royalty revenue</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">893</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 62.5pt"><font style=
"FONT-SIZE:10pt">Total revenue</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">1,503</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,310</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">Operating expenses:</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Research</font>
<font style="FONT-SIZE:10pt">and development</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,408</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">3,879</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">General</font>
<font style="FONT-SIZE:10pt">and administrative</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,010</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">678</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0.7pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 63pt"><font style=
"FONT-SIZE:10pt">Total operating expenses</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5,418</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">4,557</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0.7pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 1.25in"><font style=
"FONT-SIZE:10pt">Operating loss</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(3,915</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,247</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:1pt; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Other
income and (expenses):</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Bargain purchase
gain</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">6,988</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Interest</font>
<font style="FONT-SIZE:10pt">income</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">5</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">13</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Interest</font>
<font style="FONT-SIZE:10pt">expense</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(437</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(744</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt; COLOR:black">Non-cash interest expense on
liability related to sale of future royalties</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(298</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt; COLOR:black">(Loss) gain on revaluation of
financial instruments</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(3</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">182</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt; COLOR:black">Foreign exchange gain,
net</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 63pt"><font style=
"FONT-SIZE:10pt">Total other income and (expenses)</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">6,257</font></p>
</td>
<td width="2%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(549</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
&nbsp;</p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr>
<td width="69%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 0.75in; TEXT-INDENT:-0.25in">
<font style="FONT-SIZE:10pt">Net income (<font style=
"COLOR:black">loss) before income taxes</font></font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,342</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,796</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
<tr style="HEIGHT:12.6pt">
<td width="69%" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:69.98%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 71.5pt"><font style=
"FONT-SIZE:10pt">Provision for income taxes</font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:1.6%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:11.88%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">28</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:2.04%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:1.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:12.24%; BACKGROUND:#cceeff; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">—</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:12.6pt; BORDER-RIGHT:0px; WIDTH:1.02%; BACKGROUND:#cceeff; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
</tr>
<tr style="HEIGHT:13pt">
<td width="69%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:69.98%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt 35.5pt"><font style=
"FONT-SIZE:10pt">Net income (<font style=
"COLOR:black">loss)</font></font></p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1.6%; BORDER-BOTTOM:windowtext 2pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="11%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:11.88%; BORDER-BOTTOM:windowtext 2pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">2,314</font></p>
</td>
<td width="2%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:2.04%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt">&nbsp;</p>
</td>
<td width="1%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1.24%; BORDER-BOTTOM:windowtext 2pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">$</font></p>
</td>
<td width="12%" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:12.24%; BORDER-BOTTOM:windowtext 2pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">
<font style="FONT-SIZE:10pt">(2,796</font></p>
</td>
<td width="1%" nowrap="nowrap" style=
"BORDER-TOP:0px; HEIGHT:13pt; BORDER-RIGHT:0px; WIDTH:1.02%; BORDER-BOTTOM:0px; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.7pt; BORDER-LEFT:0px; PADDING-RIGHT:0.7pt"
valign="bottom">
<p style="MARGIN:0in 0in 0pt"><font style=
"FONT-SIZE:10pt">)</font></p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Revenue from Government
Contract</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our revenue from a government contract for the three months ended
March&nbsp;31, 2018 and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">610</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">2,310</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">(74)%</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">For the
three months ended March&nbsp;31, 2018, revenue from government
contract decreased by $1.7 million, or 74%, compared to the three
months ended March&nbsp;31, 2017. The government contract with HHS
BARDA, as modified, is a cost plus fixed fee contract, which
reimburses the company for allowable direct contract costs plus
allowable indirect costs and a fixed fee, totaling
$15.7&nbsp;million through June 30, 2018. During the three months
ended March 31, 2018 and 2017, we recognized revenue of
$0.6&nbsp;million and $2.3&nbsp;million, respectively. The active
phase of the contract occurred in 2016 and 2017, whereas in 2018
activities are winding down, so future revenue from this contract
is not expected to be material.</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">
<br /></p>
<p style="MARGIN:0px" align="justify"><i>Royalty Revenue</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our royalty revenue for the three months ended March&nbsp;31, 2018
and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">893</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">100%</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">30</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify">For the three months ended
March&nbsp;31, 2018, royalty revenue increased by $893,000, or
100%, compared to the three months ended March&nbsp;31, 2017.
Royalty revenue is earned on sales of Relenza<sup>®</sup> and
Inavir<sup>®</sup>, both treatments for influenza, which were
acquired in the Merger and is based on fixed percentages of net
sales of these drugs in the period from February 13 to March 31,
2018.</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">
<br /></p>
<p style="MARGIN:0px" align="justify"><i>Research and
Development</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our research and development expenses for the three months ended
March&nbsp;31, 2018 and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">3,408</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">3,879</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">(12)%</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">For the
three months ended March&nbsp;31, 2018, research and development
expenses decreased by $471,000, or 12%, compared to the three
months ended March&nbsp;31, 2017. Research and development expenses
represent costs incurred to conduct research, including the
development of Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s tablet
vaccine platform, its tablet vaccine candidates and, since the
Merger, teslexivir, including preclinical, clinical and
manufacturing costs for these activities. The reduction in the 2018
period is principally due to lower expenditures incurred under the
HHS BARDA contract.</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">
<br /></p>
<p style="MARGIN:0px" align="justify"><i>General and
Administrative</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our general and administrative expenses for the three months ended
March&nbsp;31, 2018 and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">2,010</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">678</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">196%</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">For the
three months ended March&nbsp;31, 2018, general and administrative
expenses increased by $1,332,000, or 196%, compared to the three
months ended March&nbsp;31, 2017. General and administrative
expenses consist of personnel costs, allocated expenses and
expenses for outside professional services, including legal, audit,
accounting, investor relations, market research and other
consulting services. Personnel costs consist of salaries, benefits
and stock-based compensation. Allocated expenses consist of rent,
deprecation and other facilities related expenses. The increase in
the 2018 period is due to the overlap of personnel due to
transitioning following the Merger and additional expenses as a
public company, including expenses related to compliance with the
rules and regulations of the SEC and the Nasdaq Capital Market, as
well as additional insurance, investor relations and other
professional expenses. Approximately $0.5 million in legal,
accounting and other third-party costs incurred in the three months
ended March&nbsp;31, 2018, related directly to the Merger and are
not expected to recur.</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">
<br /></p>
<p style="MARGIN:0px" align="justify"><i>Other Income and
(Expenses)</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our non-operating income and expenses for the three months ended
March&nbsp;31, 2018 and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">6,257</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">(549)</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">N/A</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="justify">For the
three months ended March&nbsp;31, 2018, we recorded net
non-operating income of $6.3 million, compared to net non-operating
expenses of $549,000 in the three months ended March&nbsp;31, 2017.
The principal source of non-operating income in the three months
ended March&nbsp;31, 2018, was a bargain purchase gain of $7.0
million, representing the excess of the fair value of net assets
acquired over the fair value of the common stock issued to acquire
them in the Merger. Interest expense was $437,000 in the 2018
period, decreasing from $744,000 in the 2017 period due to Private
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s convertible promissory notes being outstanding for only 43
days prior to the Merger, whereas they earned interest for 90 days
in the 2017 period. Non-cash interest expense on liability related
to sale of future royalties of $298,000 in the post-Merger period
in 2018 relates to accounting for sums that will become payable to
HCRP for royalty revenue earned from Inavir<sup>®</sup> as debt.
The gain on revaluation of financial instruments in the 2017 period
is principally caused by an embedded derivative liability related
to the conversion feature on Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
convertible promissory notes, which had a fair value of $3.3
million as of December 31, 2016, and zero value as of December 31,
2017. Of this change in fair value, $150,000 occurred in the three
months ended March 31, 2017. Since Private Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
convertible promissory notes and warrants converted to equity on
the Merger, there are no longer any comparable financial
instruments outstanding on which a change in fair value will be
recorded.</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="center">&nbsp;</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="center">31</p>
<p style="MARGIN:0px; LINE-HEIGHT:11.4pt" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><i>Provision for income
taxes</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">The following table presents
our provision for income taxes for the three months ended
March&nbsp;31, 2018 and 2017, respectively:</p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
<td width="12"></td>
<td width="12"></td>
<td width="6"></td>
<td width="76"></td>
</tr>
<tr>
<td width="300" colspan="10" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</b></p>
</td>
</tr>
<tr>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="83" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="center"><br /></p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center">
<b>%&nbsp;Change</b></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="185" colspan="5" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:7.5pt; MARGIN:0px" align="center"><b>(dollars
in&nbsp;thousands)</b></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">28</p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right"><font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">—</font></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="12" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="76" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="MARGIN:0px" align="right">100%</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; LINE-HEIGHT:11.4pt"
align="justify">The provision for income taxes comprises $28,000 of
withholding tax on royalty revenue earned on sales of
Inavir<sup>®</sup> in Japan, which is potentially recoverable as a
foreign tax credit but expensed because we record a 100% valuation
allowance against our deferred tax assets.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b>&nbsp;Liquidity and Capital Resources</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">Since
inception, Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s operations
have been financed primarily by net proceeds of $38.9&nbsp;million
and $29.4&nbsp;million from the sale of its convertible preferred
stock and the issuance of convertible promissory notes,
respectively, all of which were converted into common stock in the
Merger, and $4.9 million from the issuance of secured promissory
notes to Oxford Finance, repayable by January 2021. Vaxart gained
$25.5 million in cash from Aviragen in the Merger, of which $4.9
million was used to pay for severance, <font style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman",serif'><font style=
"FONT-SIZE:10pt">banker fee, D&amp;O tail insurance,</font></font>
legal and other professional costs incurred <font style=
'FONT-SIZE:12pt; FONT-FAMILY:"Times New Roman",serif'><font style=
"FONT-SIZE:10pt">by Aviragen</font></font> prior to or upon the
Merger. As of March 31, 2018, Vaxart had $17.5&nbsp;million of cash
and cash equivalents. Management believes these funds are
sufficient to fund Vaxart into, but possibly not beyond, the first
quarter of 2019.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
Vaxart<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s primary uses of cash are to fund operating expenses,
primarily research and development expenditures. Cash used to fund
operating expenses is impacted by the timing of when these expenses
are paid, as reflected in the change in its outstanding accounts
payable and accrued expenses.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
Vaxart plans to continue to fund its operations and capital funding
needs through equity and/or debt financing. Vaxart may also enter
into government funding programs and consider selectively
partnering for clinical development and commercialization. The sale
of additional equity would result in additional dilution to its
stockholders. Incurring debt financing would result in debt service
obligations, and the instruments governing such debt could provide
for operating and financing covenants that would restrict the
company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s operations. If Vaxart is unable to raise additional
capital in sufficient amounts or on acceptable terms, it may be
required to delay, limit, reduce, or terminate its product
development or future commercialization efforts or grant rights to
develop and market vaccine candidates that it would otherwise
prefer to develop and market itself. Any of these actions could
harm its business, results of operations and prospects.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
<b>Cash Flows</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The following table
summarizes our cash flows for the periods indicated:</p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"
align="center">
<tr style="FONT-SIZE:0px">
<td width="308"></td>
<td width="10"></td>
<td width="6"></td>
<td width="48"></td>
<td width="10"></td>
<td width="6"></td>
<td width="10"></td>
<td width="17"></td>
<td width="6"></td>
<td width="47"></td>
<td width="34"></td>
</tr>
<tr>
<td width="308" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="48" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="1" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="82" height="1" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="103" height="1" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
</tr>
<tr>
<td width="308" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="16" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="189" height="16" colspan="9" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>Three Months
Ended March 31,</b></p>
</td>
</tr>
<tr>
<td width="308" height="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" height="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px">&nbsp;</p>
</td>
<td width="82" height="11" colspan="5" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2018</b></p>
</td>
<td width="17" height="11" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="88" height="11" colspan="3" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>2017</b></p>
</td>
</tr>
<tr>
<td width="308" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="189" colspan="9" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px">
<p style="FONT-SIZE:8pt; MARGIN:0px" align="center"><b>(in
thousands)</b></p>
</td>
</tr>
<tr>
<td width="308" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Cash used in operating activities</p>
</td>
<td width="10" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" height="17" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">(10,590)</p>
</td>
<td width="17" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" height="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="82" height="17" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">&nbsp;(4,276)</p>
</td>
</tr>
<tr>
<td width="308" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">Cash provided by (used in) investing
activities</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="76" colspan="4" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:4px" align="right">
&nbsp;26,779</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">&nbsp;(844)</p>
</td>
</tr>
<tr>
<td width="308" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">Cash used in financing activities</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="76" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px" align="right">&nbsp;(265)</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px">&nbsp;</p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px; BACKGROUND-COLOR:#cceeff"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:4px" align="right">
&nbsp;<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">—
</font></p>
</td>
</tr>
<tr>
<td width="308" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">Net increase (decrease) in cash and cash
equivalents</p>
</td>
<td width="10" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="76" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px; PADDING-RIGHT:4px" align="right">17,495</p>
</td>
<td width="17" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="6" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px">$</p>
</td>
<td width="82" colspan="2" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 3px double; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="bottom">
<p style="MARGIN:0px" align="right">(5,120)</p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Net Cash Used in Operating
Activities</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Vaxart experienced negative
cash flow from operating activities for the three months ended
March&nbsp;31, 2018 and 2017, in the amounts of $10,590,000 and
$4,276,000, respectively. The cash used in operating activities in
the three months ended March&nbsp;31, 2018, was due to net income
of $2,314,000 being offset by $5,749,000 of adjustments for net
non-cash income related to the bargain purchase gain, depreciation
and amortization, stock-based compensation, loss on revaluation of
financial instruments, non-cash interest, amortization of note
discount and non-cash interest expense related to sale of future
royalties and $7,155,000 used by a change in working capital. The
cash used in operating activities in the three months ended
March&nbsp;31, 2017, was due to cash used to fund a net loss of
$2,796,000, adjusted for net non-cash expenses related to
depreciation and amortization, stock-based compensation,
amortization of discount on short-term investments, gain on
revaluation of financial instruments, non-cash interest and
amortization of note discount totaling $732,000, and by a change in
working capital of $2,212,000.</p>
<p style="MARGIN:0px" align="center">32</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<p style="MARGIN:0px" align="justify"><i>Net Cash Provided by (Used
in) Investing Activities</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">In the three months ended
March&nbsp;31, 2018, Vaxart received cash of $25,525,000 in the
Merger and $1,415,000 from maturities of short-term investments,
net of purchases. This was offset by $140,000 to purchase property
and equipment and $21,000 to pay for fractional shares of common
stock in the Merger. In the three months ended March&nbsp;31, 2017,
Vaxart used $765,000 to purchase short-term investments, net of
maturities, and $79,000 to purchase property and equipment.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Net Cash Used in Financing
Activities</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Vaxart used $278,000 in the
three months ended March&nbsp;31, 2018, in repayment of principal
on the secured promissory note payable to Oxford Finance, offset by
$13,000 received for the exercise of stock options. There were no
financing activities in the three months ended March&nbsp;31,
2017.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify"><i>Availability of Additional
Funds</i></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Vaxart believes funds
available at March&nbsp;31, 2018, along with its revenue, are
sufficient to fund its operations into the first quarter of 2019.
To continue operations thereafter, it is likely that Vaxart will
need to raise further capital, through the sale of additional
securities or otherwise. Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s operating
needs include the planned costs to operate its business, including
amounts required to fund working capital and capital expenditures.
Vaxart currently has no material commitments for capital
expenditures. Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s future
capital requirements and the adequacy of its available funds will
depend on many factors, most notably its ability to successfully
commercialize its products and services.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">While we believe we have
sufficient cash to fund our operating, investing and financing
activities in the near term, we consider it likely that additional
capital will be needed to sustain our operations before we achieve
profitability. We have no commitments to obtain any additional
funds and there can be no assurance that we will be able to raise
sufficient additional capital as we need it on favorable terms, or
at all. The sale of equity or convertible debt securities in the
future may be dilutive to our stockholders, and debt financing
arrangements may require us to pledge certain assets and enter into
covenants that could restrict certain business activities or our
ability to incur further indebtedness and may contain other terms
that are not favorable to us or our stockholders. If we are unable
to obtain additional capital as needed, we may not be able to
continue our efforts to develop and commercialize our products and
services and may be forced to significantly curtail or suspend our
operations.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Principles of
Consolidation</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Vaxart<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s condensed
consolidated financial statements include the accounts of Vaxart,
Inc. and its subsidiaries Vaxart Biosciences, Inc., Biota Holdings
Pty, Ltd., Biota Scientific Management Pty, Ltd., Biota Europe
Limited and Anaconda Pharma S.A.S. All significant inter-company
transactions and balances are eliminated in consolidation.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b>Critical
Accounting Policies and Estimates</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">Our
management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s discussion
and analysis of financial condition and results of operations is
based on our condensed consolidated financial statements, which
have been prepared in accordance with generally accepted accounting
principles in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect
the reported amounts of assets, liabilities and expenses. On an
ongoing basis, we evaluate these estimates and judgments. We base
our estimates on historical experience and on various assumptions
that we believe to be reasonable under the circumstances. These
estimates and assumptions form the basis for making judgments about
the carrying values of assets and liabilities and the recording of
expenses that are not readily apparent from other sources. Actual
results may differ materially from these estimates. We believe that
the accounting policies discussed below are critical to
understanding our historical and future performance, as these
policies relate to the more significant areas involving
management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s judgments
and estimates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b>Accrued Research
and Development Expenses</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">We
record accrued expenses for estimated costs of research and
development activities conducted by external service providers,
which include the conduct of clinical and contract formulation and
manufacturing activities. We record the estimated costs of
development activities based upon the estimated amount of services
provided but not yet invoiced. We include these costs in accrued
liabilities in the condensed consolidated balance sheet and within
development expenses in the condensed consolidated statement of
operations and comprehensive income (loss). These costs are a
significant component our research and development expenses. We
record accrued expenses for these costs based on the estimated
amount of work completed and in accordance with agreements
established with these external service providers.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">33</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We estimate the
amount of work completed through discussions with internal
personnel and external service providers as to the progress or
stage of completion of the services and the agreed-upon fee to be
paid for such services. We make significant judgments and estimates
in determining the accrued balance in each reporting period. As
actual costs become known, we adjust our accrued estimates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b>Intangible
Assets</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
Intangible assets acquired in the Merger on February 13, 2018, were
recorded at their estimated fair values of $20.6 million and $1.8
million for developed technologies Inavir<sup>®</sup> and
Relenza<sup>®</sup>, respectively, which are being amortized on a
straight-line basis over the estimated periods of future royalties
of 11.75 and 1.3 years, respectively, and $1.6 million for
in-process research and development related to teslexivir which is
indefinite-lived. These valuations were prepared by an independent
third party based on estimated discounted cash flows based on
probability-weighted future development expenditures and revenue
streams, which are highly subjective.</p>
<p style="MARGIN:0px" align="justify"><b>Off-Balance Sheet
Arrangements</b></p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style="MARGIN:0px" align="justify">We have no off-balance sheet
arrangements that have or are reasonably likely to have a current
or future effect on our financial condition, changes in financial
condition, revenues or expenses, result of operations, liquidity,
capital expenditures or capital resources that is material to
stockholders.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b>Recent Accounting Pronouncements</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">See the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>Recent
Accounting Pronouncements<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> in
Note&nbsp;2 to the Condensed Consolidated Financial Statements in
Part&nbsp;I, Item&nbsp;1 for information related to the issuance of
new accounting standards in the first quarter of 2018, none of
which had a material impact on our condensed consolidated financial
statements.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b><a name="QA" id="QA">Item 3. Quantitative
and Qualitative Disclosures About Market Risk</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px">Not applicable.</p>
<p style="MARGIN:0px" align="center">34</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px" align="left"><a href="#TOC">Table of
Contents</a></p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px"><b><a name="C&amp;P" id=
"C&amp;P">Item&nbsp;4.&nbsp;&nbsp;Controls and
Procedures</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><b>Management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s Report on
Internal Control over Financial Reporting</b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">Our
management, with the participation of our Chief Executive Officer
and Chief Financial Officer, has evaluated the effectiveness of our
disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) under the Securities Exchange Act of 1934, as
amended), as of the end of the period covered by this Quarterly
Report on Form 10-Q. Based on such evaluation, our Chief Executive
Officer and Chief Financial Officer have concluded that as of March
31, 2018, our disclosure controls and procedures were not effective
at the reasonable assurance level as a result of the material
weakness described below.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
<b>Material Weakness</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">We
identified the following material weakness in our internal controls
over financial reporting as of March&nbsp;31, 2018:</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; PADDING-RIGHT:40px"
align="justify">We lacked sufficient qualified resources and
adequate processes to appropriately segregate duties and perform
effective and timely review of account reconciliations and
nonroutine transactions. Therefore, there was a risk that a
potential material misstatement of the financial statements would
occur without being prevented or detected on a timely basis.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">We
are already taking steps to remediate this material weakness,
including increasing the depth and experience within our accounting
and finance organization, as well as designing and implementing
improved processes and internal controls. However, our efforts to
remediate this material weakness may not be effective or prevent
any future material weakness or significant deficiency in our
internal control over financial reporting. If our efforts are not
successful, or other material weaknesses or control deficiencies
occur in the future, we may be unable to report our financial
results accurately on a timely basis, which could cause our
reported financial results to be materially misstated and result in
the loss of investor confidence and cause the market price of our
common stock to decline.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
<b>Changes in Internal Control over Financial Reporting</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">There
was no material change in our internal control over financial
reporting that occurred during the quarter ended March&nbsp;31,
2018, that has materially affected, or is reasonably likely to
materially affect, our internal control over financial
reporting.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
<b>Limitations on Effectiveness of Controls and Procedures</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">In
designing and evaluating the disclosure controls and procedures and
internal control over financial reporting, management recognizes
that any controls and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving the
desired control objectives. In addition, the design of disclosure
controls and procedures and internal control over financial
reporting must reflect the fact that there are resource constraints
and that management is required to apply judgment in evaluating the
benefits of possible controls and procedures relative to their
costs.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">35</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center"><b><a name="OI" id="OI">PART
II OTHER INFORMATION</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b><a name="LAW" id=
"LAW">Item&nbsp;1.&nbsp;&nbsp;Legal Proceedings</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">We are not presently party to
any material legal proceedings. From time to time we may be
involved in claims arising in connection with our business. Based
on information currently available, we believe that the amount, or
range, of reasonably possible losses in connection with any pending
actions against us in excess of established reserves, in the
aggregate, not to be material to our consolidated financial
condition or cash flows. However, losses may be material to our
operating results for any particular future period, depending on
the level of income for such period.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b><a name="RISK" id=
"RISK">Item&nbsp;1A.&nbsp;&nbsp;Risk Factors</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify"><em>We operate in a rapidly
changing environment that involves a number of risks, some of which
are beyond our control. This discussion highlights some of the
risks that may affect future operating results. These are the risks
and uncertainties we believe are most important to consider. We
cannot be certain that we will successfully address these risks. If
we are unable to address these risks, our business may not grow,
our stock price may suffer and we may be unable to stay in
business. Additional risks and uncertainties not presently known to
us, which we currently deem immaterial or which are similar to
those faced by other companies in our industry or business in
general, may also impair our business operations. We have marked
with an asterisk (*) those risks described below that reflect
substantive changes from, or additions to, the risks described
in</em> <font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'><em>Aviragen’
s</em></font> <em>Annual Report on Form 10-K for the year ended
June 30, 2017.</em></p>
<p style="MARGIN-BOTTOM:16px; MARGIN-TOP:0px" align="justify">
<br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b>Risks Related to
Our Business, Financial Position and Capital Requirements</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We have a limited operating history and have generated only
limited product revenue.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Even though we
generate royalty revenue from our two commercialized influenza
products, we have not yet successfully completed a large-scale,
pivotal clinical trial, obtained marketing approval, manufactured
our tablet vaccine or small-molecule antiviral drug candidates at
commercial scale, or conducted sales and marketing activities that
will be necessary to successfully commercialize our product
candidates. Consequently, predictions about our future success or
viability may not be as accurate as they could be if it had a
longer operating history or a history of successfully developing
and commercializing product candidates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our ability to
generate significant revenue and achieve and maintain profitability
will depend upon our ability to successfully complete the
development of our small molecule antivirals and tablet vaccine
candidates for the treatment of norovirus, seasonal influenza,
respiratory syncytial virus, or RSV, cervical cancer and dysplasia
caused by human papillomavirus, or HPV and other infectious
diseases and to obtain the necessary regulatory approvals.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Even if we receive
regulatory approval for the sale of any of our product candidates,
we do not know when we will begin to generate significant revenue,
if at all. Our ability to generate significant revenue depends on a
number of factors, including our ability to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
set an acceptable price for our product candidates and obtain
coverage and adequate reimbursement from third-party payors;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
receive royalties on our products and product candidates including
in connection with sales of Relenza®<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">•</font> and
Inavir®;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
establish sales, marketing, manufacturing and distribution
systems;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
add operational, financial and management information systems and
personnel, including personnel to support our clinical,
manufacturing and planned future clinical development and
commercialization efforts and operations as a public company;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
develop manufacturing capabilities for bulk materials and
manufacture commercial quantities of our product candidates at
acceptable cost levels;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
achieve broad market acceptance of our product candidates in the
medical community and with third-party payors and consumers;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
&nbsp;attract and retain an experienced management and advisory
team;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
launch commercial sales of our product candidates, whether alone or
in collaboration with others; and</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">36</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
maintain, expand and protect our intellectual property
portfolio.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Because
of the numerous risks and uncertainties associated with vaccine
development and manufacturing, we are unable to predict the timing
or amount of increased development expenses, or when we will be
able to achieve or maintain profitability, if at all. Our expenses
could increase beyond expectations if we are required by the U.S.
Food and Drug Administration, or the FDA, or comparable non-U.S.
regulatory authorities, to perform studies or clinical trials in
addition to those we currently anticipate. Even if our product
candidates are approved for commercial sale, we anticipate
incurring significant costs associated with the commercial launch
of and the related commercial-scale manufacturing requirements for
our product candidates. If we cannot successfully execute on any of
the factors listed above, our business may not succeed.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We have incurred significant losses since our inception and
expect to continue to incur significant losses for the foreseeable
future and may never achieve or maintain profitability.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We have generated
only limited product revenues and we expect to continue to incur
substantial and increasing losses as we continue to develop our
product candidates. Our product candidates have not been approved
for marketing in the United States and may never receive such
approval. As a result, we are uncertain when or if we will achieve
profitability and, if so, whether we will be able to sustain it.
Our ability to generate significant revenue and achieve
profitability is dependent on our ability to complete development,
obtain necessary regulatory approvals, and have our product
candidates manufactured and successfully marketed. We cannot be
sure that we will be profitable even if we successfully
commercialize one of our product candidates. If we do successfully
obtain regulatory approval to market our tablet vaccine candidates,
our revenues will be dependent, in part, upon the size of the
markets in the territories for which regulatory approval is
received, the number of competitors in such markets, the price at
which we can offer our product candidates and whether we own the
commercial rights for that territory. If the indication approved by
regulatory authorities is narrower than we expect, or the treatment
population is narrowed by competition, physician choice or
treatment guidelines, we may not generate significant revenue from
sales of our product candidates, even if approved. Even if we do
achieve profitability, we may not be able to sustain or increase
profitability on a quarterly or annual basis. If we fail to become
and remain profitable, the market price of our common stock and our
ability to raise capital and continue operations will be adversely
affected.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We expect research
and development expenses to increase significantly for any of our
small molecule antivirals and tablet vaccines, including those for
the prevention of norovirus, influenza and RSV infection, as well
as those for the treatment of HPV related dysplasia and cancer, and
any other chronic viral infections and cancer. In addition, even if
we obtain regulatory approval, significant sales and marketing
expenses will be required to commercialize the tablet vaccine
candidates. As a result, we expect to continue to incur significant
and increasing operating losses and negative cash flows for the
foreseeable future. These losses have had and will continue to have
an adverse effect on its financial position and working capital. As
of March 31, 2018, we had an accumulated deficit of $77.7
million.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We recently completed the Merger with Aviragen and the
failure to successfully integrate could adversely affect our future
results.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our success will
depend, in significant part, on our ability to integrate
successfully and to manage successfully the challenges presented by
the integration process in the Merger with Aviragen that was
completed in February 2018. Potential difficulties that may be
encountered in the integration process include the following:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
using our cash and assets efficiently to develop our business;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
appropriately managing our liabilities;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
potential unknown or currently unquantifiable liabilities
associated with the Merger and our operations;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
difficulties in operating with a new management team as a public
company; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
performance shortfalls as a result of the diversion of the
management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s attention
caused by integrating the companies<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> operations,
in particular operating as a public company immediately post-merger
with Aviragen.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"left"><b><i>*We are largely dependent on the success of our tablet
vaccine for the prevention of norovirus infection which is still in
early-stage clinical development, and if this tablet vaccine does
not receive regulatory approval or is not successfully
commercialized, our business may be harmed.</i></b></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">37</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">None of our product
candidates are in late-stage clinical development or approved for
commercial sale and we may never be able to develop marketable
tablet vaccine candidates. We expect that a substantial portion of
our efforts and expenditures over the next few years will be
devoted to our tablet vaccine candidate for norovirus. Accordingly,
our business currently depends heavily on the successful
development, regulatory approval and commercialization of our
norovirus tablet vaccine. Our norovirus tablet vaccine may not
receive regulatory approval or be successfully commercialized even
if regulatory approval is received. The research, testing,
manufacturing, labeling, approval, sale, marketing and distribution
of tablet vaccine candidates are and will remain subject to
extensive regulation by the FDA and other regulatory authorities in
the United States and other countries that each have differing
regulations. we are not permitted to market our norovirus tablet
vaccine in the United States until we receive approval of a
biologics license application, or BLA, from the FDA, or in any
foreign countries until we receive the requisite approval from such
countries. To date, we have only completed Phase 1 clinical trials
for one of the two strains necessary for our bivalent tablet
vaccine candidate. For our small molecule antivirals, we have only
completed Phase 2 clinical trials. As a result, we have not
submitted an NDA or BLA to the FDA or comparable applications to
other regulatory authorities and do not expect to be in a position
to do so for the foreseeable future. Obtaining approval of an NDA
or BLA is an extensive, lengthy, expensive and inherently uncertain
process, and the FDA may delay, limit or deny approval of its
seasonal influenza tablet vaccine for many reasons, including:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
We may not be able to demonstrate that our norovirus tablet vaccine
is safe and effective to the satisfaction of the FDA;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may not agree that the completed Phase 1 clinical trials of
the norovirus vaccine satisfy the FDA<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
requirements and may require us to conduct additional testing;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the results of our clinical trials may not meet the level of
statistical or clinical significance required by the FDA for
marketing approval;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may disagree with the number, design, size, conduct or
implementation of one or more of our clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the contract research organizations, or CROs, that we retain to
conduct clinical trials may take actions outside of our control
that materially and adversely impact our clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may not find the data from our preclinical studies and
clinical trials sufficient to demonstrate that the clinical and
other benefits of our tablet vaccines outweigh the safety
risks;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may disagree with our interpretation of data from our
preclinical studies and clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may not accept data generated at our clinical trial
sites;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
if our NDA or BLA is reviewed by an advisory committee, the FDA may
have difficulties scheduling an advisory committee meeting in a
timely manner or the advisory committee may recommend against
approval of our application or may recommend that the FDA require,
as a condition of approval, additional preclinical studies or
clinical trials, limitations on approved labeling or distribution
and use restrictions;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may require development of a risk evaluation and mitigation
strategy, or REMS, as a condition of approval;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may identify deficiencies in our manufacturing processes or
facilities; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the FDA may change its approval policies or adopt new
regulations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"left"><b><i>*Our independent auditors have expressed doubt about
our ability to continue as a going concern.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Based on our losses
and negative cash flows from operations, our accumulated deficit
and debt obligations, our independent auditors have included an
explanatory paragraph in their report on our financial statements
as of and for the year ended December&nbsp;31, 2017, expressing
substantial doubt about our ability to continue as a going concern.
We will require additional funding no later than the first quarter
of 2019 to continue our operations at the level planned. If we are
unable to continue as a going concern, we may be forced to
liquidate our assets and the values we receive for our assets in
liquidation or dissolution could be significantly lower than the
values reflected in our financial statements.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We will require additional capital to fund our operations,
and if we fail to obtain necessary financing, we may not be able to
complete the development and commercialization of our tablet
vaccine candidates.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We expect to spend
substantial amounts to complete the development of, seek regulatory
approvals for and commercialize our tablet vaccine candidates. Even
with the cash reserves acquired in the Merger, we will require
substantial additional capital to complete the development and
potential commercialization of our tablet vaccine candidates for
norovirus, seasonal influenza, RSV, HPV, and the development of
other product candidates. If we are unable to raise capital or find
appropriate partnering or licensing collaborations, when needed or
on acceptable terms, we could be forced to delay, reduce or
eliminate one or more of our development programs or any future
commercialization efforts. In addition, attempting to secure
additional financing may divert the time and attention of our
management from day-to-day activities and harm our development
efforts.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">38</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Based upon our
current operating plan, we believe that our liquid funds will
enable us to fund our operating expenses and capital expenditure
requirements through at least the full year of 2018. Our estimate
as to what we will be able to accomplish is based on assumptions
that may prove to be inaccurate, and we could exhaust our available
capital resources sooner than is currently expected. Because the
length of time and activities associated with successful
development of our product candidates is highly uncertain, we are
unable to estimate the actual funds we will require for development
and any approved marketing and commercialization activities. Our
future funding requirements, both near and long-term, will depend
on many factors, including, but not limited to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the initiation, progress, timing, costs and results of our planned
clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the outcome, timing and cost of meeting regulatory requirements
established by the FDA, the European Medicines Agency, or EMA, and
other comparable foreign regulatory authorities;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the cost of filing, prosecuting, defending and enforcing our patent
claims and other intellectual property rights;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the cost of defending potential intellectual property disputes,
including any patent infringement actions brought by third parties
against us now or in the future;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the effect of competing technological and market developments;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the cost of establishing sales, marketing and distribution
capabilities in regions where we choose to commercialize our
product candidates on our own; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the initiation, progress, timing and results of the
commercialization of our product candidates, if approved, for
commercial sale.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">
Additional funding may not be available on acceptable terms, or at
all. If we are unable to raise additional capital in sufficient
amounts or on terms acceptable to us, we may have to significantly
delay, scale back or discontinue the development or
commercialization of our product candidates or potentially
discontinue operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Raising additional funds by issuing securities may cause
dilution to existing stockholders, and raising funds through
lending and licensing arrangements may restrict our operations or
require us to relinquish proprietary rights.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We expect that
significant additional capital will be needed in the future to
continue our planned operations. Until such time, if ever, as we
can generate substantial product revenues, we expect to finance our
cash needs through a combination of equity offerings, debt
financings, strategic alliances and license and development
agreements in connection with any collaborations. We do not
currently have any committed external source of funds. To the
extent that we raise additional capital by issuing equity
securities, our existing stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> ownership
may experience substantial dilution, and the terms of these
securities may include liquidation or other preferences that
adversely affect our common stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> rights.
Debt financing and preferred equity financing, if available, may
involve agreements that include covenants limiting or restricting
our ability to take specific actions, such as incurring additional
debt, making capital expenditures, declaring dividends, creating
liens, redeeming our stock or making investments.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If we raise
additional funds through collaborations, strategic alliances or
marketing, distribution or licensing arrangements with third
parties, we may have to relinquish valuable rights to our
technologies, future revenue streams, research programs or product
candidates or grant licenses on terms that may not be favorable to
us. If we are unable to raise additional funds through equity or
debt financings when needed, or through collaborations, strategic
alliances or marketing, distribution or licensing arrangements with
third parties on acceptable terms, we may be required to delay,
limit, reduce or terminate our product development or future
commercialization efforts or grant rights to develop and market
product candidates that we would otherwise develop and market
ourselves.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*The terms of our credit facility place restrictions on our
operating and financial flexibility</i></b>.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In
December&nbsp;2016, we entered into a loan and security agreement,
or the&nbsp;Loan Agreement, with Oxford Finance, LLC, or Oxford,
under which we borrowed $5&nbsp;million. Our outstanding debt
facility with Oxford is collateralized by substantially all of our
assets, except for intellectual property, and contains customary
financial and operating covenants limiting our ability to transfer
or dispose of assets, merge with or acquire other companies, make
investments, pay dividends, incur additional indebtedness and liens
and conduct transactions with affiliates. We therefore may not be
able to engage in any of the foregoing transactions until our
current debt obligations are paid in full or we obtain the consent
of Oxford. Compliance with these covenants may limit our
flexibility in operating our business and our ability to take
actions that might be advantageous to us and our stockholders.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Under the Loan
Agreement, an event of default will occur if, among other
things:</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">39</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we fail to make payments under the Loan Agreement;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we breach any of our covenants under the Loan Agreement, subject to
specified cure periods with respect to certain breaches;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
there occurs an event that has a material adverse effect on:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:72px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:96px; TEXT-INDENT:-2px">
our business, operations, properties, assets or financial
condition;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:72px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:96px; TEXT-INDENT:-2px">
our ability to perform or satisfy our obligations under the Loan
Agreement as they become due or Oxford<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s ability to
enforce its rights or remedies with respect to our obligations
under the Loan Agreement; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:96px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:72px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:96px; TEXT-INDENT:-2px">
the collateral or liens securing our obligations under the Loan
Agreement;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we or our assets become subject to certain legal proceedings, such
as bankruptcy proceedings;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we are unable to pay our debts as they become due; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we default on contracts with third parties which would permit
Oxford to accelerate the maturity of such indebtedness or that
could have a material adverse effect on us.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"center">We may not have enough available cash or be able to raise
additional funds through equity or debt financings to repay such
indebtedness at the time any such event of default occurs. In that
case, we may be required to delay, limit, reduce or terminate our
clinical development efforts or grant rights to develop and market
product candidates to others that we would otherwise prefer to
develop and market ourselves. Oxford could also exercise its rights
as collateral agent to take possession and dispose of the
collateral securing the Loan Agreement for its benefit. Our
business would be harmed as a result of any of these events.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our stock price is expected to be volatile, and the market
price of our common stock has fallen since the Merger.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The market price of
our common stock has been subject to significant fluctuations
following the Merger. Market prices for securities of early-stage
pharmaceutical, biotechnology and other life sciences companies
have historically been particularly volatile. Some of the factors
that cause the market price of our common stock to fluctuate
include:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our ability to develop product candidates and conduct clinical
trials that demonstrate our product candidates are safe and
effective;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our ability to negotiate and receive royalty payments on the sales
of our product candidates including Relenza® and Inavir®</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our ability to obtain regulatory approvals for our product
candidates, and delays or failures to obtain such approvals;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
failure of any of our product candidates to demonstrate safety and
efficacy, receive regulatory approval and achieve commercial
success;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
failure to maintain its existing third-party license, manufacturing
and supply agreements;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our failure, or that of our licensors, to prosecute, maintain, or
enforce our intellectual property rights;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
changes in laws or regulations applicable to our product
candidates;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
any inability to obtain adequate supply of product candidates or
the inability to do so at acceptable prices;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
adverse regulatory authority decisions;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
introduction of new or competing products by our competitors;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
failure to meet or exceed financial and development projections
that we may provide to the public;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the perception of the pharmaceutical industry by the public,
legislatures, regulators and the investment community;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
announcements of significant acquisitions, strategic partnerships,
joint ventures, or capital commitments by us or our
competitors;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
disputes or other developments relating to proprietary rights,
including patents, litigation matters, and our ability to obtain
intellectual property protection for our technologies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
additions or departures of key personnel;</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">40</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
significant lawsuits, including intellectual property or
stockholder litigation;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
if securities or industry analysts do not publish research or
reports about us, or if they issue adverse or misleading opinions
regarding our business and stock;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
changes in the market valuations of similar companies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
general market or macroeconomic conditions;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
sales of our common stock by our existing stockholders in the
future;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
trading volume of our common stock;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
adverse publicity relating to our markets generally, including with
respect to other products and potential products in such
markets;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
changes in the structure of health care payment systems; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
period-to-period fluctuations in our financial results.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Moreover,
the stock markets in general have experienced substantial
volatility that has often been unrelated to the operating
performance of individual companies. These broad market
fluctuations may also adversely affect the trading price of our
common stock.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In the past,
following periods of volatility in the market price of a
company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s securities, stockholders have often instituted class
action securities litigation against those companies. Such
litigation, if instituted, could result in substantial costs and
diversion of management attention and resources, which could
significantly harm our operations, financial performance and
reputation.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
we are required to make certain milestone payments pursuant to a
stock purchase agreement with Anaconda Pharma, we may not have the
cash necessary to make such payment or the cash set aside for
planned expenditures may need to be diverted in order to make such
payments, and if such payments are made in shares of our common
stock, our existing stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> ownership
interest would be diluted.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Pursuant to the stock
purchase agreement, dated February 25, 2015, by and among the
Company, certain shareholders of Anaconda Pharma, a French société
par actions simplifiée, or Anaconda, and the other holder
representative party thereto, an amount of up to $30.0 million as
contingent financial consideration would be payable upon the
successful achievement of two future clinical and regulatory
milestones. Of such contingent consideration, $10.0 million would
be payable, either in cash, shares of our common stock, or a
combination of cash and shares of our common stock, at our
election, upon the achievement of successful results in the Phase 2
clinical trial for teslexivir. Depending on the results of the
Phase 2 clinical trial, the $10 million milestone may be due in the
third quarter of 2018. The other contingent milestone would be
payable in cash.&nbsp;If such contingent consideration becomes due
and payable, our cash balances may not be sufficient to make such
payments. If funds that are meant for corporate or research and
development expenses are used to pay the contingent consideration,
it could have an adverse impact on our growth. To the extent that
such contingent consideration is paid in shares of our common
stock, it would lead to a dilution of our existing
stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>
ownership.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>We
do not anticipate that we will pay any cash dividends in the
foreseeable future.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The current
expectation is that we will retain our future earnings, if any, to
fund the development and growth of our business. As a result,
capital appreciation, if any, of our common stock will be the sole
source of gain, if any, for our stockholders.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Future sales of shares by existing stockholders could cause
our stock price to decline.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If our existing
stockholders sell, or indicate an intention to sell, substantial
amounts of our common stock in the public market after legal
restrictions on resale lapse, the trading price of our common stock
could decline. Of the approximately 7.1 million shares outstanding
as of March 31, 2018, approximately 3.6 million are freely
tradable, without restriction, in the public market. The remaining
approximately 3.5 million shares will become freely tradable on
August 12, 2018, when the lock-up&nbsp;agreements that restrict the
Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s executive officers and directors and principal
stockholders<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> ability to
transfer their shares, subject to specified exceptions, expire.
After the lock-up agreements expire, approximately 3.1 million
shares of our common stock presently held by directors, executive
officers and major shareholders will be subject to volume
limitations under Rule 144 under the Securities Act of 1933, as
amended, and various vesting agreements.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">41</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*One stockholder owns a significant&nbsp;percentage of our
stock and, together with our management, will be able to exert
significant control over matters subject to stockholder
approval.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">As of March&nbsp;31,
2018, entities affiliated with Care Capital, a venture capital fund
associated with two of our directors, owned approximately 39.2% of
our common stock, and Care Capital together with our executive
officers and directors owned approximately 43.6% of our common
stock. Therefore, these stockholders may be able to determine all
matters requiring stockholder approval, and the entities affiliated
with Care Capital alone will have significant ability to influence
decisions through their ownership position. For example, this
concentration of ownership may enable a small number of
stockholders to influence or control elections of directors,
amendments to our organizational documents, or approval of any
merger, sale of assets, or other major corporate transaction. This
concentration of ownership may not be in the best interests of all
our stockholders.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Because the Merger resulted in an ownership change under
Section&nbsp;382 of the Code for Aviragen, pre-merger U.S. net
operating loss carryforwards and certain other tax attributes are
subject to limitations.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If a corporation
undergoes an <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>ownership
change<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font> within the meaning of Section&nbsp;382 of the Code, the
corporation<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s U.S. net
operating loss carryforwards and certain other tax attributes
arising from before the ownership change are subject to limitations
on use after the ownership change. In general, an ownership change
occurs if there is a cumulative change in the
corporation<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s equity
ownership by certain stockholders that exceeds 50% over a
three-year period. Similar rules may apply under state and foreign
tax laws. The Merger resulted in an ownership change for Aviragen
and, accordingly, Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s U.S. net
operating loss carryforwards and certain other tax attributes are
subject to limitations on their use. Annual usage is restricted to
1.97% of Aviragen<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s value on
February 13, 2018. Additional ownership changes in the future could
result in additional limitations on the combined
organization<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s net
operating loss carryforwards. Consequently, even if we achieve
profitability, we may not be able to utilize a material portion of
our net operating loss carryforwards and other tax attributes,
which could have a material adverse effect on cash flow and results
of operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Changes in tax laws and regulations or in our operations may
impact our effective tax rate and may adversely affect our
business, financial condition and operating results.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Changes in tax laws
in any jurisdiction in which we operate, or adverse outcomes from
any tax audits that we may be subject to in any such jurisdictions,
could result in an unfavorable change in our effective tax rate,
which could adversely affect our business, financial condition, and
operating results.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Anti-takeover provisions under Delaware law could make an
acquisition more difficult and may prevent attempts by our
stockholders to replace or remove our management.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">
Because we are incorporated in Delaware, we are governed by the
provisions of Section&nbsp;203 of the DGCL, which prohibits
stockholders owning in excess of 15% of the outstanding company
voting stock from merging or combining with the company. Although
we believe these provisions collectively provide for an opportunity
to receive higher bids by requiring potential acquirers to
negotiate with our board of directors, they would apply even if the
offer was considered beneficial by some stockholders. In addition,
these provisions may frustrate or prevent any attempts by our
stockholders to replace or remove management by making it more
difficult for stockholders to replace members of our board of
directors, which is responsible for appointing the members of
management.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*If we fail to obtain or maintain adequate coverage and
reimbursement for our product candidates, our ability to generate
significant revenue could be limited.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The availability and
extent of reimbursement by governmental and private payors is
essential for most patients to be able to afford expensive
treatments. Sales of any of our product candidates that receive
marketing approval will depend substantially, both in the United
States and internationally, on the extent to which the costs of our
product candidates will be paid by health maintenance, managed
care, pharmacy benefit and similar healthcare management
organizations, or reimbursed by government health administration
authorities, private health coverage insurers and other third-party
payors. If reimbursement is not available, or is available only on
a limited basis, we may not be able to successfully commercialize
our product candidates. Even if coverage is provided, the approved
reimbursement amount may not be high enough to allow us to
establish or maintain adequate pricing that will allow us to
realize a sufficient return on our investment.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">42</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Outside the United
States, international operations are generally subject to extensive
governmental price controls and other market regulations, and we
believe the increasing emphasis on cost-containment initiatives in
Europe, Canada and other countries may cause us to price our
product candidates on less favorable terms that we currently
anticipate. In many countries, particularly the countries of the
European Union, the prices of medical products are subject to
varying price control mechanisms as part of national health
systems. In these countries, pricing negotiations with governmental
authorities can take considerable time after the receipt of
marketing approval for a product. To obtain reimbursement or
pricing approval in some countries, we may be required to conduct a
clinical trial that compares the cost-effectiveness of our product
candidates to other available therapies. In general, the prices of
products under such systems are substantially lower than in the
United States. Other countries allow companies to fix their own
prices for products, but monitor and control company profits.
Additional foreign price controls or other changes in pricing
regulation could restrict the amount that we are able to charge for
our product candidates. Accordingly, in markets outside the United
States, the level of reimbursement for our products is likely to be
reduced compared with the United States and may be insufficient to
generate commercially reasonable revenues and profits.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Moreover, increasing
efforts by governmental and third-party payors, in the United
States and internationally, to cap or reduce healthcare costs may
cause such organizations to limit both coverage and level of
reimbursement for newly approved products and, as a result, they
may not cover or provide adequate payment for our product
candidates. We expect to experience pricing pressures in connection
with the sale of any of our product candidates due to the trend
toward managed healthcare, the increasing influence of health
maintenance organizations and additional legislative changes. The
downward pressure on healthcare costs in general, particularly
prescription drugs and surgical procedures and other treatments,
has become very intense. As a result, increasingly high barriers
are being erected to the entry of new products into the healthcare
market.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our future success depends on our ability to retain
executive officers and attract, retain and motivate qualified
personnel.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We are highly
dependent on our executive officers and the other principal members
of the executive and scientific teams, particularly our President
and Chief Executive Officer, Wouter W. Latour and our Chief
Scientific Officer, Sean N. Tucker. The employment of our executive
officers is at-will and our executive officers may terminate their
employment at any time. The loss of the services of any of our
senior executive officers could impede the achievement of our
research, development and commercialization objectives. We do not
maintain <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>key
person<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font> insurance for any executive officer or employee.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Recruiting and
retaining qualified scientific, clinical, manufacturing and sales
and marketing personnel is also critical to our success. We may not
be able to attract and retain these personnel on acceptable terms
given the competition among numerous pharmaceutical and
biotechnology companies for similar personnel. We also experience
competition for the hiring of scientific and clinical personnel
from universities and research institutions. Our industry has
experienced an increasing rate of turnover of management and
scientific personnel in recent years. In addition, we rely on
consultants and advisors, including scientific and clinical
advisors, to assist us in devising our research and development and
commercialization strategy. Our consultants and advisors may be
employed by third parties and have commitments under consulting or
advisory contracts with other entities that may limit their
availability to advance our strategic objectives. If any of these
advisors or consultants can no longer dedicate a sufficient amount
of time to us, our business may be harmed.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We will need to expand our organization, and may experience
difficulties in managing this growth, which could disrupt
operations.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our future financial
performance and our ability to commercialize our product
candidates, continue to earn royalties and compete effectively will
depend, in part, on our ability to effectively manage any future
growth. As of March 31, 2018, we had 29 full-time employees. We
expect to hire additional employees for our managerial, clinical,
scientific and engineering, operational, manufacturing, sales and
marketing teams. We may have operational difficulties in connection
with identifying, hiring and integrating new personnel. Future
growth would impose significant additional responsibilities on our
management, including the need to identify, recruit, maintain,
motivate and integrate additional employees, consultants and
contractors. Also, our management may need to divert a
disproportionate amount of its attention away from our day-to-day
activities and devote a substantial amount of time to managing
these growth activities. We may not be able to effectively manage
the expansion of our operations, which may result in weaknesses in
our infrastructure, give rise to operational mistakes, loss of
business opportunities, loss of employees and reduced productivity
among remaining employees. Our expected growth could require
significant capital expenditures and may divert financial resources
from other projects, such as the development of our product
candidates. If we are unable to effectively manage our growth, our
expenses may increase more than expected, our ability to generate
and/or grow revenues could be reduced, and we may not be able to
implement our business strategy.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">43</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Many of the other
pharmaceutical companies that we compete against for qualified
personnel and consultants have greater financial and other
resources, different risk profiles and a longer history in the
industry than us. They may also provide more diverse opportunities
and better chances for career advancement. Some of these
characteristics may be more appealing to high-quality candidates
and consultants than what we are able to offer. If we are unable to
continue to attract and retain high-quality personnel and
consultants, the rate and success at which we can select and
develop our product candidates and our business will be
limited.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our employees, independent contractors, principal
investigators, consultants, commercial collaborators, service
providers and other vendors may engage in misconduct or other
improper activities, including noncompliance with regulatory
standards and requirements, which could have an adverse effect on
our results of operations.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We are exposed to the
risk that our employees and contractors, including principal
investigators, consultants, commercial collaborators, service
providers and other vendors may engage in fraudulent or other
illegal activity. Misconduct by these parties could include
intentional, reckless and/or negligent conduct or other
unauthorized activities that violate the laws and regulations of
the FDA and other similar regulatory bodies, including those laws
that require the reporting of true, complete and accurate
information to such regulatory bodies, manufacturing standards,
federal and state healthcare fraud and abuse and health regulatory
laws and other similar foreign fraudulent misconduct laws, or laws
that require the true, complete and accurate reporting of financial
information or data. Misconduct by these parties may also involve
the improper use or misrepresentation of information obtained in
the course of clinical trials, which could result in regulatory
sanctions and serious harm to our reputation. It is not always
possible to identify and deter third-party misconduct, and the
precautions we take to detect and prevent this activity may not be
effective in controlling unknown or unmanaged risks or losses or in
protecting us from governmental investigations or other actions or
lawsuits stemming from a failure to be in compliance with such laws
or regulations. If any such actions are instituted against us, and
we are not successful in defending ourselves or asserting our
rights, those actions could have a significant impact on our
business and financial results, including the imposition of
significant civil, criminal and administrative penalties, damages,
monetary fines, possible exclusion from participation in Medicare,
Medicaid and other federal healthcare programs, reputational harm,
diminished profits and future earnings, and curtailment of our
operations, any of which could adversely affect our ability to
operate our business and our results of operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our business and operations would suffer in the event of
system failures.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our computer systems
and those of our service providers, including our CROs, are
vulnerable to damage from computer viruses, unauthorized access,
natural disasters (including earthquakes), terrorism, war and
telecommunication and electrical failures. If such an event were to
occur and cause interruptions in our or their operations, it could
result in a material disruption of our development programs. For
example, the loss of preclinical or clinical trial data from
completed, ongoing or planned trials could result in delays in our
regulatory approval efforts and significantly increase our costs to
recover or reproduce the data. To the extent that any disruption or
security breach were to result in a loss of or damage to data or
applications, or inappropriate disclosure of personal, confidential
or proprietary information, we could incur liability and the
further development of our product candidates could be delayed.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We have identified a material weakness in our internal
control over financial reporting, and if we are unable to maintain
proper and effective internal controls over financial reporting,
the accuracy and timeliness of our financial reporting may be
adversely affected.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In connection with
the audits of our financial statements for each of the years ended
December 31, 2015 through 2017, our management and our independent
auditors identified a material weakness in our internal control
over financial reporting. A <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>material
weakness<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font> is a deficiency, or a combination of deficiencies, in
internal control over financial reporting such that there is a
reasonable possibility that a material misstatement of our annual
or interim financial statements will not be prevented or detected
on a timely basis. The material weakness relates to us lacking
sufficient qualified resources and adequate processes thereby
impacting our ability to appropriately segregate duties and perform
effective and timely review of account reconciliations and
nonroutine transactions.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We are already taking
steps to remediate this material weakness, including increasing the
depth and experience within our accounting and finance
organization, as well as designing and implementing improved
processes and internal controls. However, our efforts to remediate
this material weakness may not be effective or prevent any future
material weakness or significant deficiency in our internal control
over financial reporting. If our efforts are not successful, or
other material weaknesses or control deficiencies occur in the
future, we may be unable to report our financial results accurately
on a timely basis, which could cause our reported financial results
to be materially misstated and result in the loss of investor
confidence and cause the market price of our common stock to
decline.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px">We
are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to
annually furnish a report by management on, among other things, the
effectiveness of our internal control over financial reporting.
This assessment will need to include disclosure of any material
weaknesses identified by our management in our internal control
over financial reporting. Our independent registered public
accounting firm may be required to attest to the effectiveness of
our internal control over financial reporting in the event that our
public float exceeds $75 million. We will be required to disclose
changes made in our internal control and procedures on a quarterly
basis. To comply with the requirements of being a public company,
we may need to undertake various actions, such as implementing new
internal controls and procedures and hiring accounting or internal
audit staff. We have begun the costly and challenging process of
compiling the system and processing documentation necessary to
perform the evaluation needed to comply with Section 404, when
applicable; however, we may not be able to complete such
evaluation, testing and any required remediation in a timely
fashion.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">44</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We will incur significant additional costs and demands upon
management as a result of complying with the laws and regulations
affecting public companies.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We incur significant
legal, accounting and other expenses associated with public company
reporting requirements. We also incur costs associated with
corporate governance requirements, including requirements under the
Sarbanes-Oxley Act, as well as rules implemented by the SEC and The
Nasdaq Stock Market LLC. These rules and regulations impose
significant legal and financial compliance costs and make some
activities more time-consuming and costly. For example, our
management team consists of certain executive officers who have not
previously managed and operated a public company. These executive
officers and other personnel will need to devote substantial time
to gaining expertise regarding operations as a public company and
compliance with applicable laws and regulations. In addition, it
may be more difficult for us to attract and retain qualified
individuals to serve on our board of directors or as executive
officers, which may adversely affect investor confidence and could
cause our business or stock price to suffer.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>We
may be subject to securities litigation, which is expensive and
could divert management attention.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The market price of
our common stock has been and may continue to be volatile, and in
the past companies that have experienced volatility in the market
price of their stock have been subject to securities class action
litigation. We may be the target of this type of litigation in the
future. Securities litigation against us could result in
substantial costs and divert management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s attention
from other business concerns, which could seriously harm our
business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
securities or industry analysts do not publish research, or publish
inaccurate or unfavorable rating, about our business, our stock
price and trading volume could decline.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The trading market
for our common stock is influenced by independent research and
reports that securities or industry analysts publish about us or
our business from time to time. At present, there are no analysts
covering our stock, which means we have low visibility in the
financial markets, which could cause a low trading volume, which
would tend to cause our stock price to decline. There can be no
assurance that analysts will cover our stock in the future or, if
they do, provide favorable ratings. If any analysts who cover us
downgrade our stock, change their opinion of our stock or
disseminate negative information regarding our business, our share
price may decline.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="center">
<b>&nbsp;Risks Related to Clinical Development, Regulatory Approval
and Commercialization</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*If we fail to continue to develop and refine the
formulations of our tablet vaccine candidates, we may not obtain
regulatory approvals, and even if approved, the commercial
acceptance of our tablet vaccine candidates would likely be
limited.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In our H1N1 influenza
Phase 2 trial we used vaccine tablets that contained approximately
1.5 x 10<sup>10</sup> IU of vaccine. Accordingly, subjects in this
trial were required to take 7 tablets in a single setting to reach
the aggregate dose of 1 x 10<sup>11</sup> IU, the target dose for
this trial. We believe that in order for our seasonal influenza
vaccine candidate to be commercially successful we will need to
continue to refine our formulation and develop influenza vaccine
tablets that contain the desired dose for each vaccine strain in a
single tablet, resulting in a vaccination regime of no more than
four tablets. In addition, we intend to develop a seasonal
influenza vaccine tablet that contains the optimal effective dose
for all four influenza vaccines necessary to create a quadrivalent
vaccine, resulting in a vaccination regime of one tablet.
Increasing the potency of the vaccine tablets may affect the
stability profile of the vaccine and we may not be able to reduce
the vaccination regime for an influenza strain to a single tablet
or combine the four influenza strains into one vaccine tablet. In
addition, increasing the potency of the vaccine tablets or
combining the influenza strains necessary to create a quadrivalent
vaccine may adversely affect manufacturing yields and render such
tablets too costly to manufacture at commercial scale. Our efforts
to develop tablet vaccine candidates for norovirus and RSV face
similar formulation challenges. If we are unable to further develop
and refine the formulations of our tablet vaccine candidates, we
may be unable to obtain regulatory approval from the FDA or other
regulatory authorities, and even if approved, the commercial
acceptance of our tablet vaccine candidates would likely be
limited.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">45</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Clinical trials are very expensive, time-consuming,
difficult to design and implement and involve an uncertain outcome,
and if they fail to demonstrate safety and efficacy to the
satisfaction of the FDA, or similar regulatory authorities, we will
be unable to commercialize our tablet vaccine
candidates.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our tablet vaccine
candidates for norovirus and seasonal influenza are still in
early-stage clinical development and teslexivir is in Phase 2
trials. Both will require extensive additional clinical testing
before we are prepared to submit a BLA for regulatory approval for
either indication or for any other treatment regime. We cannot
predict with any certainty if or when we might submit a BLA for
regulatory approval for any of our tablet vaccine candidates, which
are currently in pre-clinical development, or whether any such BLAs
will be approved by the FDA. Human clinical trials are very
expensive and difficult to design and implement, in part because
they are subject to rigorous regulatory requirements. For instance,
the FDA may not agree with our proposed endpoints for any clinical
trial we propose, which may delay the commencement of our clinical
trials. The clinical trial process is also time-consuming. We
estimate that the clinical trials we need to conduct to be in a
position to submit BLAs for our tablet vaccine candidates for
seasonal influenza, norovirus and RSV will take several years to
complete. Furthermore, failure can occur at any stage of the
trials, and we could encounter problems that cause us to abandon or
repeat clinical trials. Tablet vaccine candidates in the later
stages of clinical trials may fail to show the desired safety and
efficacy traits despite having progressed through preclinical
studies and initial clinical trials, and the results of early
clinical trials of the tablet vaccine candidate for seasonal
influenza as well as the pre-clinical results we have observed for
our norovirus and RSV tablet vaccine candidates therefore may not
be predictive of the results of our planned Phase 1 and 2 trials. A
number of companies in the biopharmaceutical industry have suffered
significant setbacks in advanced clinical trials due to lack of
efficacy or adverse safety profiles, notwithstanding promising
results in earlier trials.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Moreover, preclinical
and clinical data are often susceptible to multiple interpretations
and analyses. Many companies that have believed their vaccine
candidates performed satisfactorily in preclinical studies and
clinical trials have nonetheless failed to obtain marketing
approval of their products. Success in preclinical testing and
early clinical trials does not ensure that later clinical trials,
which involve many more subjects and, for influenza, all four
strains rather than the one strain we have studied in Phase 1
clinical trials to date and the results of later clinical trials
may not replicate the results of prior clinical trials and
preclinical testing.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We may experience
numerous unforeseen events during, or as a result of, clinical
trials that could delay or prevent our ability to receive marketing
approval or commercialize our tablet vaccine candidates, including
that:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulators or institutional review boards may not authorize us or
our investigators to commence a clinical trial or conduct a
clinical trial at a prospective trial site;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we may experience delays in reaching or fail to reach agreement on
acceptable clinical trial contracts or clinical trial protocols
with prospective trial sites;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
clinical trials of our tablet vaccine candidates may produce
negative or inconclusive results, and we may decide, or regulators
may require us, to conduct additional clinical trials or abandon
product development programs;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the number of subjects required for clinical trials of our tablet
vaccine candidates may be larger than we anticipate; enrollment in
these clinical trials may be slower than we anticipate, or
participants may drop out of these clinical trials at a higher rate
than we anticipate;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
Our third-party contractors may fail to comply with regulatory
requirements or meet their contractual obligations to us in a
timely manner, or at all;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulators or institutional review boards may require that we or
our investigators suspend or terminate clinical research for
various reasons, including noncompliance with regulatory
requirements or a finding that the participants are being exposed
to unacceptable health risks;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the cost of clinical trials of our tablet vaccine candidates may be
greater than we anticipate; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the supply or quality of our tablet vaccine candidates or other
materials necessary to conduct clinical trials may be insufficient
or inadequate.</p>
<p style="CLEAR:left; MARGIN:0px">If we are required to conduct
additional clinical trials or other testing of our tablet vaccine
candidates beyond those that we currently contemplate, if we are
unable to successfully complete clinical trials of our tablet
vaccine candidates or other testing, if the results of these trials
or tests are not positive or are only modestly positive or if there
are safety concerns, we may:</p>
<p style="MARGIN:0px"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be delayed in obtaining marketing approval for our tablet vaccine
candidates;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
not obtain marketing approval at all;</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">46</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain approval for indications or patient populations that are not
as broad as intended or desired;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain approval with labeling that includes significant use or
distribution restrictions or safety warnings, including boxed
warnings;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be subject to additional post-marketing testing requirements;
or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
have the product removed from the market after obtaining marketing
approval.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Product
development costs will also increase if we experience delays in
testing or in receiving marketing approvals. We do not know whether
any clinical trials will begin as planned, will need to be
restructured or will be completed on schedule, or at all.
Significant clinical trial delays also could shorten any periods
during which we may have the exclusive right to commercialize our
tablet vaccine candidates, could allow our competitors to bring
products to market before we do, and could impair our ability to
successfully commercialize our tablet vaccine candidates, any of
which may harm our business and results of operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our platform includes a novel vaccine adjuvant and all of
our current tablet vaccine candidates include this novel adjuvant,
which may make it difficult for us to predict the time and cost of
tablet vaccine development as well as the requirements the FDA or
other regulatory agencies may impose to demonstrate the safety of
the tablet vaccine candidates.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Novel vaccine
adjuvants, included in some of our tablet vaccine candidates, may
pose an increased safety risk to patients. Adjuvants are compounds
that are added to vaccine antigens to enhance the activation and
improve immune response and efficacy of vaccines. Development of
vaccines with novel adjuvants requires evaluation in larger numbers
of patients prior to approval than would be typical for therapeutic
drugs. Guidelines for evaluation of vaccines with novel adjuvants
have been established by the FDA and other regulatory bodies and
expert committees. Our tablet vaccine candidates, including for
norovirus, may include one or more novel vaccine adjuvants. Any
vaccine, because of the presence of an adjuvant, may have side
effects considered to pose too great a risk to patients to warrant
approval of the vaccine. Traditionally, regulatory authorities have
required extensive study of novel adjuvants because vaccines
typically get administered to healthy populations, in particular
infants, children and the elderly, rather than to people with
disease. Such extensive study has often included long-term
monitoring of safety in large general populations that has at times
exceeded 10,000 subjects. This contrasts with the few thousand
subjects typically necessary for approval of novel therapeutics. To
date, the FDA and other major regulatory agencies have only
approved vaccines containing five adjuvants, which makes it
difficult to determine how long it will take or how much it will
cost to obtain regulatory approvals for our tablet vaccine
candidates in the United States or elsewhere.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Enrollment and retention of subjects in clinical trials is
an expensive and time-consuming process and could be made more
difficult or rendered impossible by multiple factors outside our
control.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We may encounter
delays in enrolling, or be unable to enroll, a sufficient number of
participants to complete any of our clinical trials. Once enrolled,
we may be unable to retain a sufficient number of participants to
complete any of our trials. Late-stage clinical trials of our
tablet vaccine candidate for norovirus, in particular, will require
the enrollment and retention of large numbers of subjects. Subject
enrollment and retention in clinical trials depends on many
factors, including the size of the subject population, the nature
of the trial protocol, the existing body of safety and efficacy
data with respect to the study drug, the number and nature of
competing treatments and ongoing clinical trials of competing drugs
for the same indication, the proximity of subjects to clinical
sites and the eligibility criteria for the study. Further, since
there are no reliable animal models to norovirus infection, human
challenge studies have been used to understand viral activity and
possible immune correlates that prevent infection making trials
costlier than animal-based studies. &nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Furthermore, any
negative results we may report in clinical trials of our tablet
vaccine candidates may make it difficult or impossible to recruit
and retain participants in other clinical trials of that same
tablet vaccine candidate. Delays or failures in planned subject
enrollment or retention may result in increased costs, program
delays or both, which could have a harmful effect on our ability to
develop our tablet vaccine candidates, or could render further
development impossible. In addition, we expect to rely on CROs and
clinical trial sites to ensure proper and timely conduct of our
future clinical trials and, while we intend to enter into
agreements governing their services, we will be limited in our
ability to compel their actual performance in compliance with
applicable regulations. Enforcement actions brought against these
third parties may cause further delays and expenses related to our
clinical development programs.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We face significant competition from other biotechnology and
pharmaceutical companies, and our operating results will suffer if
we fail to compete effectively.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Vaccine development
is highly competitive and subject to rapid and significant
technological advancements. In particular, for seasonal influenza
vaccine, we face competition from various sources, including larger
and better funded pharmaceutical, specialty pharmaceutical and
biotechnology companies, as well as academic institutions,
governmental agencies and public and private research institutions.
These competitors are focused on delivering therapeutics for the
treatment of influenza with products that are available and have
gained market acceptance as the standard treatment protocol.
Further, it is likely that additional drugs or other treatments
will become available in the future for the treatment of
influenza.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">47</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">For tablet vaccines,
we face competition from approved vaccines, against which new
tablet vaccines must demonstrate compelling advantages in efficacy,
convenience, tolerability and safety, and from competitors working
to patent, discover, develop or commercialize medicines before we
can do the same with tablet vaccines.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Many of our existing
or potential competitors have substantially greater financial,
technical and human resources than we do and significantly greater
experience in the discovery and development of products for the
treatment of influenza, as well as in obtaining regulatory
approvals of those products in the United States and in foreign
countries. Our current and potential future competitors also have
significantly more experience commercializing drugs that have been
approved for marketing. Mergers and acquisitions in the
pharmaceutical and biotechnology industries could result in even
more resources being concentrated among a small number of our
competitors.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Competition may
increase further as a result of advances in the commercial
applicability of technologies and greater availability of capital
for investment in these industries. Our competitors may succeed in
developing, acquiring or licensing, on an exclusive basis, drugs
that are more effective or less costly than any tablet vaccine
candidate that we may develop.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We will face
competition from other drugs currently approved or that will be
approved in the future for the treatment of the other infectious
diseases we are currently targeting. Therefore, our ability to
compete successfully will depend largely on our ability to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
develop and commercialize tablet vaccine candidates that are
superior to other vaccines in the market;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
demonstrate through our clinical trials that our tablet vaccine
candidates are differentiated from existing and future
therapies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
attract qualified scientific, vaccine development and commercial
personnel;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain patent or other proprietary protection for our tablet
vaccine candidates;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain required regulatory approvals;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain coverage and adequate reimbursement from, and negotiate
competitive pricing with, third-party payors; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
successfully develop and commercialize, independently or with
collaborators, new tablet vaccine candidates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">The
availability of our competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> vaccines
could limit the demand, and the price we are able to charge, for
any tablet vaccine candidate we develop. The inability to compete
with existing or subsequently introduced vaccines would have an
adverse impact on our business, financial condition and
prospects.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Established
pharmaceutical companies may invest heavily to accelerate discovery
and development of novel compounds or to in-license novel compounds
that could make any of its tablet vaccine candidates less
competitive. In addition, any new vaccine that competes with an
approved vaccine must demonstrate compelling advantages in
efficacy, convenience, tolerability and safety in order to overcome
price competition and to be commercially successful. Accordingly,
our competitors may succeed in obtaining patent protection,
discovering, developing, receiving the FDA<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s approval
for or commercializing medicines before we do, which would have an
adverse impact on our business and results of operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The biotechnology and
pharmaceutical industries are characterized by intense competition
to develop new technologies and proprietary products. While we
believe that our proprietary tablet vaccine candidates provide
competitive advantages, we face competition from many different
sources, including biotechnology and pharmaceutical companies,
academic institutions, government agencies, as well as public and
private research institutions. Any products that we may
commercialize will have to compete with existing products and
therapies as well as new products and therapies that may become
available in the future.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">There are other
organizations working to improve existing therapies, vaccines or
delivery methods, or to develop new vaccines, therapies or delivery
methods for its selected indications. Depending on how successful
these efforts are, it is possible they may increase the barriers to
adoption and success of our vaccine candidates, if approved.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">48</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We anticipate that we
will face intense and increasing competition as new vaccines enter
the market and advanced technologies become available. We expect
any tablet or other oral delivery vaccine candidates that we
develop and commercialize to compete on the basis of, among other
things, efficacy, safety, convenience of administration and
delivery, price, availability of therapeutics, the level of generic
competition and the availability of reimbursement from government
and other third-party payors.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our commercial
opportunity could be reduced or eliminated if our competitors
develop and commercialize products that are safer, more effective,
have fewer or less severe side effects, are more convenient or are
less expensive than any products that we may develop. Our
competitors also may obtain FDA or other regulatory approval for
their products more rapidly than we may obtain approval for our
vaccine candidates, which could result in our competitors
establishing a strong market position before we are able to enter
the market. In addition, our ability to compete may be affected in
many cases by insurers or other third-party payors seeking to
encourage the use of generic products.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We believe our
seasonal influenza vaccine candidate will compete directly with
approved vaccines in the market, which include non-recombinant and
recombinant products that are administered via injection or
intranasally. The major non-recombinant injectable vaccine
competitors include Astellas Pharma Inc., Abbott Laboratories,
AstraZeneca UK Limited, Baxter International Inc., Research
Foundation for Microbial Diseases of Osaka University,
Seqirus-bioCSL Inc., GlaxoSmithKline plc, or GlaxoSmithKline,
Sanofi S.A., or Sanofi, Pfizer Inc., and Takeda Pharmaceutical
Company Limited, or Takeda. Non-recombinant intranasal competition
includes MedImmune, Inc., or MedImmune, and potentially others.
Recombinant injectable competitors include Sanofi and Novavax,
Inc., or Novavax. Many other groups are developing new or improved
flu vaccine or delivery methods.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">There is currently no
approved norovirus vaccine for sale globally. While we are not
aware of all of our competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> efforts, we
believe, based on public statements, that Takeda is also developing
a virus-like particle-based norovirus vaccine that would be
delivered by injection.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">There is currently no
approved RSV vaccine for sale globally<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">;</font> however, a
number of vaccine manufacturers, academic institutions and other
organizations currently have, or have had, programs to develop such
a vaccine. In addition, many other companies are developing
products to prevent disease caused by RSV using a variety of
technology platforms, including monoclonal antibodies, small
molecule therapeutics, as well as various viral vector and VLP
based vaccine technologies. While we are not aware of all of our
competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> efforts, we
believe, based on public statements, that several companies are in
various stages of developing an RSV vaccine including
GlaxoSmithKline, Johnson &amp; Johnson, Bavarian Nordic, Astellas,
MedImmune, Novavax, and Sanofi, as well as the National Institute
of Allergy and Infectious Diseases, an institute under the U.S.
National Institutes of Health, and possibly others.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">There is currently no
approved HPV therapeutic vaccine for sale globally<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">;</font> however, a
number of vaccine manufacturers, academic institutions and other
organizations currently have, or have had, programs to develop such
a vaccine. We believe, based on public statements, that several
companies are in various stages of developing an HPV therapeutic
vaccine including Inovio, Advaxis, Genexine, and possibly
others.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Our tablet vaccine candidates may cause adverse
effects or have other properties that could delay or prevent their
regulatory approval or limit the scope of any approved label or
market acceptance.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Adverse events caused
by our tablet vaccine candidates could cause reviewing entities,
clinical trial sites or regulatory authorities to interrupt, delay
or halt clinical trials and could result in the denial of
regulatory approval. If an unacceptable frequency or severity of
adverse events are reported in clinical trials for our tablet
vaccine candidates, our ability to obtain regulatory approval for
such tablet vaccine candidates may be negatively impacted.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Furthermore, if any
of our tablet vaccines are approved and then cause serious or
unexpected side effects, a number of potentially significant
negative consequences could result, including:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulatory authorities may withdraw their approval of the tablet
vaccine candidates or impose restrictions on its distribution or
other risk management measures;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulatory authorities may require the addition of labeling
statements, such as warnings or contraindications;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we may be required to change the way our tablet vaccine candidates
are administered or to conduct additional clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we could be sued and held liable for injuries sustained by
patients;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we could be subject to the Vaccine Injury Compensation Program;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we could elect to discontinue the sale of its tablet vaccine
candidates; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our reputation may suffer.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">49</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Any of
these events could prevent Vaxart from achieving or maintaining
market acceptance of the affected tablet vaccine candidate and
could substantially increase the costs of commercialization.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*If we are not able to obtain, or if there are delays
in obtaining, required regulatory approvals, we will not be able to
commercialize, or will be delayed in commercializing, our tablet
vaccine candidates, and our ability to generate significant revenue
will be impaired.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our tablet vaccine
and small-molecule antiviral candidates and the activities
associated with their development and commercialization, including
their design, testing, manufacture, safety, efficacy,
recordkeeping, labeling, storage, approval, advertising, promotion,
sale and distribution, are subject to comprehensive regulation by
the FDA and other regulatory agencies in the United States and by
comparable authorities in other countries. Failure to obtain
marketing approval for a tablet vaccine candidate will prevent us
from commercializing the tablet vaccine candidate. We have not
received approval to market any of our tablet vaccine candidates
from regulatory authorities in any jurisdiction. We have only
limited experience in filing and supporting the applications
necessary to gain marketing approvals and expect to rely on CROs to
assist us in this process. Securing regulatory approval requires
the submission of extensive preclinical and clinical data and
supporting information to the various regulatory authorities for
each therapeutic indication to establish the tablet vaccine
candidate<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s safety and
efficacy. Securing regulatory approval also requires the submission
of information about the product manufacturing process to, and
inspection of manufacturing facilities by, the relevant regulatory
authority. Our tablet vaccine candidates may not be effective, may
be only moderately effective or may prove to have undesirable or
unintended side effects, toxicities or other characteristics that
may preclude us obtaining marketing approval or prevent or limit
commercial use.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The process of
obtaining marketing approvals, both in the United States and
elsewhere, is expensive, may take many years and can vary
substantially based upon a variety of factors, including the type,
complexity and novelty of the tablet vaccine candidates involved.
We cannot be sure that we will ever obtain any marketing approvals
in any jurisdiction. Changes in marketing approval policies during
the development period, changes in or the enactment of additional
statutes or regulations or changes in regulatory review for each
submitted product application may cause delays in the approval or
rejection of an application. The FDA and comparable authorities in
other countries have substantial discretion in the approval process
and may refuse to accept any application or may decide that our
data is insufficient for approval and require additional
preclinical or other studies, and clinical trials. In addition,
varying interpretations of the data obtained from preclinical
testing and clinical trials could delay, limit or prevent marketing
approval of a tablet vaccine candidate. Additionally, any marketing
approval we ultimately obtain may be limited or subject to
restrictions or post-approval commitments that render the approved
product not commercially viable.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Even if we obtain FDA approval in the United States,
we may never obtain approval for or commercialize our tablet
vaccine candidates in any other jurisdiction, which would limit our
ability to realize each product<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s full
market potential.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In order to market
any of our tablet vaccine candidates in a particular jurisdiction,
we must establish and comply with numerous and varying regulatory
requirements on a country-by-country basis regarding safety and
efficacy. Approval by the FDA in the United States does not ensure
approval by regulatory authorities in other countries or
jurisdictions. In addition, clinical trials conducted in one
country may not be accepted by regulatory authorities in other
countries, and regulatory approval in one country does not
guarantee regulatory approval in any other country. Approval
processes vary among countries and can involve additional tablet
vaccine candidate testing and validation and additional
administrative review periods. Seeking foreign regulatory approval
could result in difficulties and costs for us and require
additional preclinical studies or clinical trials which could be
costly and time consuming. Regulatory requirements can vary widely
from country to country and could delay or prevent the introduction
of our tablet vaccine candidates in those countries. We do not have
any tablet vaccine candidates approved for sale in any
jurisdiction, including in international markets, and we do not
have experience in obtaining regulatory approval in international
markets. If we fail to comply with regulatory requirements in
international markets or to obtain and maintain required approvals,
or if regulatory approvals in international markets are delayed,
our target market will be reduced and our ability to realize the
full market potential of any tablet vaccine candidate we develop
will be unrealized.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">50</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Even if we obtain regulatory approval, we will still
face extensive ongoing regulatory requirements and our tablet
vaccine candidates may face future development and regulatory
difficulties.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Any tablet vaccine
candidate for which we obtain marketing approval, along with the
manufacturing processes, post- approval clinical data, labeling,
packaging, distribution, adverse event reporting, storage,
recordkeeping, export, import, advertising and promotional
activities for such tablet vaccine candidate, among other things,
will be subject to extensive and ongoing requirements of and review
by the FDA and other regulatory authorities. These requirements
include submissions of safety, efficacy and other post-marketing
information and reports, establishment registration and drug
listing requirements, continued compliance with current Good
Manufacturing Practice, or cGMP, requirements relating to
manufacturing, quality control, quality assurance and corresponding
maintenance of records and documents, requirements regarding the
distribution of samples to physicians and recordkeeping and current
GCP requirements for any clinical trials that we conduct
post-approval. Even if marketing approval of a tablet vaccine
candidate is granted, the approval may be subject to limitations on
the indicated uses for which the tablet vaccine candidates may be
marketed or to the conditions of approval. If its tablet vaccine
candidate receives marketing approval, the accompanying label may
limit the approved use of our tablet vaccine, which could limit
sales.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The FDA may also
impose requirements for costly post-marketing studies or clinical
trials and surveillance to monitor the safety and/or efficacy of
our tablet vaccine candidates. The FDA closely regulates the
post-approval marketing and promotion of drugs to ensure drugs are
marketed only for the approved indications and in accordance with
the provisions of the approved labeling. The FDA imposes stringent
restrictions on manufacturers<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>
communications regarding off-label use and if we do not market our
tablet vaccine candidates for their approved indications, we may be
subject to enforcement action for off-label marketing. Violations
of the Federal Food, Drug, and Cosmetic Act relating to the
promotion of prescription drugs may lead to FDA enforcement actions
and investigations alleging violations of federal and state health
care fraud and abuse laws, as well as state consumer protection
laws.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In addition, later
discovery of previously unknown adverse events or other problems
with our tablet vaccine candidates, manufacturers or manufacturing
processes, or failure to comply with regulatory requirements, may
yield various results, including:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
restrictions on manufacturing such tablet vaccine candidate;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
restrictions on the labeling or marketing of a tablet vaccine
candidate;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
restrictions on tablet vaccine distribution or use;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
requirements to conduct post-marketing studies or clinical
trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
warning letters;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
withdrawal of the tablet vaccine candidate from the market;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
refusal to approve pending applications or supplements to approved
applications that we submit;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
recall of such tablet vaccine candidate;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
fines, restitution or disgorgement of profits or revenues;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
suspension or withdrawal of marketing approvals;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
refusal to permit the import or export of such tablet vaccine
candidate;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
tablet vaccine candidate seizure; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
injunctions or the imposition of civil or criminal penalties.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">The
FDA<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s policies may change, and additional government regulations
may be enacted, that could prevent, limit or delay regulatory
approval of any of our tablet vaccine candidates. If we are slow or
unable to adapt to changes in existing requirements or the adoption
of new requirements or policies, or if we are not able to maintain
regulatory compliance, we may lose any marketing approval that we
may have obtained.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Even if our tablet vaccine candidates receive
marketing approval, they may fail to achieve market acceptance by
physicians, patients, third-party payors or others in the medical
community necessary for commercial success.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If our tablet vaccine
candidates, including our vaccine for norovirus, receive marketing
approval, they may nonetheless fail to gain sufficient market
acceptance by physicians, patients, third-party payors and others
in the medical community. If they do not achieve an adequate level
of acceptance, we may not generate significant revenues and become
profitable. The degree of market acceptance, if approved for
commercial sale, will depend on a number of factors, including but
not limited to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the efficacy and potential advantages compared to alternative
treatments;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
effectiveness of sales and marketing efforts;</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">51</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the cost of treatment in relation to alternative treatments;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our ability to offer our tablet vaccine candidates for sale at
competitive prices;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the convenience and ease of administration compared to alternative
treatments;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the willingness of the target patient population to try new
therapies and of physicians to prescribe these therapies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the willingness of the medical community to offer customers our
tablet vaccine candidate option in addition to, or in the place of,
injectable vaccines;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the strength of marketing and distribution support;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the availability of third-party coverage and adequate
reimbursement;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the prevalence and severity of any side effects; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
any restrictions on the use of our tablet vaccine together with
other medications.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Because
we expect sales of our tablet vaccine candidates for norovirus, if
approved, to generate substantially all of our revenues for the
foreseeable future, the failure of this tablet vaccine to achieve
market acceptance would harm our business and could require us to
seek additional financing sooner than it otherwise plans.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*If we fail to comply with state and federal healthcare
regulatory laws, we could face substantial penalties, damages,
fines, disgorgement, exclusion from participation in governmental
healthcare programs, and the curtailment of our operations, any of
which could harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Although we do not
provide healthcare services or submit claims for third-party
reimbursement, we are subject to healthcare fraud and abuse
regulation and enforcement by federal and state governments, which
could significantly impact our business. The laws that may affect
our ability to operate include, but are not limited to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal anti-kickback statute, which prohibits, among other
things, persons and entities from knowingly and willfully
soliciting, receiving, offering, or paying remuneration, directly
or indirectly, in cash or in kind, in exchange for or to induce
either the referral of an individual for, or the purchase, lease,
order or recommendation of, any good, facility, item or service for
which payment may be made, in whole or in part, under federal
healthcare programs such as Medicare and Medicaid. A person or
entity does not need to have actual knowledge of this statute or
specific intent to violate it;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the civil False Claims Act, or FCA, which prohibits, among other
things, individuals or entities from knowingly presenting, or
causing to be presented, claims for payment from Medicare, Medicaid
or other third-party payors that are false or fraudulent; knowingly
making, using, or causing to be made or used, a false record or
statement to get a false or fraudulent claim paid or approved by
the government; or knowingly making, using, or causing to be made
or used, a false record or statement to avoid, decrease or conceal
an obligation to pay money to the federal government;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the criminal FCA, which imposes criminal fines or imprisonment
against individuals or entities who make or present a claim to the
government knowing such claim to be false, fictitious or
fraudulent;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal Health Insurance Portability and Accountability Act of
1996, or HIPAA, which created federal criminal laws that prohibit
executing a scheme to defraud any healthcare benefit program or
making false statements relating to healthcare matters;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal civil monetary penalties statute, which prohibits,
among other things, the offering or giving of remuneration to a
Medicare or Medicaid beneficiary that the person knows or should
know is likely to influence the beneficiary<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s selection
of a particular supplier of items or services reimbursable by a
Federal or state governmental program;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal physician sunshine requirements under the Affordable
Care Act, which require certain manufacturers of drugs, devices,
biologics, and medical supplies to report annually to the U.S.
Department of Health and Human Services information related to
payments and other transfers of value to physicians, other
healthcare providers, and teaching hospitals, and ownership and
investment interests held by physicians and other healthcare
providers and their immediate family members; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
state law equivalents of each of the above federal laws, such as
anti-kickback and false claims laws that may apply to items or
services reimbursed by any third-party payor, including commercial
insurers; state laws that require pharmaceutical companies to
comply with the device industry<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s voluntary
compliance guidelines and the relevant compliance guidance
promulgated by the federal government, or otherwise restrict
payments that may be made to healthcare providers and other
potential referral sources; and state laws that require device
manufacturers to report information related to payments and other
transfers of value to physicians and other healthcare providers or
marketing expenditures.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">52</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Further,
the Affordable Care Act, among other things, amended the intent
requirements of the federal anti-kickback statute and certain
criminal statutes governing healthcare fraud. A person or entity
can now be found guilty of violating the statute without actual
knowledge of the statute or specific intent to violate it. In
addition, Affordable Care Act provided that the government may
assert that a claim including items or services resulting from a
violation of the federal Anti- Kickback Statute constitutes a false
or fraudulent claim for purposes of the FCA. Moreover, while we do
not, and will not, submit claims and our customers will make the
ultimate decision on how to submit claims, we may provide
reimbursement guidance to our customers from time to time. If a
government authority were to conclude that we provided improper
advice to our customers or encouraged the submission of false
claims for reimbursement, we could face action against us by
government authorities. Any violations of these laws, or any action
against us for violation of these laws, even if we successfully
defend against it, could result in a material adverse effect on our
reputation, business, results of operations and financial
condition.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We have entered into
consulting and scientific advisory board arrangements with
physicians and other healthcare providers. Compensation for some of
these arrangements includes the provision of stock options. While
we have worked to structure our arrangements to comply with
applicable laws, because of the complex and far-reaching nature of
these laws, regulatory agencies may view these transactions as
prohibited arrangements that must be restructured, or discontinued,
or for which we could be subject to other significant penalties. We
could be adversely affected if regulatory agencies interpret our
financial relationships with providers who influence the ordering
of and use our products to be in violation of applicable laws.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The scope and
enforcement of each of these laws is uncertain and subject to rapid
change in the current environment of healthcare reform, especially
in light of the lack of applicable precedent and regulations.
Federal and state enforcement bodies have recently increased their
scrutiny of interactions between healthcare companies and
healthcare providers, which has led to a number of investigations,
prosecutions, convictions and settlements in the healthcare
industry.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Responding to
investigations can be time- and resource-consuming and can divert
management<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s attention
from the business. Additionally, as a result of these
investigations, healthcare providers and entities may have to agree
to additional onerous compliance and reporting requirements as part
of a consent decree or corporate integrity agreement. Any such
investigation or settlement could increase our costs or otherwise
have an adverse effect on our business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Product liability lawsuits against us could cause us
to incur substantial liabilities and could limit the
commercialization of any tablet vaccine candidates we may
develop.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We face an inherent
risk of product liability exposure related to the testing of our
tablet vaccine candidates in human clinical trials and will face an
even greater risk if we commercially sell any products that we may
develop after approval. For instance, since our norovirus tablet
challenge study is being conducted in healthy human volunteers, any
adverse reactions could result in claims from these injuries and we
could incur substantial liabilities. Regardless of merit or
eventual outcome, liability claims may result in:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
decreased demand for any tablet vaccine candidates that it may
develop;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
injury to our reputation and significant negative media
attention;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
withdrawal of clinical trial participants;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
significant costs to defend any related litigation;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
substantial monetary awards to trial subjects or patients;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
loss of revenue; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the inability to commercialize any products we may develop.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Although
we maintain product liability insurance coverage in the amount of
up to $5 million per claim and in the aggregate, it may not be
adequate to cover all liabilities that we may incur. Additionally,
seasonal influenza is a covered vaccine of the National Vaccine
Injury Compensation Program, and our participation in that program
may require time and resources that impede product uptake, if
approved. We anticipate that we will need to increase our insurance
coverage as we continue clinical trials and if we successfully
commercialize any products. Insurance coverage is increasingly
expensive. We may not be able to maintain insurance coverage at a
reasonable cost or in an amount adequate to satisfy any liability
that may arise.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center">53</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
a product liability claim is successfully brought against us for
uninsured liabilities, or such claim exceeds our insurance
coverage, we could be forced to pay substantial damage awards that
could materially harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The use of any of our
existing or future product candidates in clinical trials and the
sale of any approved pharmaceutical products may expose us to
significant product liability claims. We currently have product
liability insurance coverage for our ongoing clinical trials in the
amount of $5 million. Further, we also require clinical research
and manufacturing organizations that assist us in the conduct of
our trials or manufacture materials used in these trials to carry
product liability insurance against such claims. This insurance
coverage may not protect us against any or all of the product
liability claims that may be brought against us in the future. We
may not be able to acquire or maintain adequate product liability
insurance coverage at a commercially reasonable cost or in
sufficient amounts or scope to protect ourselves against potential
losses. In the event a product liability claim is brought against
us, we may be required to pay legal and other expenses to defend
the claim, as well as uncovered damage awards resulting from a
claim brought successfully against us. In the event any of our
product candidates are approved for sale by the FDA or similar
regulatory authorities in other countries and commercialized, we
may need to substantially increase the amount of our product
liability coverage. Defending any product liability claim or claims
could require us to expend significant financial and managerial
resources, which could have an adverse effect on our business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*If we are unable to establish sales, marketing and
distribution capabilities either on our own or in collaboration
with third parties, we may not be successful in commercializing our
tablet vaccine candidates, if approved.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We do not have any
infrastructure for the sales, marketing or distribution of our
tablet vaccine candidates, and the cost of establishing and
maintaining such an organization may exceed the cost-effectiveness
of doing so. In order to market any tablet vaccine candidates that
may be approved, it must build our sales, distribution, marketing,
managerial and other non-technical capabilities or make
arrangements with third parties to perform these services. To
achieve commercial success for any tablet vaccine candidates for
which we have obtained marketing approval, we will need a sales and
marketing organization. While we expect to partner our tablet
vaccines for seasonal influenza and RSV, we expect to build a
focused sales, distribution and marketing infrastructure to market
our other tablet vaccine candidates in the United States, if
approved. There are significant expenses and risks involved with
establishing our own sales, marketing and distribution
capabilities, including our ability to hire, retain and
appropriately incentivize qualified individuals, generate
sufficient sales leads, provide adequate training to sales and
marketing personnel, and effectively manage a geographically
dispersed sales and marketing team. Any failure or delay in the
development of our internal sales, marketing and distribution
capabilities could delay any tablet vaccine candidate launch, which
would adversely impact commercialization.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Factors that may
inhibit our efforts to commercialize our tablet vaccine candidates
on our own include:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our inability to recruit, train and retain adequate numbers of
effective sales and marketing personnel;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the inability of sales personnel to obtain access to physicians or
attain adequate numbers of physicians to administer our tablet
vaccines; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
unforeseen costs and expenses associated with creating an
independent sales and marketing organization.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">We intend
to pursue collaborative arrangements regarding the sale and
marketing of our tablet vaccine candidates, if approved, for
certain international markets; however, we may not be able to
establish or maintain such collaborative arrangements and, if able
to do so, our collaborators may not have effective sales. To the
extent that we depend on third parties for marketing and
distribution, any revenues we receive will depend upon the efforts
of such third parties, and there can be no assurance that such
efforts will be successful.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If we are unable to
build our own sales force in the United States or negotiate a
collaborative relationship for the commercialization of our tablet
vaccine candidates outside the United States we may be forced to
delay the potential commercialization or reduce the scope of our
sales and marketing activities. We could have to enter into
arrangements with third parties at an earlier stage than we would
otherwise choose and we may be required to relinquish rights to our
intellectual property or otherwise agree to terms unfavorable to
us, any of which may have an adverse effect on our business,
operating results and prospects.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We may be competing
with many companies that currently have extensive and well-funded
marketing and sales operations. Without an internal team or the
support of a third-party to perform marketing and sales functions,
we may be unable to compete successfully against these more
established companies.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">54</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*If we obtain approval to commercialize any tablet vaccine
candidates outside of the United States, a variety of risks
associated with international operations could harm our
business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If our tablet vaccine
candidates are approved for commercialization, we intend to enter
into agreements with third parties to market them in certain
jurisdictions outside the United States. We expect that we will be
subject to additional risks related to international operations or
entering into international business relationships, including:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
different regulatory requirements for drug approvals and rules
governing drug commercialization in foreign countries;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
reduced protection for intellectual property rights;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
unexpected changes in tariffs, trade barriers and regulatory
requirements;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
economic weakness, including inflation, or political instability in
particular foreign economies and markets;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
compliance with tax, employment, immigration and labor laws for
employees living or traveling abroad;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
foreign reimbursement, pricing and insurance regimes;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
foreign taxes;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
foreign currency fluctuations, which could result in increased
operating expenses and reduced revenues, and other obligations
incident to doing business in another country;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
workforce uncertainty in countries where labor unrest is more
common than in the United States;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
potential noncompliance with the U.S. Foreign Corrupt Practices
Act, the U.K. Bribery Act 2010 and similar anti-bribery and
anticorruption laws in other jurisdictions;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
tablet vaccination shortages resulting from any events affecting
raw material supply or manufacturing capabilities abroad; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
business interruptions resulting from geopolitical actions,
including war and terrorism, or natural disasters including
earthquakes, typhoons, floods and fires.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">We have
no prior experience in these areas. In addition, there are complex
regulatory, tax, labor and other legal requirements imposed by both
the European Union and many of the individual countries in Europe
with which we will need to comply.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Recently enacted and future legislation may increase the
difficulty and cost for us to obtain marketing approval of, and to
commercialize, our tablet vaccine candidates and affect the prices
we may obtain.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In the United States
and some foreign jurisdictions, there have been a number of
legislative and regulatory changes and proposed changes regarding
the healthcare system that could, among other things, prevent or
delay marketing approval of our tablet vaccine candidates, restrict
or regulate post-approval activities and affect our ability to
profitably sell any tablet vaccine candidates for which it obtains
marketing approval.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">For example, in March
2010, the Patient Protection and Affordable Care Act, as amended by
the Health Care Education Reconciliation Act, collectively the
Affordable Care Act, was enacted to broaden access to health
insurance, reduce or constrain the growth of healthcare spending,
enhance remedies against fraud and abuse, add new transparency
requirements for health care and health insurance industries,
impose new taxes and fees on the health industry and impose
additional health policy reforms. Although the full effect of the
Affordable Care Act may not yet be fully understood, the law has
continued the downward pressure on pharmaceutical pricing,
especially under the Medicare program, and increased the
industry<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s regulatory burdens and operating costs.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Moreover, the Drug
Supply Chain Security Act imposes obligations on manufacturers of
prescription drugs in finished dosage forms. We have not yet
adopted the significant measures that will be required to comply
with this law. We are not sure whether additional legislative
changes will be enacted, or whether the current regulations,
guidance or interpretations will be changed, or what the impact of
such changes on our business, if any, may be.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We expect that
additional state and federal healthcare reform measures will be
adopted in the future, any of which could limit the amounts that
federal and state governments will pay for healthcare vaccines,
which could result in reduced demand for our tablet vaccine
candidates or additional pricing pressures.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">55</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><b><i>*Government involvement may limit the commercial
success of our tablet vaccine candidates for influenza.</i></b></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If an influenza
outbreak occurs and is classified as a pandemic or large epidemic
by public health authorities, it is possible that one or more
government entities may take actions that directly or indirectly
have the effect of abrogating some of our rights or opportunities.
We have not manufactured a pandemic vaccine to date, but if we were
to do so, the economic value of such a vaccine to us could be
limited.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Various government
entities, including the U.S. government, are offering incentives,
grants and contracts to encourage additional investment by
commercial organizations into preventative and therapeutic agents
against influenza, which may have the effect of increasing the
number of competitors and/or providing advantages to known
competitors. Accordingly, there can be no assurance that we will be
able to successfully establish a competitive market share for our
influenza vaccines.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In addition, current
influenza vaccines are generally trivalent (contain three strains)
or quadrivalent (contain four strains). If the FDA requires or
recommends, changes in influenza vaccines, for example for a
monovalent vaccine or for use of a strain that is not currently
circulating in the human population, it is uncertain whether we
will be able to produce or manufacture such a vaccine at
commercially reasonable rates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*The seasonal nature of our target indications, in particular
influenza, may cause unpredictable royalty revenues from Relenza®
and Inavir® and significant fluctuations in our operating
results.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Influenza is seasonal
in nature with sales of current vaccines occurring primarily in the
first and fourth quarters of the calendar year. In addition,
outbreaks of norovirus and RSV typically occur in the winter
season. This seasonal concentration of product sales could cause
quarter-to-quarter operating results to vary widely and can
exaggerate the consequences of revenues of any manufacturing or
supply delays, any sudden loss of inventory, any inability to
satisfy product demand, the inability to estimate the effect of
returns and rebates, normal or unusual fluctuations in customer
buying patterns, or of any unsuccessful sales or marketing
strategies during the sales seasons.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We currently earn
royalty revenue from the net sales of Relenza<sup>®</sup> and
Inavir<sup>®</sup>, which are marketed by our licensees. Although
the royalty rates paid to us by our licensees are fixed at a
proportion of the licensees<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> net sales
of these products, our periodic and annual revenues from these
royalties have historically been variable and subject to
fluctuation based on the seasonal incidence and severity of
influenza. In addition, returns of products to our licensees that
were sold in prior years are taken into account in the calculation
of net sales for purposes of determining the royalty revenue we
receive and the amount of such returns are generally unpredictable.
Our licensees may encounter competition from new products entering
the market, which could adversely affect our royalty income. In
addition, most of our Relenza<sup>®</sup> patents have expired and
the only substantial remaining intellectual property related to the
Relenza<sup>®</sup> patent portfolio is scheduled to expire in July
2019 in Japan.&nbsp; Further, we sold a portion of our
Inavir<sup>®</sup> royalties to HealthCare Royalty Partners III,
L.P., or HCRP, in April 2016.&nbsp; We cannot predict with any
certainty what our royalty revenues are likely to be in any given
year.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
safety, tolerability, resistance, drug-drug interactions, or
efficacy concerns should arise with Relenza<sup>®</sup> or
Inavir<sup>®</sup>, our future royalty revenue may be reduced,
which would adversely affect our financial condition and
business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We currently earn
royalty revenue from Relenza<sup>®</sup> and Inavir<sup>®</sup>,
which are marketed by our licensees. Data supporting the marketing
approvals and forming the basis for the safety warnings in the
product labels for these products were obtained in controlled
clinical trials of limited duration in limited patient populations
and, in some cases, from post-approval use. As these marketed
products are used over longer periods of time and by more patients,
some with underlying health problems or taking other medicines, new
issues such as safety, tolerability, resistance or drug-drug
interaction issues could arise, which may require our licensees to
provide additional warnings or contraindications on their product
labels, or otherwise narrow the approved indications. Further,
additional information from ongoing research or clinical trials of
these products that raise any doubts or concerns about their
efficacy may arise. If serious safety, tolerability, resistance,
drug-drug interaction, efficacy, or any other concerns or issues
arise with respect to these marketed products, sales of these
products could be impaired, limited or abandoned by our licensees
or by regulatory authorities, in which case our royalty revenue
would decrease.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">56</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our success depends largely upon our ability to advance our
product candidates through the various stages of drug development.
If we are unable to successfully advance or develop our product
candidates, our business will be materially harmed.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Even though we
generate royalty revenue from our two commercialized influenza
products, all of our remaining product candidates are in early
stages of development and their commercial viability remains
subject to the successful outcome of future preclinical studies,
clinical trials, manufacturing processes, regulatory approvals and
the risks generally inherent in the development of pharmaceutical
product candidates. Failure to advance the development of one or
more of our product candidates may have a material adverse effect
on our business. The long-term success of our business ultimately
depends upon our ability to advance the development of our product
candidates through preclinical studies and clinical trials,
appropriately formulate and consistently manufacture them in
accordance with strict specifications and regulations, obtain
approval of our product candidates for sale by the FDA or similar
regulatory authorities in other countries, and ultimately have our
product candidates successfully commercialized, either by us or by
a strategic partner or licensee. We cannot be sure that the results
of our ongoing or future research, preclinical studies or clinical
trials will support or justify the continued development of our
product candidates, or that we will ultimately receive approval
from the FDA, or similar regulatory authorities in other countries,
to advance the development of our product candidates<i>.</i></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our product
candidates must satisfy rigorous regulatory standards of safety,
efficacy and manufacturing before we can advance or complete their
development and before they can be approved for sale by the FDA or
similar regulatory authorities in other countries. To satisfy these
standards, we must engage in expensive and lengthy studies and
clinical trials, develop acceptable and cost-effective
manufacturing processes, and obtain regulatory approval of our
product candidates. Despite these efforts, our product candidates
may not:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
demonstrate clinically meaningful therapeutic or other medical
benefits as compared to a patient receiving no treatment or over
existing drugs or other product candidates in development to treat
the same patient population;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be shown to be safe and effective in future preclinical studies or
clinical trials;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
have the desired therapeutic or medical effects;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be tolerable or free from undesirable or unexpected side
effects;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
meet applicable regulatory standards;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be capable of being appropriately formulated and manufactured in
commercially suitable quantities or scale and at an acceptable
cost; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
be successfully commercialized, either by us or by our licensees or
collaborators.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Even if
we demonstrate favorable results in preclinical studies and
early-stage clinical trials, we cannot be sure that the results of
late-stage clinical trials will be sufficient to support the
continued development of our product candidates. Many, if not most,
companies in the pharmaceutical and biopharmaceutical industries
have experienced significant delays, setbacks and failures in all
stages of development, including late-stage clinical trials, even
after achieving promising results in preclinical testing or
early-stage clinical trials. Accordingly, results from completed
preclinical studies and early-stage clinical trials of our product
candidates may not be predictive of the results we may obtain in
future late-stage trials. Furthermore, even if the data collected
from preclinical studies and clinical trials involving any of our
product candidates demonstrate a satisfactory safety, tolerability
and efficacy profile, such results may not be sufficient to obtain
regulatory approval from the FDA in the United States, or other
similar regulatory agencies in other jurisdictions, which is
required to market and sell the product.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="center">
<b><i>*If the actual or perceived therapeutic benefits, or the
safety or tolerability profile of any of our product candidates are
not equal to or superior to other competing treatments approved for
sale or in clinical development, we may terminate the development
of any of our product candidates at any time, and our business
prospects and potential profitability could be harmed.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We are aware of a
number of companies marketing or developing various classes of
anti-infective product candidates or products for the treatment of
patients infected with Human Rhinovirus, or HRV, HPV and RSV that
are either approved for sale or further advanced in clinical
development than ours, such that their time to approval and
commercialization may be shorter than that for our product
candidates.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">57</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Currently, there no
approved HPV-specific direct acting anti-viral drugs to treat
genital warts. Treatments for genital warts can be divided broadly
into two categories: provider-administered ablative/cytodestructive
therapies (including cryotherapy, laser ablation, and
trichloroacetic acid) and patient-administered topical therapies
such as podophyllotoxin (Condylox<sup>®</sup>; Actavis),
sinecatechins (Veregen<sup>®</sup>; Fougera Pharmaceuticals, Inc.),
and imiquimod (Zyclara<sup>®</sup>, Aldara<sup>®</sup>; Valeant).
We are aware that there are compounds under clinical development to
treat genital warts, including Novan<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s SB206 and
Cassiopea<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s CB-06-02.
We anticipate that teslexivir, if successfully developed, would
directly compete with the patient-applied topical treatments for
genital warts. We believe that key differentiating features of
teslexivir could be its mechanism of action, favorable local skin
tolerability, efficacy, and lower reoccurrence rate. Three
prophylactic vaccines, primarily designed to prevent cervical,
vulvar, vaginal, and anal cancers, are currently marketed: a
bivalent HPV16/18 vaccine (Cervarix<sup>®</sup>; GSK), quadrivalent
HPV16/18/6/11 (Gardasil<sup>®</sup>; Merck) and the 9-valent HPV
6/11/16/18/33/52/58 (Gardasil<sup>®</sup>9; Merck).
Gardasil<sup>®</sup> 9 is indicated for females aged 9 through 26
and males aged 9 through 15, to prevent various HPV related cancers
and genital warts in both sexes. Gardasil<sup>®</sup>,
Gardasil<sup>®</sup> 9, and Cervarix<sup>®</sup> are not known to
exhibit a therapeutic effect on existing HPV lesions.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Currently, there are
no approved direct-acting antiviral drugs to treat HRV infections.
However, if ever approved, our vapendavir product candidate would
indirectly compete with drugs approved to reduce the incidence of
exacerbations or improve lung function in patients with asthma and
COPD, such as fluticasone propionate (Advair<sup>®</sup>),
tiotoprium bromide (Spiriva<sup>®</sup>), fluticasone
furoate/vilanterol (Breo Ellipta<sup>®</sup>), and roflumilast
(Daliresp<sup>®</sup>). In addition to these approved drugs, there
are compounds at the clinical development stage that if
successfully developed for the treatment of HRV infections could
compete with vapendavir in the future.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Effective treatments
of RSV infections in pediatrics, the elderly, and the
immunocompromised are very limited. Currently, only
Virazole<sup>®</sup> (ribavirin) is indicated for the treatment of
hospitalized infants and young children with severe lower
respiratory tract infections due to RSV. We are aware that the
following compounds are under development to treat RSV infections:
Gilead<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">’
</font>s presatovir, Johnson &amp; Johnson<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
JJ-53718678 (ALS-8176), Ablynx<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s ALX-0171
and Ark Biosciences<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> AK0529. The
only approved drug for the prevention of RSV infections in high
risk infants is MedImmune<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
palivizumab (Synagis<sup>®</sup>), a monoclonal antibody. There are
several vaccines and antibody products designed to prevent RSV
infections in clinical development. Among the clinical stage
product candidates in development are Novavax<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s RSV F
vaccine, GSK<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
GSK3003898A vaccine, GSK<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
GSK3389245A vaccine, Bavarian Nordic<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s
BN<sup>®</sup> RSV vaccine, MedImmune<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s MEDI ÄM2-2
vaccine and MedImmune<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s monoclonal
antibody MEDI8897.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If at any time we
believe that any of our product candidates may not provide
meaningful or differentiated therapeutic benefits, perceived or
real, equal to or better than our competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> products or
product candidates, or we believe that our product candidates may
not have as favorable a safety or tolerability profile as
potentially competitive compounds, we may delay or terminate the
future development of any of our product candidates. We cannot
provide any assurance that the future development of any of our
product candidates will demonstrate any meaningful therapeutic
benefits over potentially competitive compounds currently approved
for sale or in development, or an acceptable safety or tolerability
profile sufficient to justify their continued development.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="center">
<b><i>&nbsp;Our product candidates may exhibit undesirable side
effects when used alone or in combination with other approved
pharmaceutical products, which may delay or preclude their
development or regulatory approval or limit their use if ever
approved.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Throughout the drug
development process, we must continually demonstrate the activity,
safety and tolerability of our product candidates in order to
obtain regulatory approval to further advance their clinical
development, or to eventually market them. Even if our product
candidates demonstrate adequate biologic activity and clear
clinical benefit, any unacceptable side effects or adverse events,
when administered alone or in the presence of other pharmaceutical
products, may outweigh these potential benefits. We may observe
adverse or serious adverse events or drug-drug interactions in
preclinical studies or clinical trials of our product candidates,
which could result in the delay or termination of their
development, prevent regulatory approval, or limit their market
acceptance if they are ultimately approved.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">58</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
the results from preclinical studies or clinical trials of our
product candidates, including those that are subject to existing or
future license or collaboration agreements, are unfavorable, we
could be delayed or precluded from the further development or
commercialization of our product candidates, which could materially
harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In order to further
advance the development of, and ultimately receive marketing
approval to sell our product candidates, we must conduct extensive
preclinical studies and clinical trials to demonstrate their safety
and efficacy to the satisfaction of the FDA or similar regulatory
authorities in other countries, as the case may be. Preclinical
studies and clinical trials are expensive, complex, can take many
years to complete, and have highly uncertain outcomes. Delays,
setbacks, or failures can and do occur at any time, and in any
phase of preclinical or clinical testing, and can result from
concerns about safety, tolerability, toxicity, a lack of
demonstrated biologic activity or improved efficacy over similar
products that have been approved for sale or are in more advanced
stages of development, poor study or trial design, and issues
related to the formulation or manufacturing process of the
materials used to conduct the trials. The results of prior
preclinical studies or early-stage clinical trials are not
predictive of the results we may observe in late-stage clinical
trials. In many cases, product candidates in clinical development
may fail to show the desired tolerability, safety and efficacy
characteristics, despite having favorably demonstrated such
characteristics in preclinical studies or early-stage clinical
trials.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In addition, we may
experience numerous unforeseen events during, or as a result of,
preclinical studies and the clinical trial process, which could
delay or impede our ability to advance the development of, receive
marketing approval for, or commercialize our product candidates,
including, but not limited to:&nbsp;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
communications with the FDA, or similar regulatory authorities in
different countries, regarding the scope or design of a trial or
trials, or placing the development of a product candidate on
clinical hold or delaying the next phase of development until
questions or issues are satisfactorily resolved, including
performing additional studies to answer their queries;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulatory authorities or institutional review boards, or IRBs, not
authorizing us to commence or conduct a clinical trial at a
prospective trial site;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
enrollment in our clinical trials being delayed, or proceeding at a
slower pace than we expected, because we have difficulty recruiting
participants or participants drop out of our clinical trials at a
higher rate than we anticipated;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our third-party contractors, upon whom we rely to conduct
preclinical studies, clinical trials and the manufacturing of our
clinical trial materials, failing to comply with regulatory
requirements or meet their contractual obligations to us in a
timely manner;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
having to suspend or ultimately terminate a clinical trial if
participants are being exposed to unacceptable health or safety
risks;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
regulatory authorities or IRBs requiring that we hold, suspend or
terminate its preclinical studies and clinical trials for various
reasons, including non-compliance with regulatory requirements;
and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the supply or quality of material necessary to conduct our
preclinical studies or clinical trials being insufficient,
inadequate or unavailable.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Even if
the data collected from preclinical studies or clinical trials
involving our product candidates demonstrate a satisfactory
tolerability, safety and efficacy profile, such results may not be
sufficient to support the submission of a BLA or NDA to obtain
regulatory approval from the FDA in the United States, or other
similar regulatory authorities in other foreign jurisdictions,
which is required for us to market and sell our product
candidates.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center">59</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center">&nbsp;</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="justify"><b><i>*We intend to manufacture the vaccine tablets
for the upcoming clinical studies for the foreseeable future at our
own facility. If we are unable to do so, or we are delayed, or if
the cost of manufacturing is not economically feasible or if we
cannot find a third-party supplier, we may be unable to produce
tablet vaccine candidates in a sufficient quantity to meet future
demand.</i></b></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="justify">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">From 2012 through the
end of December 2017, we relied on a third-party contract
manufacturer, Lonza Houston, Inc., for the manufacture, labeling,
packaging, storage, and distribution of vaccine tablets to supply
the clinical phase 1 and phase 2 trials we have conducted to date.
&nbsp;Going forward, we intend to manufacture Phase 1 and Phase 2
clinical trial materials for all our vaccine candidates at our own
facility in South San Francisco, California. This transition may
result in unanticipated delays and cost more than expected due to a
number of factors, including regulatory requirements.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If we are not able to
manufacture sufficient quantities of our tablet vaccine candidates,
our development activities would be impaired. In addition, our
manufacturing facility will be subject to ongoing, periodic
inspection by the FDA or other comparable regulatory agencies to
ensure compliance with cGMP. Any failure to follow and document our
adherence to such cGMP regulations or other regulatory requirements
may lead to significant delays in the availability of clinical bulk
drug substance and finished vaccine tablets for clinical trials,
which may result in the termination of, or a hold on, a clinical
trial, and may delay or prevent filing or approval of marketing
applications for our tablet vaccine candidates. We also may
encounter problems with the following:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
achieving adequate or clinical-grade materials that meet FDA or
other comparable regulatory agency standards or specifications with
consistent and acceptable production yield and costs;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
shortages of qualified personnel, raw materials or key contractors;
and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
ongoing compliance with cGMP regulations and other requirements of
the FDA or other comparable regulatory agencies.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left" align=
"justify">Developing advanced manufacturing techniques and process
controls is required to fully utilize our facilities. Advances in
manufacturing techniques may render our facilities and equipment
inadequate or obsolete.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;</i></b>If we encounter any of these problems or are
otherwise delayed, or if the cost of manufacturing at the South San
Francisco facility is not economically feasible and we cannot find
a third-party supplier, we may not be able to produce tablet
vaccine candidates in a sufficient quantity to meet future
demand.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>If
third-party vendors, upon whom we rely to conduct our preclinical
studies or clinical trials, do not perform or fail to comply with
strict regulations, these studies or trials may be delayed,
terminated, or fail, or we could incur significant additional
expenses, which could materially harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We have limited
resources dedicated to designing, conducting and managing our
preclinical studies and clinical trials. We have historically
relied on, and intend to continue to rely on, third parties,
including clinical research organizations, consultants and
principal investigators, to assist us in designing, managing,
conducting, monitoring and analyzing the data from our preclinical
studies and clinical trials. We rely on these vendors and
individuals to perform many facets of the clinical development
process on our behalf, including conducting preclinical studies,
the recruitment of sites and patients for participation in our
clinical trials, maintenance of good relations with the clinical
sites, and ensuring that these sites are conducting our trials in
compliance with the trial protocol and applicable regulations. If
these third parties fail to perform satisfactorily, or do not
adequately fulfill their obligations under the terms of our
agreements with them, we may not be able to enter into alternative
arrangements without undue delay or additional expenditures, and
therefore the preclinical studies and clinical trials of our
product candidates may be delayed or prove unsuccessful.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Further, the FDA, or
similar regulatory authorities in other countries, may inspect some
of the clinical sites participating in our clinical trials or our
third-party vendors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> sites to
determine if our clinical trials are being conducted according to
GCP or similar regulations. If we, or a regulatory authority,
determine that our third-party vendors are not in compliance with,
or have not conducted our clinical trials according to, applicable
regulations, we may be forced to exclude certain data from the
results of the trial, or delay, repeat or terminate such clinical
trials.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">60</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>We
have a limited capacity for managing clinical trials, which could
delay or impair our ability to initiate or complete clinical trials
of our product candidates on a timely basis and materially harm our
business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We have a limited
capacity to recruit and manage all of the clinical trials necessary
to obtain approval for our product candidates by the FDA or similar
regulatory authorities in other countries. By contrast, larger
pharmaceutical and biopharmaceutical companies often have
substantial staff or departments with extensive experience in
conducting clinical trials with multiple product candidates across
multiple indications and obtaining regulatory approval in various
countries. In addition, these companies may have greater financial
resources to compete for the same clinical investigators, sites and
patients that we are attempting to recruit for our clinical trials.
As a result, we may be at a competitive disadvantage that could
delay the initiation, recruitment, timing and completion of our
clinical trials and obtaining of marketing approvals, if achieved
at all, for our product candidates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;Our industry is highly competitive and subject to rapid
technological changes. As a result, we may be unable to compete
successfully or develop innovative or differentiated products,
which could harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our industry is
highly competitive and characterized by rapid technological change.
Key competitive factors in our industry include, among others, the
ability to successfully advance the development of a product
candidate through preclinical and clinical trials; the efficacy,
toxicology, tolerability, safety, resistance or cross-resistance,
interaction or dosing profile of a product or product candidate;
the timing and scope of marketing approvals, if ever achieved;
reimbursement rates for and the average selling price of competing
products and pharmaceutical products in general; the availability
of raw materials and qualified contract manufacturing and
manufacturing capacity to produce our product candidates; relative
manufacturing costs; establishing, maintaining and protecting our
intellectual property and patent rights; and sales and marketing
capabilities.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Developing
pharmaceutical product candidates is a highly competitive,
expensive and risky activity with a long business cycle. Many
organizations, including the large pharmaceutical and
biopharmaceutical companies that have existing products on the
market or in clinical development that may compete with our product
candidates, have substantially more resources than us, as well as
much greater capabilities and experience than we have in research
and discovery, designing and conducting preclinical studies and
clinical trials, operating in a highly regulated environment,
formulating and manufacturing drug substances, products and
devices, and marketing and sales. Our competitors may be more
successful than us in obtaining regulatory approvals for their
product candidates and achieving broad market acceptance once they
are approved. Our competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> products or
product candidates may be more effective, have fewer adverse
effects, be more convenient to administer, have a more favorable
resistance profile, or be more effectively marketed and sold than
any product that we, or our potential future licensees or
collaborators, may develop or commercialize. New drugs or classes
of drugs from competitors may render our product candidates
obsolete or non-competitive before we are able to successfully
develop them or, if approved, before we can recover the expenses of
developing and commercializing them. We anticipate that we, or our
potential future licensees or collaborators, will face intense and
increasing competition as new drugs and drug classes enter the
market and advanced technologies or new drug targets become
available. If our product candidates do not demonstrate any
meaningful competitive advantages over existing products, or new
products or product candidates, we may terminate the development or
commercialization of our product candidates at any time.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our competitors,
either alone or with their collaborators, may succeed in developing
product candidates or products that are more effective, safer, less
expensive or easier to administer than ours. Accordingly, our
competitors may succeed in obtaining regulatory approval for their
product candidates more rapidly than we can. Companies that can
complete clinical trials, obtain required marketing approvals and
commercialize their products before their competitors do so may
achieve a significant competitive advantage, including certain
patent and marketing exclusivity rights that could delay the
ability of competitors to market certain products.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We also face, and
expect that we will continue to face, intense competition from
other companies in a number of other areas, including (i)
attracting larger pharmaceutical and biopharmaceutical companies to
enter into collaborative arrangements with us to acquire, license
or co-develop our product candidates, (ii) identifying and
obtaining additional clinical-stage development programs to bolster
our pipeline, (iii) attracting investigators and clinical sites
capable of conducting our clinical trials, and (iv) recruiting
patients to participate in our clinical trials. There can be no
assurance that product candidates resulting from our research and
development efforts, or from joint efforts with our potential
future licensees or collaborators, will be able to compete
successfully with our competitors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> existing
products or product candidates in development.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">61</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>We
may be unable to successfully develop a product candidate that is
the subject of an existing or future license agreement or
collaboration if our licensee or collaborator does not perform or
fulfill its contractual obligations, delays the development of our
product candidate, or terminates the agreement.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We expect to continue
to enter into and rely on license and collaboration agreements in
the future, or other similar business arrangements with third
parties, to further develop and/or commercialize some or all of our
existing and future product candidates. Such licensees or
collaborators may not perform as agreed upon or anticipated, may
fail to comply with strict regulations, or may elect to delay or
terminate their efforts in developing or commercializing our
product candidates even though we have met our obligations under
the arrangement.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">A majority of the
potential revenue from existing and any future licenses and
collaborations we may enter into will likely consist of contingent
milestone payments, such as payments received for achieving
development or regulatory milestones, and royalties payable on the
sales of approved products. Milestone and royalty revenues that we
may receive under these licenses and collaborations will depend
primarily upon our licensees<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> or
collaborators<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> ability to
successfully develop and commercialize our product candidates. In
addition, our licensees or collaborators may decide to enter into
arrangements with third parties to commercialize products developed
under our existing or future collaborations using our technologies,
which could reduce the milestone and royalty revenue that we may
receive, if any. In many cases, we will not be directly or closely
involved in the development or commercialization of our product
candidates that are subject to licenses or collaborations and,
accordingly, we will depend largely on our licensees or
collaborators to develop or commercialize our product candidates.
Our licensees may encounter competition from new products entering
the market, which could adversely affect our royalty income. Our
licensees or collaborators may fail to develop or effectively
commercialize our product candidates because they:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
do not allocate the necessary resources due to internal
constraints, such as limited personnel with the requisite
scientific expertise, limited capital resources, or the belief that
other product candidates or internal programs may have a higher
likelihood of obtaining regulatory approval, or may potentially
generate a greater return on investment;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
do not have sufficient resources necessary to fully support the
product candidate through clinical development, regulatory approval
and commercialization;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
are unable to obtain the necessary regulatory approvals; or</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
prioritize other programs or otherwise diminish their support for
developing and/or marketing our product candidate or product due to
a change in management, business operations or strategy.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Should
any of these events occur, we may not realize the full potential or
intended benefit of our license or collaboration arrangements, and
our results of operations may be adversely affected. In addition, a
licensee or collaborator may decide to pursue the development of a
competitive product candidate developed outside of our agreement
with them. Conflicts may also arise if there is a dispute about the
progress of, or other activities related to, the clinical
development or commercialization of a product candidate, the
achievement and payment of a milestone amount, the ownership of
intellectual property that is developed during the course of the
arrangement, or other license agreement terms. If a licensee or
collaborator fails to develop or effectively commercialize our
product candidates for any of these reasons, we may not be able to
replace them with another third party willing to develop and
commercialize our product candidates under similar terms, if at
all. Similarly, we may disagree with a licensee or collaborator as
to which party owns newly or jointly-developed intellectual
property. Should an agreement be revised or terminated as a result
of a dispute and before we have realized the anticipated benefits
of the arrangement, we may not be able to obtain certain
development support or revenues that we anticipated receiving. We
may also be unable to obtain, on terms acceptable to us, a license
from such collaboration partner to any of its intellectual property
that may be necessary or useful for us to continue to develop and
commercialize the product candidate. There can be no assurance that
any product candidates will emerge from any existing or future
license or collaboration agreements we may enter into for any of
our product candidates.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center">62</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; CLEAR:left"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;If government and third-party payers fail to provide
adequate reimbursement or coverage for our products or those that
are developed through licenses or collaborations, our revenues and
potential for profitability may be harmed.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In the United States
and most foreign markets, product revenues or related royalty
revenue, and therefore the inherent value of our products, will
depend largely upon the reimbursement rates established by
third-party payers for such products. Third-party payers include
government health administration authorities, managed-care
organizations, private health insurers and other similar
organizations. Third-party payers are increasingly examining the
cost effectiveness of medical products, services and pharmaceutical
drugs and challenging the price of these products and services. In
addition, significant uncertainty exists as to the reimbursement
status, if any, of newly approved pharmaceutical products. Further,
the comparative effectiveness of new products over existing
therapies and the assessment of other non-clinical outcomes are
increasingly being considered in the decision by payers to
establish reimbursement rates. We, or our licensees or
collaborators if applicable, may also be required to conduct
post-marketing clinical trials in order to demonstrate the
cost-effectiveness of our products. Such studies may require us to
commit a significant amount of management time and financial
resources. There can be no assurance that any products that we or
our licensees or collaborators may successfully develop will be
reimbursed in part, or at all, by any third-party payers in any
country.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Many governments
continue to propose legislation designed to expand the coverage,
yet reduce the cost, of healthcare, including pharmaceutical
products. In many foreign markets, governmental agencies control
the pricing of prescription drugs. In the United States,
significant changes in federal health care policy were approved
over the past several years and continue to evolve and will likely
result in reduced reimbursement rates for many pharmaceutical
products in the future. We expect that there will continue to be
federal and state proposals to implement increased government
control over reimbursement rates of pharmaceutical products. In
addition, we expect that increasing emphasis on managed care and
government intervention in the U.S. healthcare system will continue
to put downward pressure on the pricing of pharmaceutical products
there. Recent events have resulted in increased public and
governmental scrutiny of the cost of drugs, especially in
connection with price increases following companies<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>
acquisitions of the rights to certain drug products. In particular,
U.S. federal prosecutors recently issued subpoenas to a
pharmaceutical company seeking information about its drug pricing
practices, among other issues, and members of the U.S. Congress
have sought information from certain pharmaceutical companies
relating to post-acquisition drug-price increases. Our revenue and
future profitability could be negatively affected if these
inquiries were to result in legislative or regulatory proposals
that limit our ability to increase the prices of our products that
may be approved for sale in the future. Legislation and regulations
affecting the pricing of pharmaceutical products may change before
our product candidates are approved for sale, which could further
limit or eliminate their reimbursement rates. Further, social and
patient activist groups, whose goal it is to reduce the cost of
healthcare, and in particular the price of pharmaceutical products,
may also place downward pressure on the price of these products,
which could result in decreases in the price of our products.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;If any product candidates that we develop
independently, or through licensees or collaborators if applicable,
are approved but do not gain meaningful acceptance in their
intended markets, we are not likely to generate significant
revenues.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Even if our product
candidates are successfully developed and we or a licensee or
collaborator obtains the requisite regulatory approvals to market
them in the future, they may not gain market acceptance or broad
utilization among physicians, patients or third-party payers. The
degree of market acceptance that any of our products may achieve
will depend on a number of factors, including:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the efficacy or perceived clinical benefit of the product, if any,
relative to existing therapies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the timing of market approval and the existing market for
competitive drugs, including the presence of generic drugs;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the level of reimbursement provided by third-party payers to cover
the cost of the product to patients;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the net cost of the product to the user or third-party payer;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the convenience and ease of administration of the product;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the product<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s potential
advantages over existing or alternative therapies;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the actual or perceived safety of similar classes of products;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the actual or perceived existence, incidence and severity of
adverse effects;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the effectiveness of sales, marketing and distribution
capabilities; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the scope of the product label approved by the FDA or similar
regulatory agencies in other jurisdictions.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">63</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">There can
be no assurance that physicians will choose to prescribe or
administer our products, if approved, to the intended patient
population. If our products do not achieve meaningful market
acceptance, or if the market for our products proves to be smaller
than anticipated, we may never generate significant revenues.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*Our headquarters is located near known earthquake
fault zones. The occurrence of an earthquake, fire or any other
catastrophic event could disrupt our operations or the operations
of third parties who provide vital support functions to us, which
could have a material adverse effect on our business and financial
condition.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We are vulnerable to
damage from catastrophic events, such as power loss, natural
disasters, terrorism and similar unforeseen events beyond our
control. Our corporate headquarters and other facilities are
located in the San Francisco Bay Area, which in the past has
experienced severe earthquakes and fires.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We do not have a
disaster recovery and business continuity plan in place.
Earthquakes or other natural disasters could severely disrupt our
operations and have a material adverse effect on our business,
results of operations, financial condition and prospects.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If a natural
disaster, power outage or other event occurred that prevented us
from using all or a significant portion of our headquarters,
damaged critical infrastructure, such as our financial systems or
manufacturing facility, or that otherwise disrupted our operations,
it may be difficult or, in certain cases, impossible for us to
continue business operations for a substantial period of time.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="center">
<b>&nbsp;Risks Related to Dependence on Third Parties</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>&nbsp;*If third-party contract manufacturers, upon whom we
may have to rely to formulate and manufacture our product
candidates, do not perform, fail to manufacture according to our
specifications, or fail to comply with strict government
regulations, our preclinical studies or clinical trials could be
adversely affected and the development of our product candidates
could be delayed or terminated, or we could incur significant
additional expenses.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our reliance on these
third-party contract manufacturers, which in some cases may be sole
sourced, exposes us to a number of risks, any of which could delay
or prevent the completion of our preclinical studies or clinical
trials, or the regulatory approval or commercialization of our
product candidates, result in higher costs, or deprive us of
potential product revenues in the future. Some of these risks
include, but are not limited to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers failing to develop an acceptable
formulation to support late-stage clinical trials for, or the
commercialization of, our product candidates;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers failing to manufacture our product
candidates according to their own standards, our specifications,
current good manufacturing practices, or cGMP, or regulatory
guidelines, or otherwise manufacturing material that we or
regulatory authorities deem to be unsuitable for our clinical
trials or commercial use;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers being unable to increase the scale of or
the capacity for, or reformulate the form of, our product
candidates, which may cause us to experience a shortage in supply
or cause the cost to manufacture our product candidates to
increase. There can be no assurance that our contract manufacturers
will be able to manufacture our product candidates at a suitable
commercial scale, or that we will be able to find alternative
manufacturers acceptable to us that can do so;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers placing a priority on the manufacture of
other customers<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> or their
own products, rather than our products;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers failing to perform as agreed or exiting
from the contract manufacturing business; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our contract manufacturers<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> plants
being closed as a result of regulatory sanctions or a natural
disaster.</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center">64</p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style=
"MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-LEFT:0px; MARGIN-LEFT:0px; TEXT-INDENT:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">
Manufacturers of pharmaceutical drug products are subject to
ongoing periodic inspections by the FDA, the U.S. Drug Enforcement
Administration, or DEA, and corresponding state and other foreign
agencies to ensure strict compliance with FDA-mandated cGMPs, other
government regulations and corresponding foreign standards. We do
not have control over our third-party contract
manufacturers<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> compliance
with these regulations and standards and accordingly, failure by
our third-party manufacturers, or us, to comply with applicable
regulations could result in sanctions being imposed on us or our
manufacturers, which could significantly and adversely affect our
business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left"><b><i>In
the event that we need to change our third-party contract
manufacturers, our preclinical studies or our clinical trials, the
commercialization of our product candidates could be delayed,
adversely affected or terminated, or such a change may result in
the need for us to incur significantly higher costs, which could
materially harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Due to
various regulatory restrictions in the United States and many other
countries, as well as potential capacity constraints on
manufacturing that occur from time-to-time in our industry, various
steps in the manufacture of our product candidates are sole-sourced
to certain contract manufacturers. In accordance with cGMPs,
changing manufacturers may require the re-validation of
manufacturing processes and procedures, and may require further
preclinical studies or clinical trials to show comparability
between the materials produced by different manufacturers. Changing
our current or future contract manufacturers may be difficult, if
not impossible for us, and could be extremely costly if we do make
such a change, which could result in our inability to manufacture
its product candidates for an extended period of time and a delay
in the development of its product candidates. Further, in order to
maintain its development timelines in the event of a change in a
third-party contract manufacturer, we may incur significantly
higher costs to manufacture our product candidates.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We may not be able to manufacture our product candidates in
sufficient quantities to commercialize them.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">In
order to receive FDA approval of our product candidates, we will
need to manufacture such product candidates in larger quantities.
We may not be able to increase successfully the manufacturing
capacity for our product candidates in a timely or economic manner,
or at all. In the event FDA approval is received, we will need to
increase production of our product candidates.
Significant&nbsp;scale-up&nbsp;of manufacturing may require
additional validation studies, which the FDA must review and
approve. If we are unable to successfully increase the
manufacturing capacity for our product candidates, the clinical
trials, the regulatory approval and the commercial launch of our
product candidates may be delayed, or there may be a shortage in
supply. Our product candidates require precise, high quality
manufacturing. Failure to achieve and maintain high quality
manufacturing, including the incidence of manufacturing errors,
could result in patient injury or death, delays or failures in
testing or delivery, cost overruns or other problems that could
harm our business, financial condition and results of
operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*The manufacture of pharmaceutical products in compliance
with cGMP regulations requires significant expertise and capital
investment, including the development of advanced manufacturing
techniques and process controls.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Manufacturers of
pharmaceutical products often encounter difficulties in production,
including difficulties with production costs and yields, quality
control, including stability of the product candidates and quality
assurance testing, or shortages of qualified personnel. If we were
to encounter any of these difficulties or otherwise fail to comply
with our obligations under applicable regulations, our ability to
provide study materials in our clinical trials would be
jeopardized. Any delay or interruption in the supply of clinical
trial materials could delay the completion of our clinical trials,
increase the costs associated with maintaining our clinical trial
programs and, depending upon the period of delay, require us to
commence new trials at significant additional expense or to
terminate the studies and trials completely.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We must comply with
cGMP requirements enforced by the FDA through its facilities
inspection program. These requirements include, among other things,
quality control, quality assurance and the maintenance of records
and documentation. Manufacturers of our component materials may be
unable to comply with these cGMP requirements and with other FDA,
state and foreign regulatory requirements. The FDA or similar
foreign regulatory agencies at any time may also implement new
standards, or change their interpretation and enforcement of
existing standards for manufacture, packaging or testing of
products. We have little control over our manufacturers<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> compliance
with these regulations and standards. A failure to comply with
these requirements may result in fines and civil penalties,
suspension of production, suspension or delay in product approval,
product seizure or recall, or withdrawal of product approval. If
the safety of any product supplied is compromised due to our
failure, or that our third-party manufacturers, to adhere to
applicable laws or for other reasons, we may not be able to obtain
regulatory approval for or successfully commercialize our products,
and we may be held liable for any injuries sustained as a result.
Any of these factors could cause a delay of clinical trials,
regulatory submissions, approvals or commercialization of any
product candidates we may develop or acquire in the future, or
entail higher costs, or impair our reputation.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">65</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*We currently
rely on single source vendors for key tablet vaccine components and
certain strains needed in our tablet vaccine candidates, which
could impair our ability to manufacture and supply our tablet
vaccine candidates.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We currently depend
on single source vendors for certain raw materials used in the
manufacture of our tablet vaccine candidates. Any production
shortfall that impairs the supply of the relevant raw materials
could have a material adverse effect on our business, financial
condition and results of operations. An inability to continue to
source product from these suppliers, which could be due to
regulatory actions or requirements affecting the supplier, adverse
financial or other strategic developments experienced by a
supplier, labor disputes or shortages, unexpected demands or
quality issues, could materially adversely affect our operating
results or our ability to conduct clinical trials, either of which
could significantly harm our business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*We intend to
rely on third parties to conduct, supervise and monitor our
clinical trials, and if those third parties perform in an
unsatisfactory manner, it may harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We intend to rely on
CROs and clinical trial sites to ensure the proper and timely
conduct of our clinical trials, and we expect to have limited
influence over their actual performance.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We intend to rely
upon CROs to monitor and manage data for our clinical programs, as
well as the execution of future nonclinical studies. We expect to
control only certain aspects of our CROs<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font> activities.
Nevertheless, we will be responsible for ensuring that each of our
studies is conducted in accordance with the applicable protocol,
legal, regulatory and scientific standards and our reliance on the
CROs does not relieve us of these regulatory responsibilities.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We and our CROs will
be required to comply with the Good Laboratory Practices and GCPs,
which are regulations and guidelines enforced by the FDA and are
also required by the Competent Authorities of the Member States of
the European Economic Area and comparable foreign regulatory
authorities in the form of International Conference on
Harmonization guidelines for any of our product candidates that are
in preclinical and clinical development. The Regulatory authorities
enforce GCPs through periodic inspections of trial sponsors,
principal investigators and clinical trial sites. If we or our CROs
fail to comply with GCPs, the clinical data generated in our
clinical trials may be deemed unreliable and the FDA or comparable
foreign regulatory authorities may require us to perform additional
clinical trials before approving our marketing applications.
Accordingly, if our CROs fail to comply with these regulations or
fail to recruit a sufficient number of subjects, we may be required
to repeat clinical trials, which would delay the regulatory
approval process.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our CROs will not be
our employees, and we will not control whether or not they devote
sufficient time and resources to our future clinical and
nonclinical programs. These CROs may also have relationships with
other commercial entities, including our competitors, for whom they
may also be conducting clinical trials, or other drug development
activities which could harm our competitive position. We face the
risk of potential unauthorized disclosure or misappropriation of
our intellectual property by CROs, which may reduce our trade
secret protection and allow our potential competitors to access and
exploit our proprietary technology. If our CROs do not successfully
carry out their contractual duties or obligations, fail to meet
expected deadlines, or if the quality or accuracy of the clinical
data they obtain is compromised due to the failure to adhere to our
clinical protocols or regulatory requirements or for any other
reasons, our clinical trials may be extended, delayed or
terminated, and we may not be able to obtain regulatory approval
for, or successfully commercialize, any product candidate that we
develop. As a result, our financial results and the commercial
prospects for any product candidate that we develop would be
harmed, our costs could increase, and our ability to generate
significant revenues could be delayed.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If our relationship
with these CROs terminate, we may not be able to enter into
arrangements with alternative CROs or do so on commercially
reasonable terms. Switching or adding additional CROs involves
substantial cost and requires management time and focus. In
addition, there is a natural transition period when a new CRO
commences work. As a result, delays occur, which can materially
impact our ability to meet our desired clinical development
timelines. Though we intend to carefully manage our relationships
with our CROs, there can be no assurance that we will not encounter
challenges or delays in the future or that these delays or
challenges will not have an adverse impact on our business,
financial condition and prospects.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*We may seek to
selectively establish collaborations, and, if we are unable to
establish them on commercially reasonable terms, we may have to
alter our development and commercialization plans.</i></b></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px">
Our product development programs and the potential
commercialization of our product candidates will require
substantial additional cash to fund expenses. For some of our
product candidates, including our seasonable influenza and RSV
tablets, we may decide to collaborate with governmental entities or
additional pharmaceutical and biotechnology companies for the
development and potential commercialization of those product
candidates.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">66</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We face significant
competition in seeking appropriate collaborators. Whether we reach
a definitive agreement for a collaboration will depend, among other
things, upon our assessment of the collaborator<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s resources
and expertise, the terms and conditions of the proposed
collaboration and the proposed collaborator<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s evaluation
of a number of factors. Those factors may include the design or
results of clinical trials, the likelihood of approval by the FDA
or similar regulatory authorities outside the United States, the
potential market for the subject product candidate, the costs and
complexities of manufacturing and delivering such product candidate
to patients, the potential of competing products, the existence of
uncertainty with respect to our ownership of technology, which can
exist if there is a challenge to such ownership without regard to
the merits of the challenge and industry and market conditions
generally. The collaborator may also consider alternative product
candidates for similar indications that may be available to
collaborate on and whether such a collaboration could be more
attractive than the one with us for our product candidate.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*Our
relationships with customers and third-party payors will be subject
to applicable anti-kickback, fraud and abuse and other healthcare
laws and regulations, which could expose us to criminal sanctions,
civil penalties, contractual damages, reputational harm and
diminished profits and future earnings.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Healthcare providers,
physicians and third-party payors play a primary role in the
recommendation and prescription of any product candidates for which
we obtain marketing approval. Our future arrangements with
third-party payors and customers may expose us to broadly
applicable fraud and abuse and other healthcare laws and
regulations that may constrain the business or financial
arrangements and relationships through which we market, sell and
distribute our medicines for which we obtain marketing approval.
Restrictions under applicable federal and state healthcare laws and
regulations include the following:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal healthcare anti-kickback statute prohibits, among other
things, persons from knowingly and willfully soliciting, offering,
receiving or providing remuneration, directly or indirectly, in
cash or in kind, to induce or reward either the referral of an
individual for, or the purchase, order or recommendation of, any
good or service, for which payment may be made under federal and
state healthcare programs such as Medicare and Medicaid;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal FCA imposes criminal and civil penalties, including
civil whistleblower or qui tam actions, against individuals or
entities for knowingly presenting, or causing to be presented, to
the federal government, claims for payment that are false or
fraudulent or making a false statement to avoid, decrease or
conceal an obligation to pay money to the federal government;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal HIPAA, as amended by the Health Information Technology
for Economic and Clinical Health Act, imposes criminal and civil
liability for executing a scheme to defraud any healthcare benefit
program and also imposes obligations, including mandatory
contractual terms, with respect to safeguarding the privacy,
security and transmission of individually identifiable health
information;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal false statements statute prohibits knowingly and
willfully falsifying, concealing or covering up a material fact or
making any materially false statement in connection with the
delivery of or payment for healthcare benefits, items or
services;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
the federal transparency requirements under the Affordable Care Act
requires manufacturers of drugs, devices, biologics and medical
supplies to report to the Department of Health and Human Services
information related to physician payments and other transfers of
value and physician ownership and investment interests; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
analogous state laws and regulations, such as state anti-kickback
and false claims laws, may apply to sales or marketing arrangements
and claims involving healthcare items or services reimbursed by
non- governmental third-party payors, including private insurers,
and some state laws require pharmaceutical companies to comply with
the pharmaceutical industry<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s voluntary
compliance guidelines and the relevant compliance guidance
promulgated by the federal government in addition to requiring
vaccine manufacturers to report information related to payments to
physicians and other health care providers or marketing
expenditures.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:13px; CLEAR:left" align=
"center"><b>&nbsp;Risks Related to Intellectual Property</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:13px; CLEAR:left" align=
"left"><b><i>*If we are unable to obtain and maintain patent
protection for our platform technology and product candidates or if
the scope of the patent protection obtained is not sufficiently
broad, we may not be able to compete effectively in our
markets.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We rely upon a
combination of patents, trade secret protections and
confidentiality agreements to protect the intellectual property
related to our drug development programs and product candidates.
Our success depends in large part on our ability to obtain and
maintain patent protection in the United States and other
countries. We seek to protect our proprietary position by filing
patent applications in the United States and abroad related to our
development programs and product candidates. The patent prosecution
process is expensive and time-consuming, and we may not be able to
file and prosecute all necessary or desirable patent applications
at a reasonable cost or in a timely manner.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">67</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">It is also possible
that we will fail to identify patentable aspects of our research
and development output before it is too late to obtain patent
protection. The patent applications that we own or in-license may
fail to result in issued patents with claims that cover any of our
product candidates in the United States or in other countries.
There is no assurance that the entire potentially relevant prior
art relating to our patents and patent applications has been found,
which can invalidate a patent or prevent a patent from issuing from
a pending patent application. Even if patents do successfully
issue, third parties may challenge their validity, enforceability
or scope, which may result in such patents being narrowed,
invalidated, or held unenforceable. Any successful challenge to
these patents or any other patents owned by or licensed to us could
deprive us of rights necessary for the successful commercialization
of any product candidates or companion diagnostic that we may
develop. Further, if we encounter delays in regulatory approvals,
the period of time during which we could market a product candidate
and companion diagnostic under patent protection could be
reduced.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">If the patent
applications we hold with respect to our platform technology and
product candidates fail to issue, if their breadth or strength of
protection is threatened, or if they fail to provide meaningful
exclusivity for our product candidates, it could dissuade companies
from collaborating with us to develop product candidates and
threaten our ability to commercialize future drugs. Any such
outcome could harm our business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The patent position
of biotechnology and pharmaceutical companies generally is highly
uncertain, involves complex legal and factual questions and has in
recent years been the subject of much litigation. In addition, the
laws of foreign countries may not protect its rights to the same
extent as the laws of the United States. For example, European
patent law restricts the patentability of methods of treatment of
the human body more than U.S. law does. Publications of discoveries
in scientific literature often lag behind the actual discoveries,
and patent applications in the United States and other
jurisdictions are typically not published until 18 months after
filing, or in some cases not at all. Therefore, we cannot know with
certainty whether we were the first to make the inventions claimed
in our owned or licensed patents or pending patent applications, or
that we were the first to file for patent protection of such
inventions. As a result, the issuance, scope, validity,
enforceability and commercial value of our patent rights are highly
uncertain. Our pending and future patent applications may not
result in patents being issued which protect our technology or
product candidates, in whole or in part, or which effectively
prevent others from commercializing competitive technologies and
vaccines. Changes in either the patent laws or interpretation of
the patent laws in the United States and other countries may
diminish the value of our patents or narrow the scope of our patent
protection.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Recent patent reform
legislation could increase the uncertainties and costs surrounding
the prosecution of our patent applications and the enforcement or
defense of its issued patents. On September 16, 2011, the
Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed
into law. The Leahy-Smith Act includes a number of significant
changes to United States patent law. These include provisions that
affect the way patent applications are prosecuted and may also
affect patent litigation. The U.S. Patent Office recently developed
new regulations and procedures to govern administration of the
Leahy-Smith Act, and many of the substantive changes to patent law
associated with the Leahy-Smith Act, and in particular, the first
to file provisions, only became effective on March 16, 2013.
Accordingly, it is not clear what, if any, impact the Leahy-Smith
Act will have on the operation of our business. However, the
Leahy-Smith Act and its implementation could increase the
uncertainties and costs surrounding the prosecution of our patent
applications and the enforcement or defense of our issued patents,
all of which could have an adverse effect on our business and
financial condition.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Moreover, we may be
subject to a third-party pre-issuance submission of prior art to
the U.S. Patent and Trademark Office, or USPTO, or become involved
in derivation, reexamination, inter partes review, post-grant
review or interference proceedings challenging our patent rights or
the patent rights of others. In other countries, we may be subject
to or become involved in opposition proceedings challenging our
patent rights or the patent rights of others. An adverse
determination in any such submission or proceeding could reduce the
scope of, or invalidate, our patent rights, allow third parties to
commercialize our technology or product candidates and compete
directly with us, without payment to us, or result in our inability
to manufacture or commercialize product candidates without
infringing third-party patent rights. In addition, if the breadth
or strength of protection provided by our patents and patent
applications is threatened, it could dissuade companies from
collaborating with us to license, develop or commercialize current
or future product candidates.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">68</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The issuance of a
patent is not conclusive as to its inventorship, scope, validity or
enforceability, and our owned and licensed patents may be
challenged in the courts or patent offices in the United States and
abroad. Such challenges may result in patent claims being narrowed,
invalidated or held unenforceable, in whole or in part, which could
limit our ability to stop others from using or commercializing
similar or identical technology and tablet vaccines or small
molecule antivirals, or limit the duration of the patent protection
of our technology and product candidates. Moreover, patents have a
limited lifespan. In the United States and other countries, the
natural expiration of a patent is generally 20 years after it is
filed. Various extensions may be available, however, the life of a
patent, and the protection it affords, is limited. Without patent
protection for our current or future tablet vaccine and
small-molecule antiviral drug candidates, we may be open to
competition from generic versions of such product candidates. Given
the amount of time required for the development, testing and
regulatory review of new product candidates, patents protecting
such candidates might expire before or shortly after such
candidates are commercialized. As a result, our owned and licensed
patent portfolio may not provide us with sufficient rights to
exclude others from commercializing product candidates similar or
identical to ours.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*If we are
unable to adequately protect or expand our intellectual property
related to products acquired in the Merger, our business prospects
could be materially harmed.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our business success
depends in part on our ability to:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
obtain, maintain and protect our intellectual property rights;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
protect our trade secrets; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
prevent others from infringing on our proprietary rights or
patents.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">We can
protect our proprietary intellectual property rights from
unauthorized use by third parties only to the extent that our
proprietary rights are covered by valid and enforceable patents or
are effectively maintained as trade secrets. The patent position of
pharmaceutical and biopharmaceutical companies involves complex
legal and factual questions, and, therefore, we cannot predict with
certainty whether we will be able to ultimately enforce our patents
or proprietary rights or avoid infringing on the patents or
proprietary rights of others. Any issued patents that we own or
otherwise have rights to may be challenged, invalidated or
circumvented, and may not provide us with the protection against
competitors that we anticipate.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The degree of future
protection of our proprietary intellectual property rights is
uncertain because issued patents and other legal means of
establishing proprietary rights afford only limited protection and
may not adequately protect our rights or permit us to gain or keep
our competitive advantage. Our future patent position will be
influenced by the following factors:</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
we, or our licensors, may not have been the first to discover the
inventions covered by each of our, or our licensors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>, pending
patent applications and issued patents, and we may have to engage
in expensive and protracted interference proceedings to determine
priority of invention;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our, or our licensors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>, pending
patent applications may be denied and may not result in issued
patents;</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:8px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
our, or its licensors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>, issued
patents may not provide a basis for commercially viable products,
may not provide us with any competitive advantages, or may be
challenged by third parties; and</p>
<p style=
"MARGIN-BOTTOM:-2px; FONT-FAMILY:'Symbol'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left; CLEAR:left; TEXT-INDENT:24px">
·</p>
<p style=
"MARGIN-BOTTOM:13px; MARGIN-TOP:0px; PADDING-LEFT:48px; TEXT-INDENT:-2px">
third parties may develop intellectual property that circumvents
our, or our licensors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>, patent
claims, or design competitive intellectual property and ultimately
product candidates that fall outside the scope of our, or our
licensors<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>,
patents.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px; CLEAR:left">Due to
the extensive time required for the development, testing and
regulatory review and approval of a product candidate, it is
possible that before our product candidates may be approved for
sale and commercialized, our relevant patent rights may expire, or
such patent rights may remain in force for only a short period
following marketing approval. We currently rely on certain patents
to provide us and our licensees with exclusive rights for certain
of our products. When all patents underlying a license expire, our
revenue from that license may cease, and there can be no assurance
that we will be able to replace it with revenue from new or
existing licenses.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Zanamivir, a
neuraminidase inhibitor approved for the treatment and prevention
of influenza A and B, is marketed worldwide as Relenza<sup>®</sup>
by GSK. Most of our Relenza<sup>®</sup> patents have expired and
the only substantial remaining intellectual property related to the
Relenza<sup>®</sup> patent portfolio, which we own and have
exclusively licensed to GSK, is scheduled to expire in July 2019 in
Japan.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">69</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">LANI, a long acting
NI for the treatment and prevention of influenza A and B, is
currently marketed as Inavir<sup>®</sup> in Japan by
Daiichi-Sankyo. The patent relating to the structure of LANI
expired in 2017 in the United States, the European Union, or EU,
and Japan, although the product has received patent term extension
in Japan until 2021 for treatment and 2022 for prevention. The
patent relating to hydrates and the crystalline form of LANI
actually used in the product expires in 2021 (not including
extensions) in the United States and EU and in 2024 in Japan. In
February 2015, a patent containing claims relevant to the
manufacture of Inavir<sup>®</sup> was issued in Japan and expires
in December 2029. The dry-powder inhaler device patent portfolio,
which includes TwinCaps<sup>®</sup>, is owned by Hovione
International Limited, or Hovione, and is exclusively licensed to
Daiichi Sankyo and us worldwide for the prevention and treatment of
influenza and other influenza-like viral infections. These patents
will expire in 2029 in the United States, and in 2027 in the
European Union and Japan. <font style="COLOR:#212121">On Feb 23,
2018 Osaka-based</font> <font style=
"COLOR:#212121">drugmaker</font> <font style=
"COLOR:#212121">Shionogi &amp; Co gained marketing approval
for</font> <font style="COLOR:#212121">Xofluza</font><font style=
"COLOR:#212121">, a new drug to treat influenza in Japan. The drug
was approved for use against type A and B influenza viruses and
requires only a single dose regardless of age.</font> <font style=
"COLOR:#212121">Xofluza</font> <font style="COLOR:#212121">may gain
significant market share from</font> Inavir<sup>®</sup>
<font style="COLOR:#212121">in Japan, substantially reducing the
sales of</font> Inavir<sup>®</sup><font style="COLOR:#212121">.
This may significantly decrease the royalty payments we receive
from Daiichi Sankyo.</font></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Vapendavir is an oral
antiviral picornavirus capsid binder that we are developing to
treat HRV infections, although this project is presently inactive.
We exclusively own the vapendavir patent portfolio. Issued claims
under this portfolio will begin to expire in some countries in
December 2021, not including extensions. Claims from patents
related to a comparably bioavailable compound comprising an
anhydrous crystalline free base form of vapendavir and the
preferred commercialization form of vapendavir have been allowed in
the United States and other countries and extend intellectual
property to 2034 without extensions.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Teslexivir is a
direct-acting antiviral that we are developing as a topical
treatment for genital warts caused by HPV 6 and 11, which together
comprise more than 95% of cases. The patent containing composition
of matter claims expires in the United States in 2029 without
extensions. A United States patent with claims to method of use
have been issued and will expire in 2033 without extensions.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We also own a patent
portfolio focused on developing oral antivirals for RSV. Issued
patent claims covering the Enzaplatovir composition of matter will
begin to expire in 2031 without extensions.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Patent rights may not
provide us with adequate proprietary protection or competitive
advantages against competitors with or developing similar
technologies or approaches to ours. The laws of certain foreign
countries do not protect intellectual property rights to the same
extent as do the laws of the United States, and certain countries
may lack adequate rules and procedures for defending our
intellectual property rights. For example, we may not be able to
prevent a third-party from infringing our patents in a country that
does not recognize or enforce patent rights, or that imposes
compulsory licenses on, or restricts the prices of, drugs. Changes
in either patent laws or in interpretations of patent laws in the
United States and other countries may diminish the value of our
intellectual property. We may need to in-license certain
technologies to successfully develop and commercialize our product
candidates. We may not develop or obtain rights to products or
processes that are patentable. Even if we, or our licensors, do
obtain patents, such patents may not adequately protect the
products or technologies licensed, or may otherwise be limited in
scope. In addition, we may not have total control over the patent
prosecution of subject matter that we license from others.
Accordingly, we may be unable to exercise the same degree of
control over this intellectual property as we would over our own.
Others may challenge, seek to invalidate, infringe or circumvent
any pending or issued patents we own or license, and rights we
receive under those issued patents may not provide us with
competitive advantages. There can be no assurance of the degree of
protection that will be afforded by any of our issued or pending
patents, or those we license.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">There can be no
assurance that any patents will be issued from the patent
applications we own or have licensed or, should any patents be
issued, that we will be provided with adequate protection against
potentially competitive products. Furthermore, we cannot be sure
that patents issued or licensed to us will be of any commercial
value, or that private parties or competitors will not successfully
challenge these patents or circumvent our patent position in the
United States or abroad. In the absence of adequate patent
protection, our business may be adversely affected by competitors
who develop comparable technology or products.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">70</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*We may be
involved in lawsuits to protect or enforce our patents, the patents
of our licensors or our other intellectual property rights, which
could be expensive, time consuming and unsuccessful.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Competitors may
infringe or otherwise violate our patents, the patents of our
licensors or our other intellectual property rights. To counter
infringement or unauthorized use, we may be required to file legal
claims, which can be expensive and time-consuming. In addition, in
an infringement proceeding, a court may decide that a patent of
ours or our licensors is not valid, or is unenforceable, or may
refuse to stop the other party from using the technology at issue
on the grounds that such patents do not cover the technology in
question. An adverse result in any litigation or defense
proceedings could put one or more of our patents at risk of being
invalidated or interpreted narrowly and could put our patent
applications at risk of not issuing. The initiation of a claim
against a third-party may also cause the third-party to bring
counter claims against us such as claims asserting that our patents
are invalid or unenforceable. In patent litigation in the United
States, defendant counterclaims alleging invalidity or
unenforceability are commonplace. Grounds for a validity challenge
could be an alleged failure to meet any of several statutory
requirements, including lack of novelty, obviousness,
non-enablement or lack of statutory subject matter. Grounds for an
unenforceability assertion could be an allegation that someone
connected with prosecution of the patent withheld relevant material
information from the USPTO, or made a materially misleading
statement, during prosecution. Third parties may also raise similar
validity claims before the USPTO in post-grant proceedings such as
inter partes review, or post-grant review, or oppositions or
similar proceedings outside the United States, in parallel with
litigation or even outside the context of litigation. The outcome
following legal assertions of invalidity and unenforceability is
unpredictable. We cannot be certain that there is no invalidating
prior art, of which we and the patent examiner were unaware during
prosecution. For the patents and patent applications that we have
licensed, we may have limited or no right to participate in the
defense of any licensed patents against challenge by a third-party.
If a defendant were to prevail on a legal assertion of invalidity
or unenforceability, we would lose at least part, and perhaps all,
of any future patent protection on our current or future product
candidates. Such a loss of patent protection could harm our
business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We may not be able to
prevent, alone or with our licensors, misappropriation of our
intellectual property rights, particularly in countries where the
laws may not protect those rights as fully as in the United States.
Our business could be harmed if in litigation the prevailing party
does not offer us a license on commercially reasonable terms. Any
litigation or other proceedings to enforce our intellectual
property rights may fail, and even if successful, may result in
substantial costs and distract our management and other
employees.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Furthermore, because
of the substantial amount of discovery required in connection with
intellectual property litigation, there is a risk that some of our
confidential information could be compromised by disclosure during
this type of litigation. There could also be public announcements
of the results of hearings, motions or other interim proceedings or
developments. If securities analysts or investors perceive these
results to be negative, it could have an adverse effect on the
price of our common stock.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*If a third
party claims we are infringing on its intellectual property rights,
we could incur significant expenses, or be prevented from further
developing or commercializing our product candidates, which could
materially harm our business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Our success will
largely depend on our ability to operate without infringing the
patents and other proprietary intellectual property rights of third
parties. This is generally referred to as having the <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">“</font>freedom to
operate.<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">”
</font> The biotechnology and pharmaceutical industries are
characterized by extensive litigation regarding patents and other
intellectual property rights. The defense and prosecution of
intellectual property claims, interference proceedings and related
legal and administrative proceedings, both in the United States and
internationally, involve complex legal and factual questions. As a
result, such proceedings are lengthy, costly and time-consuming,
and their outcome is highly uncertain. We may become involved in
protracted and expensive litigation in order to determine the
enforceability, scope and validity of the proprietary rights of
others, or to determine whether we have the freedom to operate with
respect to the intellectual property rights of others.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Patent applications
in the United States are, in most cases, maintained in secrecy
until approximately 18 months after the patent application is
filed. The publication of discoveries in scientific or patent
literature frequently occurs substantially later than the date on
which the underlying discoveries were made. Therefore, patent
applications relating to product candidates similar to ours may
have already been filed by others without our knowledge. In the
event that a third party has also filed a patent application
covering our product candidate or other claims, we may have to
participate in an adversarial proceeding, known as an interference
proceeding, in the USPTO, or similar proceedings in other
countries, to determine the priority of invention. In the event an
infringement claim is brought against us, we may be required to pay
substantial legal fees and other expenses to defend such a claim
and, should we be unsuccessful in defending the claim, we may be
prevented from pursuing the development and commercialization of a
product candidate and may be subject to injunctions and/or damage
awards.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">71</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="left"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">In the future, the
USPTO or a foreign patent office may grant patent rights to our
product candidates or other claims to third parties. Subject to the
issuance of these future patents, the claims of which will be
unknown until issued, we may need to obtain a license or sublicense
to these rights in order to have the appropriate freedom to further
develop or commercialize them. Any required licenses may not be
available to us on acceptable terms, if at all. If we need to
obtain such licenses or sublicenses, but are unable to do so, we
could encounter delays in the development of our product
candidates, or be prevented from developing, manufacturing and
commercializing our product candidates at all. If it is determined
that we have infringed an issued patent and do not have the freedom
to operate, we could be subject to injunctions, and/or compelled to
pay significant damages, including punitive damages. In cases where
we have in-licensed intellectual property, our failure to comply
with the terms and conditions of such agreements could harm our
business.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">It is becoming common
for third parties to challenge patent claims on any successfully
developed product candidate or approved drug. If we or our
licensees or collaborators become involved in any patent
litigation, interference or other legal proceedings, we could incur
substantial expense, and the efforts and attention of our technical
and management personnel could be significantly diverted. A
negative outcome of such litigation or proceedings may expose us to
the loss of our proprietary position or to significant liabilities
or require us to seek licenses that may not be available from third
parties on commercially acceptable terms, if at all. We may be
restricted or prevented from developing, manufacturing and selling
our product candidates in the event of an adverse determination in
a judicial or administrative proceeding, or if we fail to obtain
necessary licenses.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:13px" align="left">
<b><i>Obtaining and maintaining our patent protection depends on
compliance with various procedures, document submission, fee
payment and other requirements imposed by governmental patent
agencies, and our patent protection could be reduced or eliminated
for non-compliance with these requirements.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Periodic maintenance
fees on any issued patent are due to be paid to the USPTO and
foreign patent agencies in several stages over the lifetime of the
patent. The USPTO and various foreign governmental patent agencies
require compliance with a number of procedures, documentary fee
payments and other provisions during the patent application
process. While an inadvertent lapse can in many cases be cured by
payment of a late fee or by other means in accordance with the
applicable rules, there are situations in which noncompliance can
result in abandonment or lapse of the patent or patent application,
resulting in partial or complete loss of patent rights in the
relevant jurisdiction. Non-compliance events that could result in
abandonment or lapse of a patent or patent application include, but
are not limited to, failure to respond to official actions within
prescribed time limits, non-payment of fees and failure to properly
legalize and submit formal documents. If we and our licensors fail
to maintain the patents and patent applications covering our
product candidates, our competitive position would be adversely
affected.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px"><b><i>*Changes in
U.S. patent law could diminish the value of patents in general,
thereby impairing our ability to protect our product
candidates.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">The United States has
recently enacted and implemented wide-ranging patent reform
legislation. The United States Supreme Court has ruled on several
patent cases in recent years, either narrowing the scope of patent
protection available in certain circumstances or weakening the
rights of patent owners in certain situations. In addition to
increasing uncertainty with regard to our ability to obtain patents
in the future, this combination of events has created uncertainty
with respect to the value of patents, once obtained. Depending on
actions by the U.S. Congress, the federal courts, and the USPTO,
the laws and regulations governing patents could change in
unpredictable ways that would weaken our ability to obtain new
patents or to enforce patents that we have licensed or that we
might obtain in the future.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*We may not be able to protect our intellectual property
rights throughout the world, which could impair our
business.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Filing, prosecuting
and defending patents covering our product candidates throughout
the world would be prohibitively expensive. Competitors may use our
technologies in jurisdictions where we have not obtained patent
protection to develop their own vaccines and, further, may export
otherwise infringing vaccines to territories where we may obtain
patent protection, but where patent enforcement is not as strong as
that in the United States. These vaccines may compete with our
product candidates in jurisdictions where we do not have any issued
or licensed patents and any future patent claims or other
intellectual property rights may not be effective or sufficient to
prevent them from so competing.</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center">72</p>
<p style="MARGIN-BOTTOM:0px; MARGIN-TOP:0px; PADDING-BOTTOM:0px"
align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><a href=
"#TOC">Table of Contents</a></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left"><b><i>We
may be subject to claims that our employees have wrongfully used or
disclosed alleged trade secrets of their former
employers.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">Many of our
employees, including our senior management, were previously
employed at other biotechnology or pharmaceutical companies. These
employees typically executed proprietary rights, non-disclosure and
non-competition agreements in connection with their previous
employment. Although we try to ensure that our employees do not use
the proprietary information or know-how of others in their work for
us, we may be subject to claims that it or these employees have
used or disclosed intellectual property, including trade secrets or
other proprietary information, of any such employee<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s former
employer. We are not aware of any threatened or pending claims
related to these matters, but in the future litigation may be
necessary to defend against such claims. If we fail in defending
any such claims, in addition to paying monetary damages, we may
lose valuable intellectual property rights or personnel. Even if we
are successful in defending against such claims, litigation could
result in substantial costs and be a distraction to
management<b>.</b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="left">
<b><i>*Our reliance on third parties requires us to share our trade
secrets, which increases the possibility that a competitor will
discover them or that our trade secrets will be misappropriated or
disclosed.</i></b></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px">We seek to protect
our proprietary technology in part by entering into confidentiality
agreements with third parties and, if applicable, material transfer
agreements, consulting agreements or other similar agreements with
our advisors, employees, third-party contractors and consultants
prior to beginning research or disclosing proprietary information.
These agreements typically limit the rights of the third parties to
use or disclose our confidential information, including our trade
secrets. Despite the contractual provisions employed when working
with third parties, the need to share trade secrets and other
confidential information increases the risk that such trade secrets
become known by our competitors, are inadvertently incorporated
into the technology of others, or are disclosed or used in
violation of these agreements. Given that our proprietary position
is based, in part, on our know-how and trade secrets, a
competitor<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s discovery
of our trade secrets or other unauthorized use or disclosure would
impair our competitive position and may have an adverse effect on
our business and results of operations.</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">In
addition, these agreements typically restrict the ability of our
advisors, employees, third-party contractors and consultants to
publish data potentially relating to our trade secrets, although
our agreements may contain certain limited publication rights.
Despite our efforts to protect our trade secrets, our competitors
may discover our trade secrets, either through breach of our
agreements with third parties, independent development, or
publication of information by any of our third-party collaborators.
A competitor<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s discovery
of our trade secrets would impair our competitive position and have
an adverse impact on our business.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">
<b>Item 2.</b></p>
<p style="MARGIN:0px; TEXT-INDENT:-2px" align="justify"><b><a name=
"SALE" id="SALE">Unregistered Sales of Equity Securities and Use of
Proceeds</a></b></p>
<p style="CLEAR:left; MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">On
March 12, 2018 Sean Tucker, Ph.D., our Chief Scientific Officer,
exercised options to purchase 2,013 shares of our common stock at
$6.49 per share. The exercise was exempt pursuant to Exchange Act
Rule 16b-3 as it was a discretionary transaction made pursuant to a
benefit plan. The exercise was done at the volition of Dr. Tucker,
a recipient of grants made under our Amended and Restated 2007
Equity Incentive Plan. The exercise was not made in connection with
Dr. Tucker<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s death,
disability, retirement or termination of employment. The exercise
was not required to be made available to Dr. Tucker pursuant to any
provision of the Internal Revenue Code. The exercise resulted in a
cash distribution funded by a volitional disposition of the equity
security.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">
<b>Item 3.</b></p>
<p style="MARGIN:0px; TEXT-INDENT:-2px" align="justify"><b><a name=
"DEF" id="DEF">Defaults Upon Senior Securities</a></b></p>
<p style="CLEAR:left; MARGIN:0px; TEXT-INDENT:639px">&nbsp;</p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">Not
applicable.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">
<b>Item 4.</b></p>
<p style="MARGIN:0px; TEXT-INDENT:-2px" align="justify"><b><a name=
"MINE" id="MINE">Mine Safety Disclosures</a></b></p>
<p style="CLEAR:left; MARGIN:0px"><br /></p>
<p style="MARGIN-BOTTOM:13px; MARGIN-TOP:0px" align="justify">Not
applicable.</p>
<p style="MARGIN:0px" align="justify"><br /></p>
<p style=
"MARGIN-BOTTOM:-2px; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">
<b>Item 5.</b></p>
<p style="MARGIN:0px; TEXT-INDENT:-2px" align="justify"><b><a name=
"OIN" id="OIN">Other Matters</a></b></p>
<p style="CLEAR:left; MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="justify">Not applicable.</p>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">73</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px"><a href="#TOC">Table of Contents</a></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><b>Item&nbsp;6.&nbsp;&nbsp;<a name="EXH" id=
"EXH">Exhibits</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px; LINE-HEIGHT:14.4pt" align="left"><br /></p>
<table width="720" bordercolor="transparent" style="WIDTH:720px"
cellspacing="0">
<tr>
<td></td>
<td style="VERTICAL-ALIGN:bottom" valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">&nbsp;</p>
</td>
<td colspan="4" style=
"VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid" align=
"center" valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Incorporated
by Reference</b></p>
</td>
</tr>
<tr>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit<br />
Number</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px"><b>Description of
Document</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Schedule/Form</b></p>
</td>
<td style="BORDER-BOTTOM:#000000 1px solid">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>File<br />
Number</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Filing
Date</b></p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td width="53" style="WIDTH:53px; VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.1</p>
</td>
<td width="278" style="WIDTH:278px; VERTICAL-ALIGN:top" valign=
"top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/avir20171220_s4a.htm">
Agreement and Plan of Merger and Reorganization dated October 27,
2017, by and among Aviragen Therapeutics, Inc., Vaxart, Inc. and
Agora Merger Sub, Inc. (included as Annex A to the proxy
statement/prospectus/information statement forming a part of this
registration statement).</a></p>
</td>
<td width="88" style="WIDTH:88px; VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4</p>
</td>
<td width="83" style="WIDTH:83px; VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="58" style="WIDTH:58px; VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.1</p>
</td>
<td width="108" style="WIDTH:108px; VERTICAL-ALIGN:top" valign=
"top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.2</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774918001951/ex_104594.htm">
Amendment No. 1 to Agreement and Plan of Merger and Reorganization
dated February 7, 2018 by and among Aviragen Therapeutics, Inc.,
Vaxart, Inc. and Agora Merger Sub, Inc.</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.1</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">February 7,
2018</p>
</td>
</tr>
<tr>
<td style="VERTICAL-ALIGN:top; TEXT-ALIGN:left" align="center"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.3</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774915009555/ex2-1.htm">
Stock Purchase Agreement dated February 25, 2015, among Biota
Pharmaceuticals, Inc., each of the shareholders of Anaconda Pharma
party thereto and the Holder Representative thereunder</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">2.1</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 8, 2015</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.1</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774916038645/ex3-1.htm">
<u>Restated Certificate of Incorporation of Aviragen Therapeutics,
Inc.</u></a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.1</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">September 13,
2016</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.2</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex31.htm">
Certificate of Amendment to Restated Certificate of Incorporation
of Aviragen Therapeutics, Inc.</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.1</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">February 20,
2018</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.3</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000119312518049470/d536843dex32.htm">
Certificate of Amendment to Restated Certificate of Incorporation
of Vaxart, Inc.</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.2</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">February 20,
2018</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.4</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774916038645/ex3-2.htm">
<u>Restated By-laws of Aviragen Therapeutics, Inc.</u></a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">3.2</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">September 13,
2016</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1+</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-5.htm">
Collaboration and License Agreement dated September 29, 2003,
between Biota Holdings Limited and Sankyo Co., Ltd.</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.5</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 10,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.2+</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-6.htm">
<u>Amendment #1 to Collaboration and License Agreement dated June
30, 2005, between Biota Holdings Limited, Biota Scientific
Management Pty. Ltd. and Sankyo Company, Ltd.</u></a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.6</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 10,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.3</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-7.htm">
Amendment #2 to Collaboration and License Agreement, dated March
27, 2009, between Biota Holdings Limited, Biota Scientific
Management Pty. Ltd. and Daiichi Sankyo Company, Limited</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.7</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 10,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.4+</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-8.htm">
<u>Commercialization Agreement dated March 27, 2009, between Biota
Holdings Limited, Biota Scientific Management Pty. Ltd and Daiichi
Sankyo Company, Ltd.</u></a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.8</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 10,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.5+</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005823/ex10-9.htm">
Contract dated March 31, 2011, between Biota Scientific Management
Pty. Ltd. and Office of Biomedical Advanced Research and
Development Authority within the Office of the Assistant Secretary
for preparedness and Response at the U.S. Department of Health and
Human Services</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.9</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 10,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.6+</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913012393/ex10-6.htm">
Research and License Agreement dated February 21, 1990, by and
among Biota Scientific Management Pty. Ltd., Biota Holdings
Limited, Glaxo Australia Pty. Ltd. and Glaxo Group Limited</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.6</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">September 27,
2013</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.7</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913005361/bota20130506_8kex10-1.htm">
<u>Form of Indemnification Agreement for Directors and Executive
Officers</u></a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 6, 2013</p>
</td>
</tr>
<tr>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
10.8<font style="FONT-SIZE:12pt">#</font></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774915002008/ex10-18.htm">
<u>Employment Agreement, dated as of October 1, 2014, between Biota
Pharmaceuticals, Inc., and Russell H. Plumb</u></a></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.18</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">February 6,
2015</p>
</td>
</tr>
<tr>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
10.9<font style="FONT-SIZE:12pt">#</font></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774915002008/ex10-17.htm">
<u>Amended Executive Employment Agreement, dated as of October 1,
2014, between Biota Pharmaceuticals, Inc., and Joseph M.
Patti</u></a></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.17</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">February 6,
2015</p>
</td>
</tr>
<tr>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
10.10<font style="FONT-SIZE:12pt">#</font></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000119312512471037/d439059dex103.htm">
<u>Form Non-Plan Stock Units Agreement</u></a></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.3</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">November 14,
2012</p>
</td>
</tr>
</table>
<p style="MARGIN:0px" align="justify">&nbsp;</p>
<p style="MARGIN:0px" align="center">74</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<br />
<p style="MARGIN:0px"><a href="#TOC">Table of
Contents</a><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"></p>
<table width="720" bordercolor="transparent" style=
"FONT-SIZE:10pt; WIDTH:720px; MARGIN-TOP:0px" cellpadding="0"
cellspacing="0" align="left">
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">&nbsp;</p>
</td>
<td width="327" colspan="4" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Incorporated
by Reference</b></p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit<br />
Number</b></p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px"><b>Description of
Document</b></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Schedule/Form</b></p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>File<br />
Number</b></p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit</b></p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Filing
Date</b></p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
10.11<font style="FONT-SIZE:12pt">#</font></p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000119312512471037/d439059dex104.htm">
Form of Letter Agreement for Stock Option Grant</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.4</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">November 14,
2012</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.12#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000119312507079679/ddef14a.htm">
2007 Omnibus Equity and Incentive Plan (included as Appendix A to
the proxy statement)</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">DEF 14A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">000-04829</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">-</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">April 12,
2007</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.13#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913015475/ex10-1.htm">
Executive Employment Agreement, dated as of November 26, 2013,
between Biota Pharmaceuticals, Inc., and Peter Azzarello</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">November 27,
2013</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.14#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913015786/ex10-1.htm">
Form of Employee Stock Option Agreement under the 2007 Omnibus
Equity and Incentive Plan</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 10,
2013</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.15#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774913015786/ex10-2.htm">
Form of Market-Based Stock Unit Award Agreement under the 2007
Omnibus Equity and Incentive Plan</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.2</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 10,
2013</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.16#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774915019294/ex10-1.htm">
<u>Executive Employment Agreement, effective as of November 2,
2015, between Biota Pharmaceuticals, Inc. and Mark
Colonnese</u></a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">November 2,
2015</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.17+</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774916029948/ex10-1.htm">
<u>Royalty Interest Acquisition Agreement by and between Aviragen
Therapeutics, Inc., Biota Holdings Pty Ltd, Biota Scientific
Management Pty. Ltd. and HealthCare Royalty Partners III, L.P.
dated April 22, 2016</u></a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">April 26,
2016</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.18</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774916029948/ex10-2.htm">
Protective Rights Agreement between Aviragen Therapeutics, Inc. and
HealthCare Royalty Partners III, L.P. dated April 22, 2016</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 8-K</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.2</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">April 26,
2016</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.19#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917008297/ex10-1.htm">
Form of Employee Stock Option Agreement under the 2016 Equity
Incentive Plan</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form 10-Q</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.1</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">May 8, 2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.20#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774916039160/bota20160927_def14a.htm">
2016 Equity Incentive Plan (included as Appendix A to the proxy
statement)</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">DEF 14A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">001-35285</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">-</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">September 27,
2016</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.21#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917020581/ex_101915.htm">
<u>Director Stock Option Grant Form</u></a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.22</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 12,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.22</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102434.htm">
Form of Indemnity Agreement by and between Vaxart, Inc. and its
directors and officers</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.23</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.23#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102435.htm">
Vaxart, Inc. Amended and Restated 2007 Equity Incentive Plan, Stock
Option Agreement, form of Notice of Stock Option Grant, form of
Additional Terms and Conditions to Option and Stock Option Exercise
Agreement</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.24</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.24#</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102447.htm">
Offer Letter, dated May 25, 2011, and Amendment to Offer Letter and
Option Grant Agreement, dated October 1, 2011, by and between
Vaxart, Inc. and Wouter W. Latour, M.D.</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.25</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.25</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102448.htm">
<u>Industrial Lease dated October 28, 2013, by and between Vaxart,
Inc. and Oyster Point LLC</u></a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.26</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.26</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102449.htm">
<u>Lease Agreement dated April 17, 2015, by and between Vaxart,
Inc. and CRP Edgewater, LLC</u></a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.27</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.27</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102465.htm">
Loan and Security Agreement dated December 22, 2016, by and between
Vaxart, Inc. and Oxford Finance LLC</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.28</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
<tr>
<td width="50" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.28</p>
</td>
<td width="271" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"http://www.sec.gov/Archives/edgar/data/72444/000143774917021271/ex_102457.htm">
Warrant to Purchase Stock dated December 22, 2016, by and between
Vaxart, Inc. and Oxford Finance LLC</a></p>
</td>
<td width="87" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">Form S-4/A</p>
</td>
<td width="75" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">333-222009</p>
</td>
<td width="52" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">10.29</p>
</td>
<td width="111" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:3px; PADDING-RIGHT:3px"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">December 29,
2017</p>
</td>
</tr>
</table>
<p style="MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">75</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<p style="MARGIN:0px"><a href="#TOC">Table of
Contents</a><br /></p>
<p style="MARGIN:0px">&nbsp;</p>
<p style="MARGIN:0px"></p>
<table width="720" bordercolor="transparent" style="WIDTH:720px"
cellspacing="0">
<tr>
<td></td>
<td style="VERTICAL-ALIGN:bottom" valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px">&nbsp;</p>
</td>
<td colspan="4" style=
"VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid" align=
"center" valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Incorporated
by Reference</b></p>
</td>
</tr>
<tr>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit<br />
Number</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px"><b>Description of
Document</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Schedule/Form</b></p>
</td>
<td style="BORDER-BOTTOM:#000000 1px solid">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>File<br />
Number</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
<b>Exhibit</b></p>
</td>
<td style="VERTICAL-ALIGN:bottom; BORDER-BOTTOM:#000000 1px solid"
valign="bottom">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center"><b>Filing
Date</b></p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td width="53" style="WIDTH:53px; VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">31.1*</p>
</td>
<td width="278" style="WIDTH:278px; VERTICAL-ALIGN:top" valign=
"top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"exhibit31_1.htm">Certification of Chief Executive Officer pursuant
to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</a></p>
</td>
<td width="88" style="WIDTH:88px; VERTICAL-ALIGN:top" valign="top">
</td>
<td width="83" style="WIDTH:83px; VERTICAL-ALIGN:top" valign="top">
</td>
<td width="58" style="WIDTH:58px; VERTICAL-ALIGN:top" valign="top">
</td>
<td width="108" style="WIDTH:108px; VERTICAL-ALIGN:top" valign=
"top"></td>
</tr>
<tr>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">31.2*</p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"exhibit31_2.htm">Certification of Chief Financial Officer pursuant
to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td></td>
<td></td>
</tr>
<tr>
<td style="VERTICAL-ALIGN:top; TEXT-ALIGN:left" align="center"
valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
32.1*<font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'>§</font></p>
</td>
<td>
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"exhibit32_1.htm">Certification of Principal Executive Officer and
Principal Financial Officer pursuant to Rule 13a-14(b) of the
Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">
32.2*<font style=
'FONT-SIZE:10pt; FONT-FAMILY:"Times New Roman",serif'>§</font></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px"><a href=
"exhibit32_2.htm">Certification of Principal Financial Officer and
Principal Financial Officer pursuant to Rule 13a-14(b) of the
Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002</a></p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">101 *</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px">The following financial
information from the Company<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">’</font>s Quarterly
Report on Form&nbsp;10-Q for the period ended March&nbsp;31, 2018,
formatted in Extensible Business Reporting Language (XBRL): (i) the
Condensed Consolidated Balance Sheets as of March&nbsp;31, 2018 and
December&nbsp;31, 2017, (ii) the Condensed Consolidated Statements
of Operations and Comprehensive Income (Loss) for the three months
ended March&nbsp;31, 2018 and 2017, (iii) the Condensed
Consolidated Statements of Cash Flows for the three months ended
March&nbsp;31, 2018 and 2017, and (iv) Notes to the Condensed
Consolidated Financial Statements</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">*</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px">Filed herewith</p>
</td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
<td style="VERTICAL-ALIGN:top" valign="top"></td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">#</p>
</td>
<td colspan="5" style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px">Management contract or
compensation plan or arrangement.</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px" align="center">+</p>
</td>
<td colspan="5" style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px">Confidential portions of this
exhibit have been omitted and filed separately with the Commission
pursuant to confidential treatment granted under Rule 24b-2
promulgated under the Exchange Act.</p>
</td>
</tr>
<tr style="VERTICAL-ALIGN:top" valign="top">
<td style="VERTICAL-ALIGN:top" valign="top">
<p style="MARGIN:0px" align="center">§</p>
</td>
<td colspan="5" style="VERTICAL-ALIGN:top" valign="top">
<p style="FONT-SIZE:9pt; MARGIN:0px">In accordance with Item
601(b)(32)(ii) of Regulation S-K and SEC Release Nos. 33-8238 and
34-47986, Final Rule: Management's Reports on Internal Control Over
Financial Reporting and Certification of Disclosure in Exchange Act
Periodic Reports, the certifications furnished in Exhibits 32.1 and
32.2 hereto are deemed to accompany this Quarterly Report on Form
10-Q and will not be deemed <font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">
“</font>filed<font style=
"FONT-FAMILY:Arial Unicode MS,Times New Roman">”</font> for
purposes of Section 18 of the Exchange Act. Such certifications
will not be deemed to be incorporated by reference into any filing
under the Securities Act or the Exchange Act, except to the extent
that the registrant specifically incorporates it by reference.</p>
</td>
</tr>
</table>
<br />
<p style="MARGIN:0px" align="justify">__________</p>
<p style="MARGIN:0px" align="center">76</p>
<p style="MARGIN:0px" align="center"></p>
<hr />
<div style="PAGE-BREAK-BEFORE: always"></div>
<a href="#TOC">Table of Contents</a><br />
<br />
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center"><b><a name="SIGN" id=
"SIGN">SIGNATURES</a></b></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<table bordercolor="transparent" style=
"FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0">
<tr style="FONT-SIZE:0px">
<td width="264"></td>
<td width="30"></td>
<td width="211"></td>
<td width="95"></td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">VAXART, INC.</p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Dated: May&nbsp;15, 2018</p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">By:&nbsp;&nbsp;/s/&nbsp;WOUTER W. LATOUR</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Wouter W. Latour</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">President and Chief Executive Officer</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">(Principal Executive Officer)</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px"><br /></p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Dated: May&nbsp;15, 2018</p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; BORDER-BOTTOM:#000000 1px solid; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">By:&nbsp;&nbsp;/s/&nbsp;JOHN M. HARLAND</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">John M. Harland</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">Chief Financial Officer</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
<tr>
<td width="264" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="30" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
<td width="211" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px">(Principal Financial Officer)</p>
</td>
<td width="95" style=
"MARGIN-TOP:0px; PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; PADDING-RIGHT:0px"
valign="top">
<p style="MARGIN:0px"><br /></p>
</td>
</tr>
</table>
<p style="MARGIN:0px"><br /></p>
<p style="MARGIN:0px" align="center">&nbsp;</p>
<p style="MARGIN:0px" align="center">77</p>
<!-- EDGAR Validation Code: BBA36898 -->
</body>
</html>

